{
    "paper_id": "xml_output_cochrane\\Ayeleke_et_al-2020-Cochrane_Database_of_Systematic_Reviews",
    "header": {
        "generated_with": "S2ORC 1.0.0",
        "date_generated": "2024-04-05T17:20:05.595964Z"
    },
    "title": "Intra-uterine insemination for unexplained subfertility",
    "authors": [
        {
            "first": "Reuben",
            "middle": [
                "Olugbenga"
            ],
            "last": "Ayeleke",
            "suffix": "",
            "affiliation": {},
            "email": ""
        },
        {
            "first": "Joyce",
            "middle": [
                "Danielle"
            ],
            "last": "Asseler",
            "suffix": "",
            "affiliation": {},
            "email": ""
        },
        {
            "first": "Ben",
            "middle": [
                "J"
            ],
            "last": "Cohlen",
            "suffix": "",
            "affiliation": {},
            "email": ""
        },
        {
            "first": "Susanne",
            "middle": [
                "M"
            ],
            "last": "Veltman-Verhulst",
            "suffix": "",
            "affiliation": {},
            "email": ""
        }
    ],
    "year": "",
    "venue": null,
    "identifiers": {},
    "abstract": "",
    "pdf_parse": {
        "paper_id": "xml_output_cochrane\\Ayeleke_et_al-2020-Cochrane_Database_of_Systematic_Reviews",
        "_pdf_hash": "",
        "doi": "10.1002/14651858.cd001838.pub6",
        "keywords": [],
        "abstract": [],
        "body_text": [
            {
                "text": "To determine whether, for couples with unexplained subfertility, the live birth rate is improved following IUI treatment with or without OH compared to timed intercourse (TI) or expectant management with or without OH, or following IUI treatment with OH compared to IUI in a natural cycle.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Objectives",
                "sec_num": null
            },
            {
                "text": "We searched the Cochrane Gynaecology and Fertility (CGF) Group trials register, CENTRAL, MEDLINE, Embase, PsycINFO, CINAHL and two trials registers up to 17 October 2019, together with reference checking and contact with study authors for missing or unpublished data.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Search methods",
                "sec_num": null
            },
            {
                "text": "Randomised controlled trials (RCTs) comparing IUI with TI or expectant management, both in stimulated or natural cycles, or IUI in stimulated cycles with IUI in natural cycles in couples with unexplained subfertility.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Selection criteria",
                "sec_num": null
            },
            {
                "text": "Two review authors independently performed study selection, quality assessment and data extraction.Primary review outcomes were live birth rate and multiple pregnancy rate.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Data collection and analysis",
                "sec_num": null
            },
            {
                "text": "We include 15 trials with 2068 women.The evidence was of very low to moderate quality.The main limitation was very serious imprecision.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Main results",
                "sec_num": null
            },
            {
                "text": "It is uncertain whether treatment with IUI in a natural cycle improves live birth rate compared to treatment with expectant management in a natural cycle (odds ratio (OR) 1.60, 95% confidence interval (CI) 0.92 to 2.78; 1 RCT, 334 women; low-quality evidence).If we assume the chance of a live birth with expectant management in a natural cycle to be 16%, that of IUI in a natural cycle would be between 15%",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "IUI in a natural cycle versus timed intercourse or expectant management in a natural cycle",
                "sec_num": null
            },
            {
                "text": "It is uncertain whether treatment with IUI in a stimulated cycle improves live birth rates compared to treatment with TI in a stimulated cycle (OR 1.59, 95% CI 0.88 to 2.88; 2 RCTs, 208 women; I 2 = 72%; low-quality evidence).If we assume the chance of achieving a live birth with TI in a stimulated cycle was 26%, the chance with IUI in a stimulated cycle would be between 23% and 50%.It is uncertain whether treatment with IUI in a stimulated cycle reduces multiple pregnancy rates compared to control (OR 1.46, 95% CI 0.55 to 3.87; 4 RCTs, 316 women; I 2 = 0%; low-quality evidence).",
                "cite_spans": [
                    {
                        "start": 529,
                        "end": 534,
                        "text": "3.87;",
                        "ref_id": null
                    },
                    {
                        "start": 535,
                        "end": 542,
                        "text": "4 RCTs,",
                        "ref_id": null
                    },
                    {
                        "start": 543,
                        "end": 546,
                        "text": "316",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "IUI in a stimulated cycle versus timed intercourse or expectant management in a stimulated cycle",
                "sec_num": null
            },
            {
                "text": "In couples with a low prediction score of natural conception, treatment with IUI combined with clomiphene citrate or letrozole probably results in a higher live birth rate compared to treatment with expectant management in a natural cycle (OR 4.48, 95% CI 2.00 to 10.01; 1 RCT; 201 women; moderate-quality evidence).If we assume the chance of a live birth with expectant management in a natural cycle was 9%, the chance of a live birth with IUI in a stimulated cycle would be between 17% and 50%.It is uncertain whether treatment with IUI in a stimulated cycle results in a lower multiple pregnancy rate compared to control (OR 3.01, 95% CI 0.47 to 19.28; 2 RCTs, 454 women; I 2 = 0%; low-quality evidence).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "IUI in a stimulated cycle versus timed intercourse or expectant management in a natural cycle",
                "sec_num": null
            },
            {
                "text": "Treatment with IUI in a natural cycle probably results in a higher cumulative live birth rate compared to treatment with expectant management in a stimulated cycle (OR 1.95, 95% CI 1.10 to 3.44; 1 RCT, 342 women: moderate-quality evidence).If we assume the chance of a live birth with expectant management in a stimulated cycle was 13%, the chance of a live birth with IUI in a natural cycle would be between 14% and 34%.It is uncertain whether treatment with IUI in a natural cycle results in a lower multiple pregnancy rate compared to control (OR 1.05, 95% CI 0.07 to 16.90; 1 RCT, 342 women; low-quality evidence).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "IUI in a natural cycle versus timed intercourse or expectant management in a stimulated cycle",
                "sec_num": null
            },
            {
                "text": "Treatment with IUI in a stimulated cycle may result in a higher cumulative live birth rate compared to treatment with IUI in a natural cycle (OR 2.07, 95% CI 1.22 to 3.50; 4 RCTs, 396 women; I 2 = 0%; low-quality evidence).If we assume the chance of a live birth with IUI in a natural cycle was 14%, the chance of a live birth with IUI in a stimulated cycle would be between 17% and 36%.It is uncertain whether treatment with IUI in a stimulated cycle results in a higher multiple pregnancy rate compared to control (OR 3.00, 95% CI 0.11 to 78.27; 2 RCTs, 65 women; low-quality evidence).",
                "cite_spans": [
                    {
                        "start": 155,
                        "end": 171,
                        "text": "CI 1.22 to 3.50;",
                        "ref_id": null
                    },
                    {
                        "start": 172,
                        "end": 179,
                        "text": "4 RCTs,",
                        "ref_id": null
                    },
                    {
                        "start": 180,
                        "end": 183,
                        "text": "396",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "IUI in a stimulated cycle versus IUI in a natural cycle",
                "sec_num": null
            },
            {
                "text": "Due to insu icient data, it is uncertain whether treatment with IUI with or without OH compared to timed intercourse or expectant management with or without OH improves cumulative live birth rates with acceptable multiple pregnancy rates in couples with unexplained subfertility.However, treatment with IUI with OH probably results in a higher cumulative live birth rate compared to expectant management without OH in couples with a low prediction score of natural conception.Similarly, treatment with IUI in a natural cycle probably results in a higher cumulative live birth rate compared to treatment with timed intercourse with OH.Treatment with IUI in a stimulated cycle may result in a higher cumulative live birth rate compared to treatment with IUI in a natural cycle.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Authors' conclusions",
                "sec_num": null
            },
            {
                "text": "Does treatment with intra-uterine insemination (IUI), with or without fertility drugs, compared to timed intercourse or expectant management (watchful waiting) with or without fertility drugs, or treatment with IUI with fertility drugs compared to IUI without fertility drugs improve live birth rates in couples with unexplained subfertility?Background IUI is a treatment o en used for couples with unexplained subfertility.In an IUI cycle, the male partner's sperm is prepared and placed directly in the womb around the time of ovulation.IUI cycles can be used in combination with fertility drugs to increase the number of available eggs.However, these drugs can have side e ects, and also increase the risk of multiple pregnancies.Expectant management and timed intercourse have also been shown to increase pregnancy rates, resulting in live births.With this review, we would like to enhance decision-making for couples starting treatment for unexplained subfertility.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Review question",
                "sec_num": null
            },
            {
                "text": "For most treatment groups, it is uncertain whether treatment with one IUI treatment type improves cumulative live birth rates (i.e.rates at the end of a course of treatment) with acceptable multiple pregnancy rates when compared to another treatment type.However, there is moderate-quality evidence that, in couples with a low chance of natural conception, treatment with IUI combined with fertility drugs probably improves cumulative live birth rates compared to treatment with expectant management.Similarly, there is moderate-quality evidence that treatment with IUI alone probably improves cumulative live birth rates compared to treatment with expectant management combined with fertility drugs.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Study characteristics",
                "sec_num": null
            },
            {
                "text": "The evidence was of low to moderate quality for cumulative live birth and of low quality for multiple pregnancy.The main limitation of the evidence was a lack of precision in the findings, due to the inclusion of few studies with small sample sizes.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Quality of the evidence",
                "sec_num": null
            },
            {
                "text": "Intra-uterine insemination (IUI) is a commonly-used treatment in couples with unexplained subfertility.IUI is a relatively simple procedure in which semen is 'washed' in the laboratory and inserted in the uterine cavity using a small catheter at the time of ovulation.IUI can be performed with or without drugs for ovarian hyperstimulation (OH).For correct timing of the insemination, cycle monitoring is performed.This is usually done by ultrasound assessment of follicle growth or by monitoring the pre-ovulatory luteinising hormone rise in blood or urine.In hyperstimulated cycles, ovulation is o en induced by an injection of human chorionic gonadotropin (hCG), which improves timing possibilities.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Description of the intervention",
                "sec_num": null
            },
            {
                "text": "In contrast to IUI procedure, with expectant management couples either receive cycle monitoring for correct timing of sexual intercourse, i.e. timed intercourse (TI), or no intervention at all.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Description of the intervention",
                "sec_num": null
            },
            {
                "text": "The rationale for performing IUI is that the motile spermatozoa, which are morphologically normal, can be concentrated in a small volume and placed directly into the uterus close to the released oocyte.In this way the cervix, which also acts as a reservoir for sperm, is bypassed.Accurate timing of the insemination is therefore of great importance.IUI can be performed with or without ovarian hyperstimulation (OH).The role of IUI in fertility treatment is o en debated, in particular whether or not it is superior to TI, and whether or not OH should be used at the same time (Cohlen 2005; Hughes 2003; Stewart 2003) .Commonlyused drugs for ovarian hyperstimulation are clomiphene citrate (CC) and aromatase inhibitors, such as letrozole, both of which are oral treatments, and gonadotropins which are administered by subcutaneous injection.The aim of OH is to increase the number of oocytes available for fertilisation and to enhance accurate timing.",
                "cite_spans": [
                    {
                        "start": 577,
                        "end": 590,
                        "text": "(Cohlen 2005;",
                        "ref_id": null
                    },
                    {
                        "start": 591,
                        "end": 603,
                        "text": "Hughes 2003;",
                        "ref_id": null
                    },
                    {
                        "start": 604,
                        "end": 617,
                        "text": "Stewart 2003)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "How the intervention might work",
                "sec_num": null
            },
            {
                "text": "The use of OH in fertility treatment for unexplained subfertility is associated with benefits as well as increased risk of multiple pregnancies.When Hughes 1997 published a meta-analysis indicating that the average fecundability is approximately fivefold higher for treatment with IUI and OH, the Royal College of Obstetricians and Gynaecologists (RCOG 1998) concluded accordingly that \"OH with IUI is an e ective treatment for couples with unexplained infertility\".However, major concerns were raised about the incidence of multiple pregnancies, and OH became less popular.These concerns have resulted in an adjustment of the advice for treatment of couples with unexplained subfertility.The NICE fertility guideline states that \"ovarian hyperstimulation should not be o ered to women with unexplained subfertility\" (NICE 2013).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "How the intervention might work",
                "sec_num": null
            },
            {
                "text": "The increase in multiple pregnancies is a logical consequence of stimulated growth of multiple follicles.The incidence of multiple pregnancies a er treatment with OH and IUI varies between 10% and 40%, and the overall contribution of this treatment to multiple births is estimated to be around 30% (Fauser 2005).However, recent studies have reported lower incidence of multiple pregnancies with OH.For example, a recent randomised controlled trial has reported multiple pregnancy rates of between 1.4% and 2.2% with OH (Danhof 2018) ; rates of between 3% and 10% have also been reported in another trial (Diamond 2015) .The question is whether this multiple pregnancy rate is acceptable or whether it can be reduced to acceptable numbers.Recently, more evidence has been collected showing that mild ovarian hyperstimulation with strict cancellation criteria reduces the risk of achieving multiple pregnancies to approximately 10%, without compromising pregnancy rates (ESHRE 2006; Ragni 2006; Van Rumste 2006) .Because maternal and neonatal morbidity and mortality rates are significantly increased in multiple pregnancies (Fauser 2005; Ombelet 2005 ), caregivers should take extra care to keep the multiple pregnancy rate to a minimum.Couples should be well-informed by their physicians, especially as many couples wish to conceive twins (Ryan 2004 ) and prefer a higher pregnancy chance over safety.",
                "cite_spans": [
                    {
                        "start": 519,
                        "end": 532,
                        "text": "(Danhof 2018)",
                        "ref_id": null
                    },
                    {
                        "start": 604,
                        "end": 618,
                        "text": "(Diamond 2015)",
                        "ref_id": "BIBREF16"
                    },
                    {
                        "start": 968,
                        "end": 980,
                        "text": "(ESHRE 2006;",
                        "ref_id": null
                    },
                    {
                        "start": 981,
                        "end": 992,
                        "text": "Ragni 2006;",
                        "ref_id": null
                    },
                    {
                        "start": 993,
                        "end": 1009,
                        "text": "Van Rumste 2006)",
                        "ref_id": null
                    },
                    {
                        "start": 1123,
                        "end": 1136,
                        "text": "(Fauser 2005;",
                        "ref_id": null
                    },
                    {
                        "start": 1137,
                        "end": 1149,
                        "text": "Ombelet 2005",
                        "ref_id": null
                    },
                    {
                        "start": 1339,
                        "end": 1349,
                        "text": "(Ryan 2004",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "How the intervention might work",
                "sec_num": null
            },
            {
                "text": "Some authors have stated that treatment with OH results in an unacceptably high incidence of high-order multiple pregnancies (Gleicher 2000; Nan 1994) (Balasch 2004 ).As IVF allows better control over reducing the risk of a multiple pregnancy (Gleicher 2000) , and IVF with single-embryo transfer is becoming more accepted, it has been argued that IVF is a safer treatment option than IUI with OH.",
                "cite_spans": [
                    {
                        "start": 125,
                        "end": 140,
                        "text": "(Gleicher 2000;",
                        "ref_id": "BIBREF19"
                    },
                    {
                        "start": 141,
                        "end": 150,
                        "text": "Nan 1994)",
                        "ref_id": null
                    },
                    {
                        "start": 151,
                        "end": 164,
                        "text": "(Balasch 2004",
                        "ref_id": null
                    },
                    {
                        "start": 243,
                        "end": 258,
                        "text": "(Gleicher 2000)",
                        "ref_id": "BIBREF19"
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "How the intervention might work",
                "sec_num": null
            },
            {
                "text": "Although ovarian hyperstimulation seems to result in higher pregnancy rates, it also increases the risk of multiple pregnancies and ovarian hyperstimulation syndrome (OHSS",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Why it is important to do this review",
                "sec_num": null
            },
            {
                "text": "Criteria for considering studies for this review",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "M E T H O D S",
                "sec_num": null
            },
            {
                "text": "Published and unpublished randomised controlled trials (RCTs) were eligible for inclusion.We excluded non-randomised studies (e.g.studies with evidence of inadequate sequence generation such as alternate days, patient numbers) as they are associated with a high risk of bias.We attempted to contact the author of the study if the randomisation or allocation method was unclear.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of studies",
                "sec_num": null
            },
            {
                "text": "We excluded trials that did not report separate data for women with unexplained subfertility or where such data were not obtainable from the authors.We assessed the trial design (cross-over or parallel) and included cross-over trials if we could extract pre-crossover data.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of studies",
                "sec_num": null
            },
            {
                "text": "I. Couples with unexplained subfertility, defined as follows.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of participants",
                "sec_num": null
            },
            {
                "text": "1. Normal ovulatory status (determined by either biphasic basal body temperature chart, normal luteal progesterone, in-phase endometrial biopsy or ovulation detected with ultrasound).2. Tubal patency (determined by hysterosalpingography or laparoscopy, or both).3. A normal semen sample according to World Health Organization (WHO) criteria current at the time of the trial.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of participants",
                "sec_num": null
            },
            {
                "text": "II. Couples who had tried to conceive for at least one year.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of participants",
                "sec_num": null
            },
            {
                "text": "Participants excluded were: couples with a known cause of infertility including a moderate male factor, moderate to severe endometriosis (according to the American Society for Reproductive Medicine (ASRM) classification), tubal disease, or a cervical factor.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of participants",
                "sec_num": null
            },
            {
                "text": "We contacted study authors to obtain data of couples with unexplained infertility if groups with mixed infertility causes were studied.If we could not extract relevant data separately for included participants, we excluded the study.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of participants",
                "sec_num": null
            },
            {
                "text": "We excluded trials of participants with mild to moderate endometriosis only.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of participants",
                "sec_num": null
            },
            {
                "text": "Trials with at least one of the following comparisons: We included expectant management as a variant of timed intercourse.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of interventions",
                "sec_num": null
            },
            {
                "text": "We excluded the following interventions:",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of interventions",
                "sec_num": null
            },
            {
                "text": "1. intra-cervical insemination, because we consider this to be a di erent treatment modality (Ripps 1994) and it is the topic of another Cochrane Review (Kop 2018); 2. donor insemination.We excluded pregnancies confirmed only by detection of hCG in serum or urine (biochemical pregnancies).When pregnancy was not further defined, and remained unclear even a er contacting the authors, we assumed the pregnancy to be clinical.",
                "cite_spans": [
                    {
                        "start": 93,
                        "end": 105,
                        "text": "(Ripps 1994)",
                        "ref_id": "BIBREF50"
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of interventions",
                "sec_num": null
            },
            {
                "text": "We searched for all reports which describe (or might describe) randomised controlled trials of IUI with or without OH, in couples with unexplained infertility.The original search was performed in 2005 and was last updated in October 2019, in consultation with the Gynaecology and Fertility Group (CGF) Information Specialist.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Search methods for identification of studies",
                "sec_num": null
            },
            {
                "text": "We searched:",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Electronic searches",
                "sec_num": null
            },
            {
                "text": "We handsearched reference lists of articles retrieved by the search and contacted experts in the field to obtain additional data.We also handsearched relevant journals and conference abstracts that were not covered in the Cochrane Gynaecology and Fertility register, in liaison with the Information Specialist.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Searching other resources",
                "sec_num": null
            },
            {
                "text": "A er an initial screening of titles and abstracts produced by the search, we retrieved the full texts of all potentially eligible studies.Two review authors (ROA and JDA) independently examined these full-text articles for compliance with the inclusion criteria and selected studies eligible for inclusion in the 2020 update.We contacted study investigators as required, to clarify study eligibility.We resolved any disagreements about study eligibility by discussion.We documented the selection process with a 'PRISMA' flow chart (Liberati 2009) .",
                "cite_spans": [
                    {
                        "start": 531,
                        "end": 546,
                        "text": "(Liberati 2009)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Selection of studies",
                "sec_num": null
            },
            {
                "text": "Two review authors (ROA and JDA) independently extracted data from eligible studies using a data extraction form designed and pilot-tested by the review authors, resolving any disagreements by discussion.Data extracted included study characteristics and outcome data.Where studies had multiple publications the review authors collated multiple reports of the same study, so that each study, rather than each report, was the unit of interest in the review, and such studies had a single study ID with multiple references.We contacted study investigators for further data on methods or results, or both, as required.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Data extraction and management",
                "sec_num": null
            },
            {
                "text": "Two review authors (ROA and JDA) independently assessed the included studies for risks of bias using the Cochrane 'Risk of bias' assessment tool (Higgins 2017) to assess: selection bias (random sequence generation and allocation concealment); performance bias (blinding of participants and personnel); detection bias (blinding of outcome assessors); attrition bias (incomplete outcome data); reporting bias (selective reporting); and other potential bias.We resolved disagreements by discussion or by involving a third review author.We described all judgements fully in the 'Risk of bias' table for each included study and incorporated our judgements into the interpretation of the review findings.",
                "cite_spans": [
                    {
                        "start": 145,
                        "end": 159,
                        "text": "(Higgins 2017)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of risk of bias in included studies",
                "sec_num": null
            },
            {
                "text": "Only dichotomous data were reported in this review and we used the numbers of events in the control and intervention groups of each study to calculate Mantel-Haenszel odds ratios (ORs).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Measures of treatment e ect",
                "sec_num": null
            },
            {
                "text": "We reversed the direction of e ect of individual studies, where required, to ensure consistency across trials.We presented 95% confidence intervals (CIs) for all outcomes.We assessed whether the estimates calculated in the review for individual studies were compatible in each case with the estimates reported in the study publications.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Measures of treatment e ect",
                "sec_num": null
            },
            {
                "text": "We analysed data per randomised couple or woman, because pertreatment-cycle data may lead to biased results (Dias 2008 ).In the case of a cross-over trial, we only analysed data prior to cross-over.",
                "cite_spans": [
                    {
                        "start": 108,
                        "end": 118,
                        "text": "(Dias 2008",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Unit of analysis issues",
                "sec_num": null
            },
            {
                "text": "For studies where data did not allow analysis (e.g.per-cycle data) we contacted study authors for per-woman data.Where we could not obtain appropriate data a er contact with authors, we excluded such data (per-cycle) from meta-analyses.We counted multiple live births (e.g.twins or triplets) as one live birth event.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Unit of analysis issues",
                "sec_num": null
            },
            {
                "text": "We analysed the data on an intention-to-treat basis as far as possible.In the case of missing data we contacted authors of the published trials and included the newly-obtained data in the analysis.However, where the study authors did not provide additional data, we assumed that no live births occurred in participants without a reported outcome.We assumed that women who dropped out or were excluded a er randomisation were not pregnant.Women who were excluded because they conceived before receiving treatment were included as a success in the",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Dealing with missing data",
                "sec_num": null
            },
            {
                "text": "Trusted evidence.Informed decisions.Better health.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "Cochrane Database of Systematic Reviews allocated group in the ITT analysis.For other outcomes, we analysed only the available data.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "We considered whether the clinical and methodological characteristics of the included studies were su iciently similar for meta-analysis to provide a clinically meaningful summary.We assessed statistical heterogeneity using the I 2 statistic.We took an I 2 statistic measurement greater than 50% to indicate substantial heterogeneity (Deeks 2017) .",
                "cite_spans": [
                    {
                        "start": 334,
                        "end": 346,
                        "text": "(Deeks 2017)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of heterogeneity",
                "sec_num": null
            },
            {
                "text": "In view of the di iculty of detecting and correcting for publication bias and other reporting biases, we minimised their potential impact by ensuring a comprehensive search for eligible studies and by being alert for duplication of data.Where there were 10 or more studies in an analysis, we had intended to use a funnel plot to explore the possibility of small-study e ects (a tendency for estimates of the intervention e ect to be more beneficial in smaller studies) (Sterne 2017 ).",
                "cite_spans": [
                    {
                        "start": 469,
                        "end": 481,
                        "text": "(Sterne 2017",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Assessment of reporting biases",
                "sec_num": null
            },
            {
                "text": "Where the studies were su iciently similar, we combined the data using a fixed-e ect model in the following comparisons:",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Data synthesis",
                "sec_num": null
            },
            {
                "text": "1. Intra-uterine insemination (IUI) in a natural cycle versus timed intercourse (TI) or expectant management in a natural cycle; 2. IUI in a stimulated cycle versus TI or expectant management in a stimulated cycle; 3. IUI in a stimulated cycle versus TI or expectant management in a natural cycle; 4. IUI in a natural cycle versus TI or expectant management in a stimulated cycle; 5. IUI in a stimulated cycle versus IUI in a natural cycle.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Data synthesis",
                "sec_num": null
            },
            {
                "text": "An increase in the odds of a particular outcome, which may be beneficial (e.g.live birth) or detrimental (e.g.adverse events), was displayed graphically in the meta-analyses to the right of the centre-line and a decrease in the odds of an outcome to the le of the centre-line.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Data synthesis",
                "sec_num": null
            },
            {
                "text": "When pre-cross-over data were available, we included cross-over trials in the analysis and pooled them with parallel trials.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Data synthesis",
                "sec_num": null
            },
            {
                "text": "Where data were available, we planned to conduct subgroup analyses to determine the separate evidence on the number of treatment cycles for live birth, and methods of ovarian hyperstimulation.However, there were insu icient data to perform subgroup analyses for the number of treatment cycles in any the comparisons, and for methods of ovarian hyperstimulation in some of the comparisons.We therefore did not report the findings by subgroups for any of the comparisons, except where data could not be pooled in meta-analyses due to the presence of high heterogeneity.Where a visual scan of the forest plots or the results of statistical tests indicated substantial heterogeneity, we explored possible explanations in the text or in subgroup analyses.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Subgroup analysis and investigation of heterogeneity",
                "sec_num": null
            },
            {
                "text": "Where appropriate, we performed sensitivity analyses for the review's primary outcomes (live birth and multiple pregnancy) to determine whether the results were robust to decisions made during the review process.These analyses considered the e ects of excluding the following studies:",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Sensitivity analysis",
                "sec_num": null
            },
            {
                "text": "1. Studies that did not clearly describe adequate procedures for random sequence generation and allocation concealment; 2. Studies with a unit-of-analysis error (such as those in which cross-over data were analysed as if they derived from parallel studies).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Sensitivity analysis",
                "sec_num": null
            },
            {
                "text": "We prepared 'Summary of findings' tables using GRADEpro so ware (GRADEpro GDT 2015) and Cochrane methods.These tables evaluate the overall quality of the body of evidence for the review outcomes (live birth, multiple pregnancy, pregnancy, OHSS, miscarriage, ectopic pregnancy) for the main review comparisons:",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Overall quality of the body of evidence: 'Summary of findings' tables",
                "sec_num": null
            },
            {
                "text": "1. IUI versus TI or expectant management both in a natural cycle; 2. IUI in a stimulated cycle versus TI or expectant management in a stimulated cycle; 3. IUI in a stimulated cycle versus TI or expectant management in a natural cycle; 4. IUI in a natural cycle versus TI or expectant management in a stimulated cycle; and 5. IUI in a stimulated cycle versus IUI in a natural cycle).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Overall quality of the body of evidence: 'Summary of findings' tables",
                "sec_num": null
            },
            {
                "text": "We assessed the quality of the evidence using GRADE criteria: risk of bias, consistency of e ect, indirectness, imprecision and publication bias (Sch\u00fcnemann 2017) .Two review authors working independently made judgements about evidence quality (high, moderate, low or very low), with disagreements resolved by discussion.We justified, documented, and incorporated our judgements into the reporting of results for each outcome.",
                "cite_spans": [
                    {
                        "start": 145,
                        "end": 162,
                        "text": "(Sch\u00fcnemann 2017)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Overall quality of the body of evidence: 'Summary of findings' tables",
                "sec_num": null
            },
            {
                "text": "For the 2020 update, the searches identified 925 records (most of which were also identified during the previous updates) a er removal of duplicates.We retrieved three full-text articles, one of which was eligible for inclusion (Farquhar 2018).Fourteen studies were identified from the previous updates; we therefore include a total of 15 studies (21 references) in the review.See Figure 1 for details of the screening and selection process and Characteristics of included studies for studies included in the review.",
                "cite_spans": [],
                "ref_spans": [
                    {
                        "start": 388,
                        "end": 389,
                        "text": "1",
                        "ref_id": "FIGREF1"
                    }
                ],
                "eq_spans": [],
                "section": "Results of the search",
                "sec_num": null
            },
            {
                "text": "Trusted evidence.Informed decisions.Better health.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "We tried to contact all study authors to retrieve unpublished details.Responses from three study authors resulted in the exclusion of the following trials: Nulsen 1993; Prentice 1995; Serhal 1988.Seven study authors (Agarwal 2004; Arici 1994; Bhattacharya 2008; Guzick 1999; Melis 1995; Murdoch 1991; Steures 2006a ) provided unpublished information or data, which we used in this analysis.Some authors could not provide us with the requested data, while others did not respond to our requests.",
                "cite_spans": [
                    {
                        "start": 216,
                        "end": 230,
                        "text": "(Agarwal 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 231,
                        "end": 242,
                        "text": "Arici 1994;",
                        "ref_id": null
                    },
                    {
                        "start": 243,
                        "end": 261,
                        "text": "Bhattacharya 2008;",
                        "ref_id": null
                    },
                    {
                        "start": 262,
                        "end": 274,
                        "text": "Guzick 1999;",
                        "ref_id": null
                    },
                    {
                        "start": 275,
                        "end": 286,
                        "text": "Melis 1995;",
                        "ref_id": null
                    },
                    {
                        "start": 287,
                        "end": 300,
                        "text": "Murdoch 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 301,
                        "end": 314,
                        "text": "Steures 2006a",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cochrane Database of Systematic Reviews",
                "sec_num": null
            },
            {
                "text": "We included 15 RCTs.All trials were published in journals (Janko 1998 was published as an abstract only) and were available in English.The trials were carried out in di erent countries: UK (Bhattacharya 2008; Chung 1995; Murdoch 1991) , USA (Arici 1994; Deaton 1990 ; Guzick 1999), Italy (Arcaini 1996; Melis 1995), the Netherlands (Goverde 2000; Steures 2006a) , India (Agarwal 2004), New Zealand (Farquhar 2018), Slovakia (Janko 1998), Sweden (Karlstrom 1993), and multiple European countries (Crosignani 1991).",
                "cite_spans": [
                    {
                        "start": 189,
                        "end": 208,
                        "text": "(Bhattacharya 2008;",
                        "ref_id": null
                    },
                    {
                        "start": 209,
                        "end": 220,
                        "text": "Chung 1995;",
                        "ref_id": null
                    },
                    {
                        "start": 221,
                        "end": 234,
                        "text": "Murdoch 1991)",
                        "ref_id": null
                    },
                    {
                        "start": 241,
                        "end": 253,
                        "text": "(Arici 1994;",
                        "ref_id": null
                    },
                    {
                        "start": 254,
                        "end": 265,
                        "text": "Deaton 1990",
                        "ref_id": null
                    },
                    {
                        "start": 332,
                        "end": 346,
                        "text": "(Goverde 2000;",
                        "ref_id": null
                    },
                    {
                        "start": 347,
                        "end": 361,
                        "text": "Steures 2006a)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Design",
                "sec_num": null
            },
            {
                "text": "Twelve were parallel-group studies (Agarwal 2004; Arcaini 1996; Bhattacharya 2008; Chung 1995; Farquhar 2018; Goverde 2000; Guzick 1999; Janko 1998; Karlstrom 1993; Melis 1995; Murdoch 1991; Steures 2006a) , and three were cross-over studies (Arici 1994; Crosignani 1991; Deaton 1990) . Bhattacharya 2008 , Farquhar 2018 , Goverde 2000 and Steures 2006a were the only studies which performed a power calculation.All four studies reached the targeted inclusion number to obtain enough power (80% to 90% with 5% level of significance).Further details about the included trials are provided in the Characteristics of included studies table.",
                "cite_spans": [
                    {
                        "start": 35,
                        "end": 49,
                        "text": "(Agarwal 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 50,
                        "end": 63,
                        "text": "Arcaini 1996;",
                        "ref_id": null
                    },
                    {
                        "start": 64,
                        "end": 82,
                        "text": "Bhattacharya 2008;",
                        "ref_id": null
                    },
                    {
                        "start": 83,
                        "end": 94,
                        "text": "Chung 1995;",
                        "ref_id": null
                    },
                    {
                        "start": 95,
                        "end": 109,
                        "text": "Farquhar 2018;",
                        "ref_id": null
                    },
                    {
                        "start": 110,
                        "end": 123,
                        "text": "Goverde 2000;",
                        "ref_id": null
                    },
                    {
                        "start": 124,
                        "end": 136,
                        "text": "Guzick 1999;",
                        "ref_id": null
                    },
                    {
                        "start": 137,
                        "end": 148,
                        "text": "Janko 1998;",
                        "ref_id": null
                    },
                    {
                        "start": 149,
                        "end": 164,
                        "text": "Karlstrom 1993;",
                        "ref_id": null
                    },
                    {
                        "start": 165,
                        "end": 176,
                        "text": "Melis 1995;",
                        "ref_id": null
                    },
                    {
                        "start": 177,
                        "end": 190,
                        "text": "Murdoch 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 191,
                        "end": 205,
                        "text": "Steures 2006a)",
                        "ref_id": null
                    },
                    {
                        "start": 242,
                        "end": 254,
                        "text": "(Arici 1994;",
                        "ref_id": null
                    },
                    {
                        "start": 255,
                        "end": 271,
                        "text": "Crosignani 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 272,
                        "end": 284,
                        "text": "Deaton 1990)",
                        "ref_id": null
                    },
                    {
                        "start": 287,
                        "end": 304,
                        "text": "Bhattacharya 2008",
                        "ref_id": null
                    },
                    {
                        "start": 305,
                        "end": 320,
                        "text": ", Farquhar 2018",
                        "ref_id": null
                    },
                    {
                        "start": 321,
                        "end": 335,
                        "text": ", Goverde 2000",
                        "ref_id": null
                    },
                    {
                        "start": 336,
                        "end": 353,
                        "text": "and Steures 2006a",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Design",
                "sec_num": null
            },
            {
                "text": "The 15 trials comprised a total of 2068 women with unexplained subfertility.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Participants",
                "sec_num": null
            },
            {
                "text": "The ages of the women were mentioned in most trials as either a mean \u00b1 standard deviation (SD) or a median and range.One trial (Janko 1998) did not report the women's ages.The overall age reported in the studies was similar.The mean or median age was between 30 years and 34 years (with comparable SDs).The maximum age of the participants was stated in six studies, only one of whom was above the age of 40 years (Arici 1994).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Participants",
                "sec_num": null
            },
            {
                "text": "The duration of subfertility was given in 11 trials and reported as a mean duration or range.Five studies only included couples with subfertility for more than at least three years.The overall subfertility duration ranged from one year to 15 years.Two studies used a prediction score of validated Hunault model (Hunault 2004 ), including women with a prediction score of natural conception of less than 30% (Farquhar 2018) or between 30% and 40% (Steures 2006a).",
                "cite_spans": [
                    {
                        "start": 311,
                        "end": 324,
                        "text": "(Hunault 2004",
                        "ref_id": null
                    },
                    {
                        "start": 407,
                        "end": 422,
                        "text": "(Farquhar 2018)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Participants",
                "sec_num": null
            },
            {
                "text": "The definition of unexplained subfertility was similar between studies.Six trials enrolled participants with unexplained subfertility only.Five trials also included participants with male factor subfertility.In those studies the data for unexplained subfertility were either reported separately or obtained from the authors.One study selected couples with unexplained subfertility and an intermediate prognosis (Steures 2006a) .Five studies reported the inclusion of women with either surgically-corrected endometriosis (Deaton 1990) , mild or stage II treated endometriosis (Guzick 1999) or minimal/mild endometriosis ( Bhattacharya 2008; Farquhar 2018; Karlstrom 1993) , which we considered to be unexplained subfertility.Melis 1995 specifically excluded participants if minor disorders such as minimal endometriosis were found in the investigation.Although our protocol stipulated only women with minimal and mild endometriosis, we decided to include Deaton 1990, despite the inclusion of three participants (out of 51 in total) with moderate endometriosis.",
                "cite_spans": [
                    {
                        "start": 411,
                        "end": 426,
                        "text": "(Steures 2006a)",
                        "ref_id": null
                    },
                    {
                        "start": 520,
                        "end": 533,
                        "text": "(Deaton 1990)",
                        "ref_id": null
                    },
                    {
                        "start": 619,
                        "end": 639,
                        "text": "( Bhattacharya 2008;",
                        "ref_id": null
                    },
                    {
                        "start": 640,
                        "end": 654,
                        "text": "Farquhar 2018;",
                        "ref_id": null
                    },
                    {
                        "start": 655,
                        "end": 670,
                        "text": "Karlstrom 1993)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of subfertility",
                "sec_num": null
            },
            {
                "text": "All studies reported a thorough fertility investigation, including a laparoscopy.A semen analysis was performed at least once in all studies.In nine studies the semen quality was reported according to the WHO criteria.Two studies (Arcaini 1996; Janko 1998) did not specify the criteria for a normal semen analysis.Chung 1995 used a sperm count per ejaculate instead of per ml.The data in Guzick 1999 were based only on a normal sperm count and a normal motility according to Kruger criteria.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Types of subfertility",
                "sec_num": null
            },
            {
                "text": "Nine trials contained a mixed population of couples who had never achieved a pregnancy (primary subfertility) and those who had previously been pregnant (secondary subfertility).The remaining trials did not give any description for inclusion of people with secondary subfertility.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Primary or secondary subfertility",
                "sec_num": null
            },
            {
                "text": "Couples who have previously had failed fertility treatment have a lower probability of conception in subsequent treatment attempts.It is therefore important in fertility trials to report if couples have undergone previous treatment.Of the 15 included studies only two trials included couples who had previously had unsuccessful fertility treatment (Farquhar 2018; Melis 1995) .Five trials did not include previously-treated participants (Agarwal 2004; Arici 1994; Guzick 1999; Karlstrom 1993; Murdoch 1991) and the remaining trials did not provide information about previous treatment.The number of cycles in included studies ranged from one to eight.",
                "cite_spans": [
                    {
                        "start": 348,
                        "end": 363,
                        "text": "(Farquhar 2018;",
                        "ref_id": null
                    },
                    {
                        "start": 364,
                        "end": 375,
                        "text": "Melis 1995)",
                        "ref_id": null
                    },
                    {
                        "start": 437,
                        "end": 451,
                        "text": "(Agarwal 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 452,
                        "end": 463,
                        "text": "Arici 1994;",
                        "ref_id": null
                    },
                    {
                        "start": 464,
                        "end": 476,
                        "text": "Guzick 1999;",
                        "ref_id": null
                    },
                    {
                        "start": 477,
                        "end": 492,
                        "text": "Karlstrom 1993;",
                        "ref_id": null
                    },
                    {
                        "start": 493,
                        "end": 506,
                        "text": "Murdoch 1991)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Previous treatment",
                "sec_num": null
            },
            {
                "text": "The most serious adverse e ects of ovarian hyperstimulation are multiple pregnancies and ovarian hyperstimulation syndrome (OHSS).These risks can both be reduced by the cancellation of the treatment cycle if excessive follicle stimulation occurs.It is important that fertility trials report the cancellation criteria they applied.Firstly, this ensures that participants were not exposed to a higher risk of multiple pregnancy or OHSS to increase the pregnancy rate, and secondly, it reduces the bias introduced by cancellation of treatment in initially randomised groups.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cancellation criteria",
                "sec_num": null
            },
            {
                "text": "Eleven studies described criteria for cancellation of the treatment cycle.Insemination or hCG administration did not take place if the cancellation criteria were met.Six studies used serum-E 2 levels to determine over-or under-stimulation as well as a maximum of dominant follicles (four follicles of a maximum 16 mm diameter).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cancellation criteria",
                "sec_num": null
            },
            {
                "text": "Arcaini 1996 accepted a maximum of six dominant follicles.Four studies did not describe any cancellation criteria.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cancellation criteria",
                "sec_num": null
            },
            {
                "text": "Ten trials reported live birth, our primary outcome of interest.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Outcomes",
                "sec_num": null
            },
            {
                "text": "The other studies reported pregnancy as the main outcome.Pregnancy was confirmed by ultrasound in nine trials.In Guzick 1999 pregnancy was confirmed by two hCG measurements or live birth.Others did not report the method of pregnancy confirmation.The reported pregnancies were mostly clinical.The multiple pregnancy rate was mentioned in 13 trials, miscarriage in 11, ectopic pregnancy in 11, and OHSS in 10 trials.These events were o en reported as total numbers or as post-cross-over data and therefore o en could not be used in the meta-analysis.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Outcomes",
                "sec_num": null
            },
            {
                "text": "For the 2020 update, we excluded two studies in addition to those previously excluded.One was excluded because it was a prospective cohort study (Van Eekelen 2019) while the other study (Zolghadri 2012) was excluded because it included a mix of women with unexplained infertility and polycystic ovarian syndrome, with no separate data for the two groups.We contacted the study authors for data on women with unexplained infertility but we did not receive any response.We had excluded 23 studies during the previous updates (see details below); we therefore excluded a total of 25 studies from this review update.See Characteristics of excluded studies.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Excluded studies",
                "sec_num": null
            },
            {
                "text": "For For the 2012 update, 13 studies were excluded (Aboulghar 1993; Doyle 1991; Evans 1991; Gregoriou 1995; Ho 1998; Kirby 1991; Martinez 1990; Martinez 1991; Nulsen 1993; Prentice 1995; Serhal 1988; Tummon 1997; Zikopoulos 1993) .Two studies were found not to be randomised studies (Aboulghar 1993; Serhal 1988) ; inadequate method of randomisation was the reason for exclusion of another two trials (Nulsen 1993; Prentice 1995); one study (Tummon 1997) included women with endometriosis only and thus did not focus on unexplained subfertility; Martinez 1990 reported biochemically-confirmed pregnancies only and was therefore excluded; Ho 1998 did not report separate data for couples with unexplained subfertility; six studies (Doyle 1991; Evans 1991; Gregoriou 1995; Kirby 1991; Martinez 1991; Zikopoulos 1993) reported pre-or post-cross-over 'per-cycle' only, instead of 'per randomised woman', and therefore could not be included.We contacted authors of these studies to obtain relevant data such as pre-cross-over 'per randomised woman' data but we did not receive any response from the authors.",
                "cite_spans": [
                    {
                        "start": 50,
                        "end": 66,
                        "text": "(Aboulghar 1993;",
                        "ref_id": null
                    },
                    {
                        "start": 67,
                        "end": 78,
                        "text": "Doyle 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 79,
                        "end": 90,
                        "text": "Evans 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 91,
                        "end": 106,
                        "text": "Gregoriou 1995;",
                        "ref_id": null
                    },
                    {
                        "start": 107,
                        "end": 115,
                        "text": "Ho 1998;",
                        "ref_id": null
                    },
                    {
                        "start": 116,
                        "end": 127,
                        "text": "Kirby 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 128,
                        "end": 142,
                        "text": "Martinez 1990;",
                        "ref_id": null
                    },
                    {
                        "start": 143,
                        "end": 157,
                        "text": "Martinez 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 158,
                        "end": 170,
                        "text": "Nulsen 1993;",
                        "ref_id": null
                    },
                    {
                        "start": 171,
                        "end": 185,
                        "text": "Prentice 1995;",
                        "ref_id": null
                    },
                    {
                        "start": 186,
                        "end": 198,
                        "text": "Serhal 1988;",
                        "ref_id": null
                    },
                    {
                        "start": 199,
                        "end": 211,
                        "text": "Tummon 1997;",
                        "ref_id": null
                    },
                    {
                        "start": 212,
                        "end": 228,
                        "text": "Zikopoulos 1993)",
                        "ref_id": null
                    },
                    {
                        "start": 282,
                        "end": 298,
                        "text": "(Aboulghar 1993;",
                        "ref_id": null
                    },
                    {
                        "start": 299,
                        "end": 311,
                        "text": "Serhal 1988)",
                        "ref_id": null
                    },
                    {
                        "start": 729,
                        "end": 741,
                        "text": "(Doyle 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 742,
                        "end": 753,
                        "text": "Evans 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 754,
                        "end": 769,
                        "text": "Gregoriou 1995;",
                        "ref_id": null
                    },
                    {
                        "start": 770,
                        "end": 781,
                        "text": "Kirby 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 782,
                        "end": 796,
                        "text": "Martinez 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 797,
                        "end": 813,
                        "text": "Zikopoulos 1993)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Excluded studies",
                "sec_num": null
            },
            {
                "text": "There are no studies awaiting classification.However if precross-over data of the excluded studies become available we will reconsider inclusion and report the studies in an update of this review.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Studies awaiting classification",
                "sec_num": null
            },
            {
                "text": "Trusted evidence.Informed decisions.Better health.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "Ongoing studies",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cochrane Database of Systematic Reviews",
                "sec_num": null
            },
            {
                "text": "We identified one study which was ongoing and appeared to meet the inclusion criteria (NCT03455426).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Cochrane Database of Systematic Reviews",
                "sec_num": null
            },
            {
                "text": "See the 'Risk of bias' graph (Figure 2 ) and 'Risk of bias' summary (Figure 3 ).Cochrane Database of Systematic Reviews",
                "cite_spans": [],
                "ref_spans": [
                    {
                        "start": 37,
                        "end": 38,
                        "text": "2",
                        "ref_id": null
                    },
                    {
                        "start": 76,
                        "end": 77,
                        "text": "3",
                        "ref_id": "FIGREF3"
                    }
                ],
                "eq_spans": [],
                "section": "Risk of bias in included studies",
                "sec_num": null
            },
            {
                "text": "In nine of the included studies (Agarwal 2004; Arici 1994; Bhattacharya 2008; Chung 1995; Farquhar 2018; Goverde 2000; Melis 1995; Murdoch 1991; Steures 2006a) , we considered the methods used for sequence generation and allocation concealment to be adequate and we therefore rated them as being at low risk of bias.In the remaining six trials (Arcaini 1996; Crosignani 1991; Deaton 1990; Guzick 1999; Janko 1998; Karlstrom 1993) , the methods used for random sequence generation and allocation concealment were not su iciently described to draw a conclusive judgement, so we rated the risk of bias as unclear.",
                "cite_spans": [
                    {
                        "start": 32,
                        "end": 46,
                        "text": "(Agarwal 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 47,
                        "end": 58,
                        "text": "Arici 1994;",
                        "ref_id": null
                    },
                    {
                        "start": 59,
                        "end": 77,
                        "text": "Bhattacharya 2008;",
                        "ref_id": null
                    },
                    {
                        "start": 78,
                        "end": 89,
                        "text": "Chung 1995;",
                        "ref_id": null
                    },
                    {
                        "start": 90,
                        "end": 104,
                        "text": "Farquhar 2018;",
                        "ref_id": null
                    },
                    {
                        "start": 105,
                        "end": 118,
                        "text": "Goverde 2000;",
                        "ref_id": null
                    },
                    {
                        "start": 119,
                        "end": 130,
                        "text": "Melis 1995;",
                        "ref_id": null
                    },
                    {
                        "start": 131,
                        "end": 144,
                        "text": "Murdoch 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 145,
                        "end": 159,
                        "text": "Steures 2006a)",
                        "ref_id": null
                    },
                    {
                        "start": 344,
                        "end": 358,
                        "text": "(Arcaini 1996;",
                        "ref_id": null
                    },
                    {
                        "start": 359,
                        "end": 375,
                        "text": "Crosignani 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 376,
                        "end": 388,
                        "text": "Deaton 1990;",
                        "ref_id": null
                    },
                    {
                        "start": 389,
                        "end": 401,
                        "text": "Guzick 1999;",
                        "ref_id": null
                    },
                    {
                        "start": 402,
                        "end": 413,
                        "text": "Janko 1998;",
                        "ref_id": null
                    },
                    {
                        "start": 414,
                        "end": 429,
                        "text": "Karlstrom 1993)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Allocation",
                "sec_num": null
            },
            {
                "text": "We assessed all the included studies as being at unclear risk for performance bias, as none of them reported blinding due to the nature of the interventions.For detection bias, we rated all the included studies as being at low risk; we considered that nonblinding was unlikely to a ect the outcomes of interest, as they were objectively assessed.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Blinding",
                "sec_num": null
            },
            {
                "text": "We used an intention-to-treat (ITT) analysis when possible.In three trials an ITT analysis was not possible (Crosignani 1991; Deaton 1990; Karlstrom 1993) , as the trials only reported the number of participants analysed.",
                "cite_spans": [
                    {
                        "start": 108,
                        "end": 125,
                        "text": "(Crosignani 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 126,
                        "end": 138,
                        "text": "Deaton 1990;",
                        "ref_id": null
                    },
                    {
                        "start": 139,
                        "end": 154,
                        "text": "Karlstrom 1993)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Incomplete outcome data",
                "sec_num": null
            },
            {
                "text": "In Murdoch 1991 one woman became pregnant spontaneously between treatment cycles.This pregnancy resulted in a live birth and was entered as such in the analysis.Goverde 2000 also reported spontaneous pregnancies that occurred between treatment cycles.Because it was unclear in which group these pregnancies occurred, we could not use them in the ITT analysis.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Incomplete outcome data",
                "sec_num": null
            },
            {
                "text": "Seven of the 15 included trials clearly mentioned the number of dropouts and the reasons for dropping out (Arici 1994; Deaton 1990; Farquhar 2018; Goverde 2000; Guzick 1999; Melis 1995; Steures 2006a) .Murdoch 1991 reported the number of dropouts but did not give any information on reasons for dropping out.Bhattacharya 2008 had a dropout rate of less than 1%.The studies with the highest dropout rates were Arcaini 1996 (dropout of 20.6%) and Agarwal 2004 (19%).In Agarwal the couples mainly le the study for financial reasons, which resulted in an unevenly-distributed dropout rate of 37% in the treatment group as compared to 1% in the control group.The dropout rate usually increased in studies with a longer follow-up period.Because this review included trials with di erent durations, it was di icult to compare the dropout rates.We rated nine of the included studies as being at low risk of bias, three as unclear and another three as high risk of bias.",
                "cite_spans": [
                    {
                        "start": 106,
                        "end": 118,
                        "text": "(Arici 1994;",
                        "ref_id": null
                    },
                    {
                        "start": 119,
                        "end": 131,
                        "text": "Deaton 1990;",
                        "ref_id": null
                    },
                    {
                        "start": 132,
                        "end": 146,
                        "text": "Farquhar 2018;",
                        "ref_id": null
                    },
                    {
                        "start": 147,
                        "end": 160,
                        "text": "Goverde 2000;",
                        "ref_id": null
                    },
                    {
                        "start": 161,
                        "end": 173,
                        "text": "Guzick 1999;",
                        "ref_id": null
                    },
                    {
                        "start": 174,
                        "end": 185,
                        "text": "Melis 1995;",
                        "ref_id": null
                    },
                    {
                        "start": 186,
                        "end": 200,
                        "text": "Steures 2006a)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Incomplete outcome data",
                "sec_num": null
            },
            {
                "text": "There was a risk of selective reporting in some of the studies included in this review.Live birth data were not reported in five studies (Arcaini 1996; Crosignani 1991; Deaton 1990; Janko 1998; Karlstrom 1993) .Adverse events were o en not reported by group but as a study total, which could not be included in the analysis.Multiple pregnancy rates were not reported in two trials (Crosignani 1991; Janko 1998) .We rated nine of the included studies as being at low risk of bias, five as being at unclear risk and one as being at high risk.We did not construct a funnel plot for any of the analyses, as none of them included up to 10 studies.",
                "cite_spans": [
                    {
                        "start": 137,
                        "end": 151,
                        "text": "(Arcaini 1996;",
                        "ref_id": null
                    },
                    {
                        "start": 152,
                        "end": 168,
                        "text": "Crosignani 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 169,
                        "end": 181,
                        "text": "Deaton 1990;",
                        "ref_id": null
                    },
                    {
                        "start": 182,
                        "end": 193,
                        "text": "Janko 1998;",
                        "ref_id": null
                    },
                    {
                        "start": 194,
                        "end": 209,
                        "text": "Karlstrom 1993)",
                        "ref_id": null
                    },
                    {
                        "start": 381,
                        "end": 398,
                        "text": "(Crosignani 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 399,
                        "end": 410,
                        "text": "Janko 1998)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Selective reporting",
                "sec_num": null
            },
            {
                "text": "To reduce bias introduced by a cross-over study design, we included pre-cross-over data only.Three studies used a cross-over design (Arici 1994; Crosignani 1991; Deaton 1990) .In this design participants were initially randomised to the treatment or control group but then crossed over to the other group a er a certain number of treatment cycles.The duration of these studies varied from two to eight treatment cycles per couple.In two studies (Arici 1994; Crosignani 1991 ) the participants crossed over a er one treatment cycle.In Deaton 1990 participants crossed over a er four cycles.",
                "cite_spans": [
                    {
                        "start": 132,
                        "end": 144,
                        "text": "(Arici 1994;",
                        "ref_id": null
                    },
                    {
                        "start": 145,
                        "end": 161,
                        "text": "Crosignani 1991;",
                        "ref_id": null
                    },
                    {
                        "start": 162,
                        "end": 174,
                        "text": "Deaton 1990)",
                        "ref_id": null
                    },
                    {
                        "start": 445,
                        "end": 457,
                        "text": "(Arici 1994;",
                        "ref_id": null
                    },
                    {
                        "start": 458,
                        "end": 473,
                        "text": "Crosignani 1991",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Other potential sources of bias",
                "sec_num": null
            },
            {
                "text": "We rated nine of the included studies as being at low risk of bias because baseline demographic characteristics of participants between the two treatment groups were similar.We rated the remaining six studies at unclear risk for this domain because there was insu icient information to make a conclusive judgement on the baseline demographic characteristics of participants.This section describes the results of the meta-analyses and sensitivity analyses.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Other potential sources of bias",
                "sec_num": null
            },
            {
                "text": "The results from this comparison were all obtained from Bhattacharya 2008.Data for the unexplained subfertility group only were provided by the trial author.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Comparison 1. IUI in a natural cycle versus timed intercourse (TI) or expectant management in a natural cycle",
                "sec_num": null
            },
            {
                "text": "Analysis 1.1 It is uncertain whether treatment with IUI in a natural cycle results in a higher cumulative live birth rate compared to treatment with expectant management in a natural cycle (OR 1.60, 95% CI 0.92 to 2.78; 1 RCT, 334 women; low-quality evidence).The evidence suggests that if we assume the chance of a live birth using expectant management to be 16%, that of IUI would be between 15% and 34%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Live birth rate per couple (all cycles)",
                "sec_num": "1.1"
            },
            {
                "text": "Analysis 1.2",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Multiple pregnancy rate per couple",
                "sec_num": "1.2"
            },
            {
                "text": "It is uncertain whether treatment with IUI in a natural cycle results in a lower multiple pregnancy rate compared to treatment with expectant management in a natural cycle (OR 0.50, 95% CI 0.04 to 5.53; 1 RCT, 334 women; low-quality evidence).The evidence suggests that if we assume the risk of a multiple pregnancy using",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Multiple pregnancy rate per couple",
                "sec_num": "1.2"
            },
            {
                "text": "Trusted evidence.Informed decisions.Better health.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "Cochrane Database of Systematic Reviews expectant management to be 1%, the risk using IUI would be between 0% and 6%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "We did not perform sensitivity analyses as only one trial with low risk of selection bas was included in the analysis for both primary outcomes.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "Analysis 1.3 Compared to expectant management in a natural cycle, it is uncertain whether treatment with IUI in a natural cycle results in a higher cumulative pregnancy rate (OR 1.53, 95% CI 0.88 to 2.64; 1 RCT, 334 women; low-quality evidence).The evidence suggests that if we assume the chance of a pregnancy using expectant management to be 16%, that of IUI would be between 15% and 34%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Pregnancy rate per couple (all cycles)",
                "sec_num": "1.3"
            },
            {
                "text": "Data on OHSS were not reported.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Moderate or severe ovarian hyperstimulation syndrome rate per woman",
                "sec_num": null
            },
            {
                "text": "Analysis 1.4",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Miscarriage rate per couple",
                "sec_num": "1.4"
            },
            {
                "text": "It is uncertain whether treatment with IUI in a natural cycle results in a lower miscarriage rate compared to treatment with expectant management in a natural cycle.Sixteen miscarriages were reported in a total of 334 couples, seven in the IUI group and nine in the expectant management group (OR 0.77, 95% CI 0.28 to 2.11; 1 RCT, 334 women; low-quality evidence).The evidence suggests that if we assume the risk of a miscarriage using expectant management to be 5%, that of IUI would be between 2% and 11%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Miscarriage rate per couple",
                "sec_num": "1.4"
            },
            {
                "text": "Analysis 1.5 Compared to expectant management in a natural cycle, it is uncertain whether treatment with IUI in a natural cycle results in a lower ectopic pregnancy rate.Two ectopic pregnancies were reported in a total of 334 couples, with both occurring in the IUI group (OR 5.06, 95% CI 0.24 to 106.21; 1 RCT, 334 women; lowquality evidence).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Ectopic pregnancy rate per couple",
                "sec_num": "1.5"
            },
            {
                "text": "Analysis 2.1 Only two of the six trials included in the analysis reported live birth rates (Chung 1995; Melis 1995) .It is uncertain whether treatment with IUI in a stimulated cycle results in a higher cumulative live birth rate compared to treatment with TI in a stimulated cycle (OR 1.59, 95% CI 0.88 to 2.88; 2 RCTs, 208 women; I 2 = 72%; lowquality evidence).The evidence suggests that if we assume the chance of a live birth using TI to be 26%, that of IUI would be between 23% and 50%.Statistical heterogeneity was detected (P = 0.06, I 2 = 72%) between the two studies, with inconsistency in the directions of e ect estimates.This may be explained by the fact that all participants in Melis 1995 had previously received fertility treatment.",
                "cite_spans": [
                    {
                        "start": 91,
                        "end": 103,
                        "text": "(Chung 1995;",
                        "ref_id": null
                    },
                    {
                        "start": 104,
                        "end": 115,
                        "text": "Melis 1995)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Live birth rate per couple (all cycles)",
                "sec_num": "2.1"
            },
            {
                "text": "We did not perform sensitivity analysis excluding studies at unclear or high selection bias as both trials were at low risk of selection bias",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Live birth rate per couple (all cycles)",
                "sec_num": "2.1"
            },
            {
                "text": "Analysis 2.2 Four studies reported their multiple pregnancies per treatment arm (Arcaini 1996; Chung 1995; Karlstrom 1993; Melis 1995) , with a total of 17 multiple pregnancies in 316 couples.Arcaini 1996, Chung 1995 and Karlstrom 1993 reported one high-order multiple pregnancy each.The studies reported 11 multiple pregnancies in the IUI group and six in the TI group (representing 13.5% of the total number of pregnancies in these studies).Pooling the data from these studies showed that it is uncertain whether treatment with IUI in a stimulated cycle results in a lower multiple pregnancy rate compared to treatment with TI in a stimulated cycle (OR 1.46, 95% CI 0.55 to 3.87; 4 RCTs, 316 women; I 2 = 0%; low-quality evidence).",
                "cite_spans": [
                    {
                        "start": 80,
                        "end": 94,
                        "text": "(Arcaini 1996;",
                        "ref_id": null
                    },
                    {
                        "start": 95,
                        "end": 106,
                        "text": "Chung 1995;",
                        "ref_id": null
                    },
                    {
                        "start": 107,
                        "end": 122,
                        "text": "Karlstrom 1993;",
                        "ref_id": null
                    },
                    {
                        "start": 123,
                        "end": 134,
                        "text": "Melis 1995)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Multiple pregnancy rate per couple",
                "sec_num": "2.2"
            },
            {
                "text": "The evidence suggests that if we assume the risk of a multiple pregnancy using TI to be 4%, the risk using IUI would be between 2% and 15%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Multiple pregnancy rate per couple",
                "sec_num": "2.2"
            },
            {
                "text": "Analysis 2.3 Six trials reported pregnancy rates per couple.There were 517 women included in this analysis, reporting 149 cumulative pregnancies.The result showed that treatment with IUI in a stimulated cycle may result in a higher cumulative pregnancy rate compared to treatment with TI in a stimulated cycle (OR 1.69, 95% CI 1.14 to 2.53; 6 RCTs, 517 women; I 2 = 8%; low-quality evidence).This suggests that if we assume the chance of a pregnancy with TI to be 23%, the chance of a pregnancy in women using IUI would be between 26% and 44%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Pregnancy rate per couple (all cycles)",
                "sec_num": "2.3"
            },
            {
                "text": "Analysis 2.4 One case of OHSS was reported in 36 couples who were treated with IUI, while none was reported in 32 couples who received TI.It is, however, uncertain whether treatment with IUI in a stimulated cycle results in a lower OHSS rate compared to treatment with TI in a stimulated cycle (OR 2.75, 95% CI 0.11 to 69.83; 1 RCT, 68 women; very low-quality evidence).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Moderate to severe ovarian hyperstimulation syndrome rate per woman",
                "sec_num": "2.4"
            },
            {
                "text": "Analysis 2.5 Twenty-seven miscarriages were reported in total.Fi een were reported by treatment arm, nine in the IUI group and six in the TI group.It is uncertain whether treatment with IUI in a stimulated cycle results in a lower miscarriage rate compared to treatment with TI in a stimulated cycle (OR 1.66, 95% CI 0.56 to 4.88; I 2 = 0%; 2 RCTs, 208 women; low-quality evidence).The evidence suggests that if we assume the risk of miscarriage using TI to be 6%, the risk using IUI would be between 3% and 23%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Miscarriage rate per couple",
                "sec_num": "2.5"
            },
            {
                "text": "Analysis 2. In couples with a low prediction score of natural conception, treatment with IUI in a stimulated cycle probably results in a higher cumulative live birth rate compared to treatment with expectant management in a natural cycle (OR 4.48, 95% CI 2.00 to 10.01; 1 RCT; 201 women; moderate-quality evidence).The evidence suggests that if we assume the chance of a live birth with expectant management in a natural cycle to be 9%, the chance of a live birth with IUI in a stimulated cycle would be between 17% and 50%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Ectopic pregnancy rate per couple",
                "sec_num": "2.6"
            },
            {
                "text": "It is uncertain whether treatment with IUI in a stimulated cycle results in a higher cumulative live birth rate compared to treatment with expectant management in a natural cycle (OR 0.82, 95% CI 0.45 to 1.49; 1 RCT, 253 women; low-quality evidence).The evidence suggests that if we assume the chance of a live birth with expectant management in a natural cycle to be 24%, the chance of a live birth with IUI in a stimulated cycle would be between 12% and 32%. .The evidence suggests that if we assume the risk of a multiple pregnancy with expectant management in a natural cycle to be 0%, the risk of a multiple pregnancy with IUI in a stimulated cycle would be between 0% and 8%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Clomiphene citrate or gonadotropins (Steures 2006a)",
                "sec_num": "3.1.2"
            },
            {
                "text": "We did not perform sensitivity analyses excluding studies at unclear or high selection bias, as both trials were at low risk of selection bias for the primary outcomes.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Multiple pregnancy rate per couple",
                "sec_num": "3.2"
            },
            {
                "text": "Analysis 3.3",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Pregnancy rate per couple (all cycles)",
                "sec_num": "3.3"
            },
            {
                "text": "Data on this outcome were reported by three studies (Deaton 1990; Farquhar 2018; Steures 2006a) .We did not pool data from the three studies, because of extreme statistical heterogeneity (I 2 = 86%).The presence of significant heterogeneity might be due to the use of di erent population groups and OH drugs by the three studies: Deaton 1990 investigated women with mild or moderate endometriosis, using clomiphene citrate only; Farquhar 2018 investigated women with a low chance of spontaneous conception (prediction score of natural conception less than 30%), using clomiphene citrate or letrozole; Steures 2006a included couples with an intermediate chance of spontaneous conception (prediction score of natural conception between 30% and 40%).using clomiphene citrate or gonadotropins.",
                "cite_spans": [
                    {
                        "start": 52,
                        "end": 65,
                        "text": "(Deaton 1990;",
                        "ref_id": null
                    },
                    {
                        "start": 66,
                        "end": 80,
                        "text": "Farquhar 2018;",
                        "ref_id": null
                    },
                    {
                        "start": 81,
                        "end": 95,
                        "text": "Steures 2006a)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Pregnancy rate per couple (all cycles)",
                "sec_num": "3.3"
            },
            {
                "text": "It is uncertain whether treatment with IUI in a stimulated cycle results in a higher cumulative pregnancy rate compared to treatment with TI in a natural cycle (OR 3.20, 95% CI 0.82 to 12.50; 1 RCT, 51 women; low-quality evidence).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Clomiphene citrate only (Deaton 1990)",
                "sec_num": "3.3.1"
            },
            {
                "text": "Two studies (Deaton 1990; Farquhar 2018) reported on OHSS in this comparison; there were no cases of OHSS in either study.",
                "cite_spans": [
                    {
                        "start": 12,
                        "end": 25,
                        "text": "(Deaton 1990;",
                        "ref_id": null
                    },
                    {
                        "start": 26,
                        "end": 40,
                        "text": "Farquhar 2018)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Moderate or severe ovarian hyperstimulation syndrome rate per woman",
                "sec_num": null
            },
            {
                "text": "Analysis 3.4",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Miscarriage rate per couple",
                "sec_num": "3.4"
            },
            {
                "text": "Data on this outcome were reported by Farquhar 2018 and Steures 2006a.Treatment with IUI in a stimulated cycle probably results in a higher miscarriage rate compared to treatment with expectant management in a natural cycle (OR 2.87, 95% CI 1.18 to 7.01; 2 RCTs, 454 women; I 2 = 0%; moderate-quality evidence).The evidence suggests that if we assume the risk of miscarriage with expectant management in a natural cycle to be 3%, the risk of miscarriage with IUI in a stimulated cycle would be between 4% and 18%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Miscarriage rate per couple",
                "sec_num": "3.4"
            },
            {
                "text": "Analysis 4.1",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Live birth rate per couple (all cycles)",
                "sec_num": "4.1"
            },
            {
                "text": "Treatment with IUI in a natural cycle probably results in a higher cumulative live birth rate compared to expectant management in a stimulated cycle (OR 1.95, 95% CI 1.10 to 3.44; 1 RCT, 342 women: moderate-quality evidence).The evidence suggests that if we assume the chance of a live birth with expectant management in a stimulated cycle to be 13%, the chance of a live birth with IUI in a natural cycle would be between 14% and 34%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Live birth rate per couple (all cycles)",
                "sec_num": "4.1"
            },
            {
                "text": "Analysis 4.2",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Multiple pregnancy per couple",
                "sec_num": "4.2"
            },
            {
                "text": "It is uncertain whether treatment with IUI in a natural cycle results in a lower multiple pregnancy rate compared to treatment with expectant management in a stimulated cycle (OR 1.05, 95% CI 0.07 to 16.90; 1 RCT, 342 women; low-quality evidence).The evidence suggests that if we assume the risk of a multiple pregnancy in expectant management in a stimulated cycle to be 1%, the risk of a multiple pregnancy with IUI in a natural cycle would be between 0% and 9%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Multiple pregnancy per couple",
                "sec_num": "4.2"
            },
            {
                "text": "We did not perform sensitivity analysis for the main outcomes, as we included only one study with low risk of selection bias in this comparison.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Multiple pregnancy per couple",
                "sec_num": "4.2"
            },
            {
                "text": "Treatment with IUI in a natural cycle probably results in a higher cumulative pregnancy rate compared to treatment with expectant management in a stimulated cycle (OR 1.77, 95% CI 1.01 to 3.08; 1 RCT, 342 women; moderate-quality evidence).The evidence suggests that if we assume the chance of a pregnancy with expectant management in a stimulated cycle to be 14%, the chance of a pregnancy with IUI in a natural cycle would be between 14% and 34%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Pregnancy rate per couple (all cycles)",
                "sec_num": "4.3"
            },
            {
                "text": "OHSS was not reported.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Moderate or severe ovarian hyperstimulation syndrome rate per woman",
                "sec_num": null
            },
            {
                "text": "Analysis 4.4",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Miscarriage rate per couple",
                "sec_num": "4.4"
            },
            {
                "text": "It is uncertain whether treatment with IUI in a natural cycle results in a lower miscarriage rate compared to treatment with expectant management in a stimulated cycle (OR 0.91, 95% CI 0.32 to 2.58; 1 RCT, 342 women; low-quality evidence).The evidence suggests that if we assume the risk of a miscarriage with expectant management in a stimulated cycle to be 5%, the risk of a miscarriage with IUI in a natural cycle would be between 2% and 11%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Miscarriage rate per couple",
                "sec_num": "4.4"
            },
            {
                "text": "Analysis 4.5 Although two ectopic pregnancies occurred in the IUI group, it is uncertain whether treatment with IUI in a natural cycle results in a lower ectopic pregnancy rate compared to treatment with expectant management in a stimulated cycle (OR 5.30, 95% CI 0.25 to 111.26; 1 RCT, 342 women; low-quality evidence).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Ectopic pregnancy",
                "sec_num": "4.5"
            },
            {
                "text": "Analysis 5. Cochrane Database of Systematic Reviews women; low-quality evidence).The evidence suggests that if we assume the chance of a live birth with IUI in a natural cycle to be 14%, the chance of a live birth with IUI in a stimulated cycle would be between 17% and 36%.In a sensitivity analysis, we obtained a similar result by excluding Arici 1994, a cross-over trial (OR 2.02, 95% CI 1.18 to 3.45; I 2 = 0%; 3 RCTs, 370 women); however, it is uncertain whether treatment with IUI in a stimulated cycle results in a higher cumulative live birth rate compared to treatment with IUI in a natural cycle when we excluded Guzick 1999, a study with unclear risk of bias for random sequence generation and allocation concealment (OR 1.69, 95% CI 0.83 to 3.44; I 2 = 0%; 3 RCTs, 185 women).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Live birth rate per couple (all cycles)",
                "sec_num": "5.1"
            },
            {
                "text": "Analysis 5.2 It is uncertain whether treatment with IUI in a stimulated cycle results in a higher multiple pregnancy rate compared to treatment with IUI in a natural cycle (OR 3.00, 95% CI 0.11 to 78.27; 1 RCT, 39; women; low-quality evidence) (Figure 5 ).",
                "cite_spans": [],
                "ref_spans": [
                    {
                        "start": 252,
                        "end": 253,
                        "text": "5",
                        "ref_id": "FIGREF5"
                    }
                ],
                "eq_spans": [],
                "section": "Multiple pregnancy rate per couple",
                "sec_num": "5.2"
            },
            {
                "text": "Analysis 5.3 It is uncertain whether treatment with IUI in a stimulated cycle results in a higher cumulative pregnancy rate compared to treatment with IUI in a natural cycle (OR 6.43, 95% CI 0.56 to 73.35; 1 RCT, 26 women; low-quality evidence).The evidence suggests that if we assume the chance of a pregnancy with IUI in a natural cycle to be 6%, the chance of a pregnancy with IUI in a stimulated cycle would be between 4% and 83%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Pregnancy rate per couple (all cycles)",
                "sec_num": "5.3"
            },
            {
                "text": "There were no reported cases of OHSS.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Moderate or severe ovarian hyperstimulation syndrome rate per woman",
                "sec_num": null
            },
            {
                "text": "Analysis 5.4",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Miscarriage rate per couple",
                "sec_num": "5.4"
            },
            {
                "text": "One miscarriage in the stimulated group was reported by Arici 1994.Guzick 1999 reported a total miscarriage rate of approximately 24% in all couples undergoing IUI treatment.It is uncertain whether treatment with IUI in a stimulated cycle results in a higher miscarriage rate compared to treatment with IUI in a natural cycle (OR 5.21, 95% CI 0.19 to 141.08; 1 RCT, 26 women; low-quality evidence).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Miscarriage rate per couple",
                "sec_num": "5.4"
            },
            {
                "text": "Analysis 5.5 It is uncertain whether treatment with IUI in a stimulated cycle results in a higher ectopic pregnancy rate compared to treatment with IUI in a natural cycle (OR 6.48, 95% CI 0.33 to 127.09; 1 RCTs, 211 women; very low-quality evidence).",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Ectopic pregnancy rate per couple",
                "sec_num": "5.5"
            },
            {
                "text": "This is an update of a Cochrane Review which assessed whether the live birth rate is improved with intrauterine insemination (IUI), with or without ovarian hyperstimulation (OH), compared to timed intercourse (TI) or expectant management with or without OH, or with IUI with OH compared to IUI in a natural cycle, for couples with unexplained subfertility.Fi een studies met the eligibility criteria for inclusion; they investigated di erent IUI treatment modalities in five comparisons involving a total of 2068 women.Primary outcomes reported were cumulative live birth rates and multiple pregnancy rates.Secondary outcomes reported were cumulative pregnancy rates and other adverse events, including moderate to severe ovarian hyperstimulation syndrome (OHSS) rates, miscarriage rates, and ectopic pregnancy rates.The five comparisons identified in the included studies are classified into two broad groups as follows:",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "D I S C U S S I O N Summary of main results",
                "sec_num": null
            },
            {
                "text": "We identified four comparisons in this group:",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "IUI with or without OH versus TI or expectant management with or without OH",
                "sec_num": "1."
            },
            {
                "text": "1. IUI in a natural cycle versus TI or expectant management in a natural cycle; 2. IUI in a stimulated cycle versus TI or expectant management in a stimulated cycle; 3. IUI in a stimulated cycle versus TI or expectant management in a natural cycle; and 4. IUI in a natural cycle versus TI or expectant management in a stimulated cycle.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "IUI with or without OH versus TI or expectant management with or without OH",
                "sec_num": "1."
            },
            {
                "text": "For live birth, it is uncertain whether treatment with IUI in a natural cycle results in a higher cumulative live birth rate compared to treatment with expectant management in a natural cycle.We obtained a similar result with treatment with IUI in a stimulated cycle compared to TI in a stimulated cycle.However, there is",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "IUI with or without OH versus TI or expectant management with or without OH",
                "sec_num": "1."
            },
            {
                "text": "Trusted evidence.Informed decisions.Better health.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "Cochrane Database of Systematic Reviews moderate-quality evidence that treatment with IUI in a stimulated cycle is likely to result in a higher cumulative live birth rate compared to treatment with expectant management in a natural cycle in couples with a low prediction score of natural conception.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "The evidence suggests that if we assume the chance of a live birth with expectant management in a natural cycle to be 9%, the chance of a live birth with IUI in a stimulated cycle would be between 17% and 50%.Similarly, there is moderate-quality evidence that treatment with IUI in a natural cycle is likely to result in a higher cumulative live birth rate compared to expectant management in a stimulated cycle.The evidence suggests that if we assume the chance of a live birth with expectant management in a stimulated cycle to be 13%, the chance of a live birth with IUI in a natural cycle would be between 14% and 34%.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "For multiple pregnancy, it is uncertain whether treatment with IUI with or without OH results in lower multiple pregnancy rates compared to treatment with TI or expectant management, with or without OH.For other adverse events such as OHSS rates, miscarriage rates and ectopic pregnancy rates, there were insu icient data to adequately assess the impact of these treatment modalities; data on these outcomes were either not reported or reported in single studies with small sample sizes.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "For live birth, there is low-quality evidence that treatment with IUI in a stimulated cycle may result in a higher cumulative live birth rate compared to treatment with IUI in a natural cycle.The evidence suggests that if we assume the chance of a live birth with IUI in a natural cycle to be 14%, the chance of a live birth with IUI in a stimulated cycle would be between 17% and 36%.We tested the robustness of this finding in a sensitivity analysis by excluding a study with unclear risk of bias for random sequence generation and allocation concealment; the result showed that without this trial there was probably little or no di erence in live birth rates between the two treatment groups.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "IUI in a stimulated cycle versus IUI in a natural cycle",
                "sec_num": "2."
            },
            {
                "text": "For multiple pregnancy, it is uncertain whether treatment with IUI in a stimulated cycle results in a lower multiple pregnancy rate compared with treatment with IUI in a natural cycle.For other adverse events such as OHSS rates, miscarriage rates and ectopic pregnancy rates, there were insu icient data to adequately assess the impact of this treatment modality; data on these outcomes were mostly reported in single studies with small sample sizes.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "IUI in a stimulated cycle versus IUI in a natural cycle",
                "sec_num": "2."
            },
            {
                "text": "Most of the comparisons identified in this review were investigated in single trials, thereby making it di icult to combine data in metaanalyses.Where we could pool data in meta-analyses, the overall e ect estimates usually had wide confidence intervals due to small sample sizes with low numbers of events.Furthermore, we were not able to assess all the stipulated outcomes for each comparison.There were not enough data available to adequately assess the e ects of the various interventions on live birth, multiple pregnancy and other adverse events.Many studies were not included in the review as they reported per-cycle data only.One of the areas of particular concern in fertility trials is what statisticians refer to as the 'unit of analysis' error (Vail 2003) .It is methodologically incorrect to report data per cycle when it is women or couples who are randomised, because many of the women would have undergone more than one treatment cycle (Dias 2008; Johnson 2003; Vail 2003 ).Yet pregnancy rate per cycle is a commonlyreported outcome in fertility trials and reviews.We could also not include many studies with a cross-over design in the review because they did not report pre-cross-over data.We could not include post-cross-over data because couples would have received both treatment modalities.There have been many discussions about whether a cross-over design is appropriate for fertility trials, mainly because participants drop out a er treatment success, which results in a selected participant population post-cross-over.",
                "cite_spans": [
                    {
                        "start": 756,
                        "end": 767,
                        "text": "(Vail 2003)",
                        "ref_id": "BIBREF64"
                    },
                    {
                        "start": 952,
                        "end": 963,
                        "text": "(Dias 2008;",
                        "ref_id": null
                    },
                    {
                        "start": 964,
                        "end": 977,
                        "text": "Johnson 2003;",
                        "ref_id": null
                    },
                    {
                        "start": 978,
                        "end": 987,
                        "text": "Vail 2003",
                        "ref_id": "BIBREF64"
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Overall completeness and applicability of evidence",
                "sec_num": null
            },
            {
                "text": "For this reason, it has been suggested that the cross-over design has no place in infertility trials (Daya 1993) .A cross-over design could result in an overestimation of the treatment e ect (Khan 1996; Norman 2000) .Whether this overestimation could be statistically corrected for or whether it is clinically relevant remains under debate (Cohlen 1998; McDonnell 2004; Vail 2003) .",
                "cite_spans": [
                    {
                        "start": 101,
                        "end": 112,
                        "text": "(Daya 1993)",
                        "ref_id": null
                    },
                    {
                        "start": 191,
                        "end": 202,
                        "text": "(Khan 1996;",
                        "ref_id": null
                    },
                    {
                        "start": 203,
                        "end": 215,
                        "text": "Norman 2000)",
                        "ref_id": null
                    },
                    {
                        "start": 340,
                        "end": 353,
                        "text": "(Cohlen 1998;",
                        "ref_id": null
                    },
                    {
                        "start": 354,
                        "end": 369,
                        "text": "McDonnell 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 370,
                        "end": 380,
                        "text": "Vail 2003)",
                        "ref_id": "BIBREF64"
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Overall completeness and applicability of evidence",
                "sec_num": null
            },
            {
                "text": "Adverse events were o en not mentioned, or mentioned by group instead of by treatment modality.We included studies mentioning 'no events' in the meta-analyses, which might result in underestimation of the adverse events.On the other hand, these adverse events are mostly attributed to OH and not to IUI.It seems therefore unlikely that any significant di erence in adverse events would be found when OH with TI is compared to OH with IUI.We could not determine the separate evidence for the number of treatment cycles and methods of ovarian hyperstimulation, due to insu icient studies.In addition, we did not examine the e ects of important prognostic factors such as age, duration of subfertility and previous treatment in subgroup analyses, although there would have been insu icient data to do these analyses if we had decided to do so.The extent to which some of the findings which show evidence of a di erence between the intervention groups are applicable to couples with di erent prognoses and baseline fecundity is therefore unclear.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Overall completeness and applicability of evidence",
                "sec_num": null
            },
            {
                "text": "The more recent studies adopted expectant management as a control treatment for IUI instead of timed intercourse (Bhattacharya 2008; Farquhar 2018; Steures 2006a) .Because timing of intercourse (TI) interferes with the natural coital habits of a couple, expectant management has been proposed as the more appropriate comparison treatment for IUI (Wilcox 1995) .A recent meta-analysis, however, shows no significant di erence in the pregnancy rate between studies comparing IUI versus TI and studies with IUI versus expectant management (Snick 2008) .",
                "cite_spans": [
                    {
                        "start": 113,
                        "end": 132,
                        "text": "(Bhattacharya 2008;",
                        "ref_id": null
                    },
                    {
                        "start": 133,
                        "end": 147,
                        "text": "Farquhar 2018;",
                        "ref_id": null
                    },
                    {
                        "start": 148,
                        "end": 162,
                        "text": "Steures 2006a)",
                        "ref_id": null
                    },
                    {
                        "start": 346,
                        "end": 359,
                        "text": "(Wilcox 1995)",
                        "ref_id": null
                    },
                    {
                        "start": 536,
                        "end": 548,
                        "text": "(Snick 2008)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Overall completeness and applicability of evidence",
                "sec_num": null
            },
            {
                "text": "Whether it is appropriate to pool studies including TI and expectant management in a meta-analysis remains unclear.We did not, however, pool the data from Bhattacharya 2008, Farquhar 2018 and Steures 2006a with data of trials applying TI because these trials comprised comparisons that were not subject to many other trials.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Overall completeness and applicability of evidence",
                "sec_num": null
            },
            {
                "text": "Most of the studies included in this review were of moderatelygood quality in relation to risk of bias.We excluded studies with a cross-over design which did not report pre-cross-over data.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Quality of the evidence",
                "sec_num": null
            },
            {
                "text": "Most of the included studies clearly described their methods of sequence generation and allocation concealment.None of the included studies reported blinding, due to the nature of the interventions; however, lack of blinding may not have any e ect on the outcomes of interest, as they were objectively assessed.For most comparisons, e ect estimates were associated with imprecision due to small sample sizes and wide confidence intervals.We assessed the quality of the evidence for the review's five comparisons; the quality of the evidence for our primary",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Quality of the evidence",
                "sec_num": null
            },
            {
                "text": "Trusted evidence.Informed decisions.Better health.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "Cochrane Database of Systematic Reviews outcomes (cumulative live birth and multiple pregnancy) ranged from low to moderate.The main limitations in the body of evidence were very serious imprecision due to small sample sizes with low event rates and e ect estimates with wide confidence intervals, and inadequate reporting of adverse events.We could not examine the presence of publication or reporting bias in funnel plots for any of the comparisons, as none of the analyses included 10 or more studies.We therefore did not downgrade the quality of the evidence for publication bias.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Library",
                "sec_num": null
            },
            {
                "text": "To prevent selection bias, the included studies were independently selected and data extracted by two review authors (ROA and SVV for the 2020 update).We resolved disagreements by discussion, keeping the protocol as our guideline to reduce bias.We consulted a statistician (Andy Vail) for the data extraction of complicated cross-over trials.We have extracted and calculated the events per randomised couple for this meta-analysis, which resulted in the exclusion of six studies reporting only post-cross-over or percycle data.As a consequence, the analysis is statistically less biased, although a selection bias may have occurred.We could not construct a funnel plot for any of the outcomes to check for the presence of publication bias as none of the outcomes was reported by 10 or more studies.We have, however, minimised the e ect of publication bias by undertaking a comprehensive search for all eligible studies.",
                "cite_spans": [
                    {
                        "start": 273,
                        "end": 284,
                        "text": "(Andy Vail)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Potential biases in the review process",
                "sec_num": null
            },
            {
                "text": "Previous review articles and meta-analyses (e.g. Aboulghar 2003; Balasch 2004; Cohlen 2005; Costello 2004; Hughes 1997; Zeyneloglu 1998 ) have all assessed the e ectiveness of IUI and ovarian hyperstimulation, but they have all calculated pregnancy rates per cycle, which makes it di icult to compare their findings with those of this review which included per-couple data only.Percycle data produce biased results that may exaggerate treatment results (Dias 2008) .A Cochrane Review and meta-analysis published in 2019 (Wang 2019) evaluated the e ectiveness and safety of di erent approaches to clinical management (expectant management, ovarian stimulation, intra-uterine insemination, ovarian stimulation-intra-uterine insemination, and in vitrofertilisation/intracytoplasmic sperm injection) in couples with unexplained infertility.There was insu icient evidence of di erences in live births between intra-uterine insemination or ovarian stimulation-intra-uterine insemination compared to expectant management (OR 1.21, 95% CI 0.61 to 2.43; low-certainty evidence; OR 1.61, 95% CI 0.88 to 2.94; low-certainty evidence respectively).These findings are similar to our findings on live births in the corresponding comparisons in our review.",
                "cite_spans": [
                    {
                        "start": 49,
                        "end": 64,
                        "text": "Aboulghar 2003;",
                        "ref_id": "BIBREF2"
                    },
                    {
                        "start": 65,
                        "end": 78,
                        "text": "Balasch 2004;",
                        "ref_id": null
                    },
                    {
                        "start": 79,
                        "end": 91,
                        "text": "Cohlen 2005;",
                        "ref_id": null
                    },
                    {
                        "start": 92,
                        "end": 106,
                        "text": "Costello 2004;",
                        "ref_id": "BIBREF9"
                    },
                    {
                        "start": 107,
                        "end": 119,
                        "text": "Hughes 1997;",
                        "ref_id": null
                    },
                    {
                        "start": 120,
                        "end": 135,
                        "text": "Zeyneloglu 1998",
                        "ref_id": null
                    },
                    {
                        "start": 453,
                        "end": 464,
                        "text": "(Dias 2008)",
                        "ref_id": null
                    },
                    {
                        "start": 520,
                        "end": 531,
                        "text": "(Wang 2019)",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Agreements and disagreements with other studies or reviews",
                "sec_num": null
            },
            {
                "text": "Due to insu icient data, it is uncertain whether treatment with IUI with or without OH compared to timed intercourse or expectant management with or without OH, or treatment with IUI with OH compared to IUI in a natural cycle, improves cumulative live birth rates with acceptable multiple pregnancy rates in couples with unexplained subfertility.However, there is moderatequality evidence that treatment with IUI with OH probably results in a higher cumulative live birth rate compared to expectant management, without OH in couples with a low prediction score of natural conception.Similarly, there is moderate-quality evidence that treatment with IUI in a natural cycle probably results in a higher cumulative live birth rate compared to treatment with timed intercourse with OH.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Implications for practice",
                "sec_num": null
            },
            {
                "text": "None of the comparisons examined in this review were adequately addressed, due to insu icient data; questions still remain as to whether live birth rates can be improved while keeping the risk of multiple pregnancy and other adverse events to acceptable levels.There is therefore a need for better-designed randomised controlled trials which evaluate the e ects of di erent IUI modalities on important outcome measures.Furthermore, future trials should endeavour to report live birth and other outcome data in forms which enable appropriate analyses.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "Implications for research",
                "sec_num": null
            },
            {
                "text": "We wish to thank all colleagues of Cochrane Gynaecology and Fertility for their help.Special thanks to Elena Kostova, Marian Showell, Cindy Farquhar, Helen Nagels and statistician Andy Vail for all their advice and support.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "A C K N O W L E D G E M E N T S",
                "sec_num": null
            },
            {
                "text": "We also thank all authors for their responses and additional information on their trials.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "A C K N O W L E D G E M E N T S",
                "sec_num": null
            },
            {
                "text": "We acknowledge the contribution of Professor Maas Jan Heineman and Professor Ed Hughes to previous versions of this review.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "A C K N O W L E D G E M E N T S",
                "sec_num": null
            },
            {
                "text": "We would like to thank Abha Maheshwari, Rik van Eekelen, Astrid Cantineau, and Rui Wang for their valuable peer review comments.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "A C K N O W L E D G E M E N T S",
                "sec_num": null
            },
            {
                "text": "Protocol first published: Issue 3, 1999 Review first published: Issue 4, 2006 ",
                "cite_spans": [
                    {
                        "start": 64,
                        "end": 77,
                        "text": "Issue 4, 2006",
                        "ref_id": null
                    }
                ],
                "ref_spans": [],
                "eq_spans": [],
                "section": "H I S T O R Y",
                "sec_num": null
            },
            {
                "text": "Intra-uterine insemination for unexplained subfertility (Review)Copyright \u00a9 2020 The Cochrane Collaboration.Published by John Wiley & Sons, Ltd.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "",
                "sec_num": null
            }
        ],
        "back_matter": [
            {
                "text": "\u2022 Van Harreveld Stichting, Netherlands.\u2022 Marco Polo fonds, Netherlands.\u2022 Stichting de Korinthiers, Netherlands.\u2022 Jan Kornelis de Kock Stichting, Netherlands.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "External sources",
                "sec_num": null
            },
            {
                "text": "1. We reclassified multiple pregnancy rate to be a primary outcome in the 2016 and 2020 updates.2. We included aromatase inhibitors such as letrozole as agents for ovarian hyperstimulation in the 2020 update and this was reflected in the search strategies.3. We conducted sensitivity analyses for the primary outcomes (live birth and multiple pregnancy) for studies with 'Risk of bias' or 'unit of analysis' errors in the 2020 update.",
                "cite_spans": [],
                "ref_spans": [],
                "eq_spans": [],
                "section": "D I F F E R E N C E S B E T W E E N P R O T O C O L A N D R E V I E W",
                "sec_num": null
            }
        ],
        "bib_entries": {
            "BIBREF1": {
                "ref_id": "b1",
                "title": "Intrauterine insemination (IUI) with or without letrozole for unexplained or mild male factor infertility: a randomized pilot study",
                "authors": [
                    {
                        "first": "S",
                        "middle": [],
                        "last": "Huang",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Wang",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Li",
                        "suffix": ""
                    },
                    {
                        "first": "H",
                        "middle": [],
                        "last": "Yan",
                        "suffix": ""
                    },
                    {
                        "first": "N",
                        "middle": [],
                        "last": "Li",
                        "suffix": ""
                    },
                    {
                        "first": "H",
                        "middle": [],
                        "last": "Wang",
                        "suffix": ""
                    }
                ],
                "year": 2019,
                "venue": "Human Reproduction",
                "volume": "34",
                "issue": "Suppl 1",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF2": {
                "ref_id": "b2",
                "title": "Diagnosis and management of unexplained infertility: an update",
                "authors": [
                    {
                        "first": "M",
                        "middle": [
                            "A"
                        ],
                        "last": "Aboulghar",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [
                            "T"
                        ],
                        "last": "Mansour",
                        "suffix": ""
                    },
                    {
                        "first": "G",
                        "middle": [
                            "I"
                        ],
                        "last": "Serour",
                        "suffix": ""
                    },
                    {
                        "first": "Al-Inany",
                        "middle": [],
                        "last": "Hg",
                        "suffix": ""
                    }
                ],
                "year": 2003,
                "venue": "Archives of Gynecology and Obstetrics",
                "volume": "267",
                "issue": "4",
                "pages": "177--188",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF4": {
                "ref_id": "b4",
                "title": "Gonadotrophin ovarian stimulation and intrauterine insemination for unexplained infertility",
                "authors": [
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Balasch",
                        "suffix": ""
                    }
                ],
                "year": 2004,
                "venue": "Reproductive Biomedicine Online",
                "volume": "9",
                "issue": "6",
                "pages": "664--672",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF6": {
                "ref_id": "b6",
                "title": "Crossover or parallel design in infertility trials? The discussion continues",
                "authors": [
                    {
                        "first": "B",
                        "middle": [
                            "J"
                        ],
                        "last": "Cohlen",
                        "suffix": ""
                    },
                    {
                        "first": "Te",
                        "middle": [],
                        "last": "Velde",
                        "suffix": ""
                    },
                    {
                        "first": "E",
                        "middle": [
                            "R"
                        ],
                        "last": "Looman",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [
                            "W"
                        ],
                        "last": "Eijckemans",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Habbema",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "D"
                        ],
                        "last": "",
                        "suffix": ""
                    }
                ],
                "year": 1998,
                "venue": "Fertility and Sterility",
                "volume": "70",
                "issue": "1",
                "pages": "40--45",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF8": {
                "ref_id": "b8",
                "title": "Multiple pregnancy a er assisted reproduction",
                "authors": [
                    {
                        "first": "B",
                        "middle": [],
                        "last": "Cohlen",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Cantineau",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [],
                        "last": "'hooghe",
                        "suffix": ""
                    },
                    {
                        "first": "T",
                        "middle": [],
                        "last": "",
                        "suffix": ""
                    },
                    {
                        "first": "Te",
                        "middle": [],
                        "last": "Velde",
                        "suffix": ""
                    },
                    {
                        "first": "E",
                        "middle": [],
                        "last": "",
                        "suffix": ""
                    }
                ],
                "year": 2005,
                "venue": "Lancet",
                "volume": "366",
                "issue": "",
                "pages": "452--453",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF9": {
                "ref_id": "b9",
                "title": "Systematic review of the treatment of ovulatory infertility with clomiphene citrate and intrauterine insemination",
                "authors": [
                    {
                        "first": ";",
                        "middle": [],
                        "last": "Costello",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [
                            "F"
                        ],
                        "last": "Costello",
                        "suffix": ""
                    }
                ],
                "year": 2004,
                "venue": "Australian & New Zealand Journal of Obstetrics & Gynaecology",
                "volume": "44",
                "issue": "2",
                "pages": "93--102",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF11": {
                "ref_id": "b11",
                "title": "Follicle stimulating hormone versus clomiphene citrate in intrauterine insemination for unexplained subfertility: a randomized controlled trial",
                "authors": [
                    {
                        "first": "N",
                        "middle": [
                            "A"
                        ],
                        "last": "Danhof",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Van Wely",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [],
                        "last": "Repping",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [],
                        "last": "Koks",
                        "suffix": ""
                    },
                    {
                        "first": "H",
                        "middle": [
                            "R"
                        ],
                        "last": "Verhoeve",
                        "suffix": ""
                    },
                    {
                        "first": "De",
                        "middle": [],
                        "last": "Bruin",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "P"
                        ],
                        "last": "",
                        "suffix": ""
                    }
                ],
                "year": 2018,
                "venue": "Human Reproduction",
                "volume": "33",
                "issue": "10",
                "pages": "1866--1874",
                "other_ids": {
                    "DOI": [
                        "10.1093/humrep/dey268"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF13": {
                "ref_id": "b13",
                "title": "Is there a place for the crossover design in infertility trials?",
                "authors": [
                    {
                        "first": "S",
                        "middle": [],
                        "last": "Daya",
                        "suffix": ""
                    }
                ],
                "year": 1993,
                "venue": "Fertility and Sterility",
                "volume": "59",
                "issue": "1",
                "pages": "6--7",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF15": {
                "ref_id": "b15",
                "title": "on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking metaanalyses",
                "authors": [
                    {
                        "first": "J",
                        "middle": [
                            "J"
                        ],
                        "last": "Deeks",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "P"
                        ],
                        "last": "Higgins",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [
                            "G"
                        ],
                        "last": "Altman",
                        "suffix": ""
                    }
                ],
                "year": 2017,
                "venue": "Cochrane Handbook for Systematic Reviews of Interventions version 5",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF16": {
                "ref_id": "b16",
                "title": "Letrozole, gonadotropin,or clomiphene for unexplained infertility",
                "authors": [
                    {
                        "first": "M",
                        "middle": [
                            "P"
                        ],
                        "last": "Diamond",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [
                            "L"
                        ],
                        "last": "Richar",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [],
                        "last": "Coutifaris",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Alvero",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Robinson",
                        "suffix": ""
                    },
                    {
                        "first": "P",
                        "middle": [],
                        "last": "Casson",
                        "suffix": ""
                    }
                ],
                "year": 2015,
                "venue": "New England Journal of Medicine",
                "volume": "373",
                "issue": "13",
                "pages": "1230--1240",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF18": {
                "ref_id": "b18",
                "title": "Bias in frequently reported analyses of subfertility trials",
                "authors": [
                    {
                        "first": "S",
                        "middle": [],
                        "last": "Dias",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Mcnamee",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Vail",
                        "suffix": ""
                    }
                ],
                "year": 2008,
                "venue": "Statistics in Medicine",
                "volume": "27",
                "issue": "27",
                "pages": "5605--5619",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF19": {
                "ref_id": "b19",
                "title": "Reducing the risk of high-order multiple pregnancy a er ovarian stimulation with gonadotropins",
                "authors": [
                    {
                        "first": "N",
                        "middle": [],
                        "last": "Gleicher",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [
                            "M"
                        ],
                        "last": "Oleske",
                        "suffix": ""
                    },
                    {
                        "first": "I",
                        "middle": [],
                        "last": "Tur-Kaspa",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Vidali",
                        "suffix": ""
                    },
                    {
                        "first": "V",
                        "middle": [],
                        "last": "Karande",
                        "suffix": ""
                    }
                ],
                "year": 2000,
                "venue": "New England Journal of Medicine",
                "volume": "343",
                "issue": "1",
                "pages": "2--7",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF21": {
                "ref_id": "b21",
                "title": "Further considerations on natural or mild hyperstimulation cycles for intrauterine insemination treatment: e ects on pregnancy and multiple pregnancy rates",
                "authors": [
                    {
                        "first": "A",
                        "middle": [
                            "J"
                        ],
                        "last": "Goverde",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [
                            "B"
                        ],
                        "last": "Lambalk",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Mcdonnell",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Schats",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Homburg",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "P"
                        ],
                        "last": "Vermeiden",
                        "suffix": ""
                    }
                ],
                "year": 2005,
                "venue": "Human Reproduction",
                "volume": "20",
                "issue": "11",
                "pages": "3141--3146",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF22": {
                "ref_id": "b22",
                "title": "GRADEpro Guideline Development Tool",
                "authors": [
                    {
                        "first": "Gdt",
                        "middle": [],
                        "last": "Gradepro",
                        "suffix": ""
                    }
                ],
                "year": 2015,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF24": {
                "ref_id": "b24",
                "title": "Chapter 8: Assessing risk of bias in included studies",
                "authors": [],
                "year": 2017,
                "venue": "Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF26": {
                "ref_id": "b26",
                "title": "The e ectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: a meta-analysis",
                "authors": [
                    {
                        "first": "E",
                        "middle": [
                            "G"
                        ],
                        "last": "Hughes",
                        "suffix": ""
                    }
                ],
                "year": 1997,
                "venue": "Human Reproduction",
                "volume": "12",
                "issue": "9",
                "pages": "1865--1872",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF28": {
                "ref_id": "b28",
                "title": "Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility.'E ective treatment' or 'not a natural choice'?",
                "authors": [
                    {
                        "first": "E",
                        "middle": [
                            "G"
                        ],
                        "last": "Hughes",
                        "suffix": ""
                    }
                ],
                "year": 2003,
                "venue": "Human Reproduction",
                "volume": "18",
                "issue": "5",
                "pages": "912--914",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF30": {
                "ref_id": "b30",
                "title": "Two new prediction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models",
                "authors": [
                    {
                        "first": "C",
                        "middle": [
                            "C"
                        ],
                        "last": "Hunault",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "D"
                        ],
                        "last": "Habbema",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [
                            "J"
                        ],
                        "last": "Eijkemans",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "A"
                        ],
                        "last": "Collins",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "L"
                        ],
                        "last": "Evers",
                        "suffix": ""
                    },
                    {
                        "first": "Te",
                        "middle": [],
                        "last": "Velde",
                        "suffix": ""
                    },
                    {
                        "first": "E",
                        "middle": [
                            "R"
                        ],
                        "last": "",
                        "suffix": ""
                    }
                ],
                "year": 2004,
                "venue": "Human Reproduction",
                "volume": "19",
                "issue": "9",
                "pages": "2019--2026",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF32": {
                "ref_id": "b32",
                "title": "Gaps in the evidence for fertility treatment -an analysis of the Cochrane Menstrual Disorders and Subfertility Group database",
                "authors": [
                    {
                        "first": "N",
                        "middle": [
                            "P"
                        ],
                        "last": "Johnson",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Proctor",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [
                            "M"
                        ],
                        "last": "Farquhar",
                        "suffix": ""
                    }
                ],
                "year": 2003,
                "venue": "Human Reproduction",
                "volume": "18",
                "issue": "5",
                "pages": "947--954",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF34": {
                "ref_id": "b34",
                "title": "Empirical evidence of bias in infertility research: overestimation of treatment e ect in crossover trials using pregnancy as the outcome measure",
                "authors": [
                    {
                        "first": "K",
                        "middle": [
                            "S"
                        ],
                        "last": "Khan",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [],
                        "last": "Daya",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "A"
                        ],
                        "last": "Collins",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [
                            "D"
                        ],
                        "last": "Walter",
                        "suffix": ""
                    }
                ],
                "year": 1996,
                "venue": "Fertility and Sterility",
                "volume": "65",
                "issue": "5",
                "pages": "939--945",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF36": {
                "ref_id": "b36",
                "title": "Intrauterine insemination versus intracervical insemination in donor sperm treatment",
                "authors": [
                    {
                        "first": "Pal",
                        "middle": [],
                        "last": "Kop",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [
                            "H"
                        ],
                        "last": "Mochtar",
                        "suffix": ""
                    },
                    {
                        "first": "O'",
                        "middle": [],
                        "last": "Brien",
                        "suffix": ""
                    },
                    {
                        "first": "P",
                        "middle": [
                            "A"
                        ],
                        "last": "Van Der Veen",
                        "suffix": ""
                    },
                    {
                        "first": "F",
                        "middle": [],
                        "last": "Van Wely",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "",
                        "suffix": ""
                    }
                ],
                "year": 2018,
                "venue": "Cochrane Database of Systematic Reviews",
                "volume": "",
                "issue": "1",
                "pages": "",
                "other_ids": {
                    "DOI": [
                        "10.1002/14651858.CD000317.pub4"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF38": {
                "ref_id": "b38",
                "title": "Chapter 6: Searching for studies",
                "authors": [
                    {
                        "first": "C",
                        "middle": [],
                        "last": "Lefebvre",
                        "suffix": ""
                    },
                    {
                        "first": "E",
                        "middle": [],
                        "last": "Manheimer",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Glanville",
                        "suffix": ""
                    }
                ],
                "year": 2011,
                "venue": "Cochrane Handbook for Systematic Reviews of Interventions Version 5",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF40": {
                "ref_id": "b40",
                "title": "The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration",
                "authors": [
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Liberati",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [
                            "G"
                        ],
                        "last": "Altman",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Tetzla",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [],
                        "last": "Mulrow",
                        "suffix": ""
                    },
                    {
                        "first": "P",
                        "middle": [
                            "C"
                        ],
                        "last": "G\u00f8tzsche",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "P"
                        ],
                        "last": "Ioannidis",
                        "suffix": ""
                    }
                ],
                "year": 2009,
                "venue": "PLoS Medicine",
                "volume": "6",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF42": {
                "ref_id": "b42",
                "title": "The place of the crossover design in infertility trials: a maximum likelihood approach",
                "authors": [
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Mcdonnell",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [
                            "J"
                        ],
                        "last": "Goverde",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "P"
                        ],
                        "last": "Vermeiden",
                        "suffix": ""
                    }
                ],
                "year": 2004,
                "venue": "Human Reproduction",
                "volume": "19",
                "issue": "11",
                "pages": "2537--2544",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF44": {
                "ref_id": "b44",
                "title": "Intra-uterine insemination or timed intercourse a er ovarian stimulation for male subfertility? A controlled study",
                "authors": [
                    {
                        "first": "P",
                        "middle": [
                            "M"
                        ],
                        "last": "Nan",
                        "suffix": ""
                    },
                    {
                        "first": "B",
                        "middle": [
                            "J"
                        ],
                        "last": "Cohlen",
                        "suffix": ""
                    },
                    {
                        "first": "Te",
                        "middle": [],
                        "last": "Velde",
                        "suffix": ""
                    },
                    {
                        "first": "E",
                        "middle": [
                            "R"
                        ],
                        "last": "",
                        "suffix": ""
                    },
                    {
                        "first": "Van",
                        "middle": [],
                        "last": "Kooij",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [
                            "J"
                        ],
                        "last": "Eimers",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Van Zonneveld",
                        "suffix": ""
                    },
                    {
                        "first": "O",
                        "middle": [],
                        "last": "",
                        "suffix": ""
                    }
                ],
                "year": 1994,
                "venue": "Human Reproduction",
                "volume": "9",
                "issue": "11",
                "pages": "2022--2026",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF45": {
                "ref_id": "b45",
                "title": "Assessment and treatment for people with fertility problems",
                "authors": [],
                "year": 2013,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF47": {
                "ref_id": "b47",
                "title": "The alternating-sequence design (or multiple-period crossover) trial for evaluating treatment e icacy in infertility",
                "authors": [
                    {
                        "first": "G",
                        "middle": [
                            "R"
                        ],
                        "last": "Norman",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [],
                        "last": "Daya",
                        "suffix": ""
                    }
                ],
                "year": 2000,
                "venue": "Fertility and Sterility",
                "volume": "74",
                "issue": "2",
                "pages": "319--324",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF49": {
                "ref_id": "b49",
                "title": "Multiple gestation and infertility treatment: registration, reflection and Ripps",
                "authors": [
                    {
                        "first": "W",
                        "middle": [],
                        "last": "Ombelet",
                        "suffix": ""
                    },
                    {
                        "first": "De",
                        "middle": [],
                        "last": "Sutter",
                        "suffix": ""
                    },
                    {
                        "first": "P",
                        "middle": [],
                        "last": "Van Der Elst",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Martens",
                        "suffix": ""
                    },
                    {
                        "first": "G",
                        "middle": [],
                        "last": "",
                        "suffix": ""
                    }
                ],
                "year": 1994,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF50": {
                "ref_id": "b50",
                "title": "Intrauterine insemination in fertile women delivers larger numbers of sperm to the peritoneal fluid than intracervical insemination",
                "authors": [
                    {
                        "first": "B",
                        "middle": [
                            "A"
                        ],
                        "last": "Ripps",
                        "suffix": ""
                    },
                    {
                        "first": "B",
                        "middle": [
                            "S"
                        ],
                        "last": "Minhas",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [
                            "A"
                        ],
                        "last": "Carson",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "E"
                        ],
                        "last": "Buster",
                        "suffix": ""
                    }
                ],
                "year": 1994,
                "venue": "Fertility and Sterility",
                "volume": "61",
                "issue": "2",
                "pages": "398--400",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF52": {
                "ref_id": "b52",
                "title": "The desire of infertile patients for multiple births",
                "authors": [
                    {
                        "first": "G",
                        "middle": [
                            "L"
                        ],
                        "last": "Ryan",
                        "suffix": ""
                    },
                    {
                        "first": "S",
                        "middle": [
                            "H"
                        ],
                        "last": "Zhang",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Dokras",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [
                            "H"
                        ],
                        "last": "Syrop",
                        "suffix": ""
                    },
                    {
                        "first": "Van",
                        "middle": [],
                        "last": "Voorhis",
                        "suffix": ""
                    },
                    {
                        "first": "B",
                        "middle": [
                            "J"
                        ],
                        "last": "",
                        "suffix": ""
                    }
                ],
                "year": 2004,
                "venue": "Fertility and Sterility",
                "volume": "81",
                "issue": "3",
                "pages": "500--504",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF54": {
                "ref_id": "b54",
                "title": "on behalf of the Cochrane Applicability and Recommendations Methods Group. Chapter 12: Interpreting results and drawing conclusions",
                "authors": [
                    {
                        "first": "H",
                        "middle": [
                            "J"
                        ],
                        "last": "Sch\u00fcnemann",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [
                            "D"
                        ],
                        "last": "Oxman",
                        "suffix": ""
                    },
                    {
                        "first": "G",
                        "middle": [
                            "E"
                        ],
                        "last": "Vist",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "P"
                        ],
                        "last": "Higgins",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "J"
                        ],
                        "last": "Deeks",
                        "suffix": ""
                    },
                    {
                        "first": "P",
                        "middle": [],
                        "last": "Glasziou",
                        "suffix": ""
                    }
                ],
                "year": 2017,
                "venue": "Cochrane Handbook for Systematic Reviews of Interventions version 5",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF56": {
                "ref_id": "b56",
                "title": "What is the most valid comparison treatment in trials of intrauterine insemination, timed or uninfluenced intercourse? A systematic review and meta-analysis of indirect evidence",
                "authors": [
                    {
                        "first": "H",
                        "middle": [
                            "K"
                        ],
                        "last": "Snick",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "A"
                        ],
                        "last": "Collins",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "L"
                        ],
                        "last": "Evers",
                        "suffix": ""
                    }
                ],
                "year": 2008,
                "venue": "Human Reproduction",
                "volume": "23",
                "issue": "10",
                "pages": "2239--2245",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF58": {
                "ref_id": "b58",
                "title": "Chapter 10: Addressing reporting biases",
                "authors": [
                    {
                        "first": "J",
                        "middle": [
                            "A"
                        ],
                        "last": "Sterne",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [],
                        "last": "Egger",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [],
                        "last": "Moher",
                        "suffix": ""
                    },
                    {
                        "first": "I",
                        "middle": [],
                        "last": "Boutron",
                        "suffix": ""
                    }
                ],
                "year": 2017,
                "venue": "Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF60": {
                "ref_id": "b60",
                "title": "Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility. Should the guidelines be changed?",
                "authors": [
                    {
                        "first": "J",
                        "middle": [
                            "A"
                        ],
                        "last": "Stewart",
                        "suffix": ""
                    }
                ],
                "year": 2003,
                "venue": "Human Reproduction",
                "volume": "18",
                "issue": "5",
                "pages": "903--907",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF61": {
                "ref_id": "b61",
                "title": "The management of infertility",
                "authors": [
                    {
                        "first": "Te",
                        "middle": [],
                        "last": "Velde",
                        "suffix": ""
                    },
                    {
                        "first": "; Te",
                        "middle": [],
                        "last": "Velde",
                        "suffix": ""
                    },
                    {
                        "first": "E",
                        "middle": [
                            "R"
                        ],
                        "last": "Cohlen",
                        "suffix": ""
                    },
                    {
                        "first": "B",
                        "middle": [
                            "J"
                        ],
                        "last": "",
                        "suffix": ""
                    }
                ],
                "year": 1999,
                "venue": "New England Journal of Medicine",
                "volume": "340",
                "issue": "3",
                "pages": "224--226",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF63": {
                "ref_id": "b63",
                "title": "Use of a prediction model for high-order multiple implantation a er ovarian stimulation with gonadotropins",
                "authors": [
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Tur",
                        "suffix": ""
                    },
                    {
                        "first": "P",
                        "middle": [
                            "N"
                        ],
                        "last": "Barri",
                        "suffix": ""
                    },
                    {
                        "first": "B",
                        "middle": [],
                        "last": "Coroleu",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Buxaderas",
                        "suffix": ""
                    },
                    {
                        "first": "N",
                        "middle": [],
                        "last": "Parera",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [],
                        "last": "Balasch",
                        "suffix": ""
                    }
                ],
                "year": 2005,
                "venue": "Fertility and Sterility",
                "volume": "83",
                "issue": "1",
                "pages": "116--121",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF64": {
                "ref_id": "b64",
                "title": "Common statistical errors in the design and analysis of subfertility trials",
                "authors": [
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Vail",
                        "suffix": ""
                    },
                    {
                        "first": "E",
                        "middle": [],
                        "last": "Gardener",
                        "suffix": ""
                    }
                ],
                "year": 2003,
                "venue": "Human Reproduction",
                "volume": "18",
                "issue": "5",
                "pages": "1000--1004",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF66": {
                "ref_id": "b66",
                "title": "Is controlled ovarian stimulation in intrauterine insemination an acceptable therapy in couples with unexplained non-conception in the perspective of multiple pregnancies?",
                "authors": [
                    {
                        "first": "M",
                        "middle": [
                            "M"
                        ],
                        "last": "Van Rumste",
                        "suffix": ""
                    },
                    {
                        "first": "Den",
                        "middle": [],
                        "last": "Hartog",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "E"
                        ],
                        "last": "Dumoulin",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "C"
                        ],
                        "last": "Evers",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "L"
                        ],
                        "last": "Land",
                        "suffix": ""
                    },
                    {
                        "first": "J",
                        "middle": [
                            "A"
                        ],
                        "last": "",
                        "suffix": ""
                    }
                ],
                "year": 2006,
                "venue": "Human Reproduction",
                "volume": "21",
                "issue": "3",
                "pages": "701--704",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF68": {
                "ref_id": "b68",
                "title": "Interventions for unexplained infertility: a systematic review and network meta-analysis",
                "authors": [
                    {
                        "first": "R",
                        "middle": [],
                        "last": "Wang",
                        "suffix": ""
                    },
                    {
                        "first": "N",
                        "middle": [
                            "A"
                        ],
                        "last": "Danhof",
                        "suffix": ""
                    },
                    {
                        "first": "R",
                        "middle": [
                            "I"
                        ],
                        "last": "Tjon-Kon-Fat",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [
                            "J"
                        ],
                        "last": "Eijkemans",
                        "suffix": ""
                    },
                    {
                        "first": "P",
                        "middle": [
                            "M"
                        ],
                        "last": "Bossuyt",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [
                            "H"
                        ],
                        "last": "Mochtar",
                        "suffix": ""
                    }
                ],
                "year": 2019,
                "venue": "Cochrane Database of Systematic Reviews",
                "volume": "",
                "issue": "9",
                "pages": "",
                "other_ids": {
                    "DOI": [
                        "10.1002/14651858.CD012692.pub2"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF70": {
                "ref_id": "b70",
                "title": "Timing of sexual intercourse in relation to ovulation. E ects on the probability of conception, survival of the pregnancy, and sex of the baby",
                "authors": [
                    {
                        "first": "A",
                        "middle": [
                            "J"
                        ],
                        "last": "Wilcox",
                        "suffix": ""
                    },
                    {
                        "first": "C",
                        "middle": [
                            "R"
                        ],
                        "last": "Weinberg",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [
                            "D"
                        ],
                        "last": "Baird",
                        "suffix": ""
                    }
                ],
                "year": 1995,
                "venue": "New England Journal of Medicine",
                "volume": "333",
                "issue": "23",
                "pages": "1517--1521",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF72": {
                "ref_id": "b72",
                "title": "Comparison of intrauterine insemination with timed intercourse in superovulated cycles with gonadotropins: a meta-analysis",
                "authors": [
                    {
                        "first": "H",
                        "middle": [
                            "B"
                        ],
                        "last": "Zeyneloglu",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [],
                        "last": "Arici",
                        "suffix": ""
                    },
                    {
                        "first": "D",
                        "middle": [
                            "L"
                        ],
                        "last": "Olive",
                        "suffix": ""
                    },
                    {
                        "first": "A",
                        "middle": [
                            "J"
                        ],
                        "last": "Duleba",
                        "suffix": ""
                    }
                ],
                "year": 1998,
                "venue": "Fertility and Sterility",
                "volume": "69",
                "issue": "3",
                "pages": "486--491",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF73": {
                "ref_id": "b73",
                "title": "Intra-uterine insemination for unexplained subfertility (Protocol)",
                "authors": [
                    {
                        "first": "B",
                        "middle": [
                            "J"
                        ],
                        "last": "Cohlen",
                        "suffix": ""
                    },
                    {
                        "first": "E",
                        "middle": [],
                        "last": "Hughes",
                        "suffix": ""
                    },
                    {
                        "first": "E",
                        "middle": [
                            "R"
                        ],
                        "last": "Velde",
                        "suffix": ""
                    },
                    {
                        "first": "Te",
                        "middle": [],
                        "last": "Velde",
                        "suffix": ""
                    },
                    {
                        "first": "E",
                        "middle": [],
                        "last": "",
                        "suffix": ""
                    }
                ],
                "year": 1999,
                "venue": "Cochrane Database of Systematic Reviews",
                "volume": "",
                "issue": "4",
                "pages": "",
                "other_ids": {
                    "DOI": [
                        "10.1002/14651858.CD001838"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF75": {
                "ref_id": "b75",
                "title": "Intra-uterine insemination for unexplained subfertility",
                "authors": [
                    {
                        "first": "S",
                        "middle": [
                            "M"
                        ],
                        "last": "Veltman-Verhulst",
                        "suffix": ""
                    },
                    {
                        "first": "B",
                        "middle": [
                            "J"
                        ],
                        "last": "Cohlen",
                        "suffix": ""
                    },
                    {
                        "first": "E",
                        "middle": [],
                        "last": "Hughes",
                        "suffix": ""
                    },
                    {
                        "first": "M",
                        "middle": [
                            "J"
                        ],
                        "last": "Heineman",
                        "suffix": ""
                    }
                ],
                "year": 2006,
                "venue": "Cochrane Database of Systematic Reviews",
                "volume": "",
                "issue": "4",
                "pages": "",
                "other_ids": {
                    "DOI": [
                        "10.1002/14651858.CD001838.pub3"
                    ]
                },
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF76": {
                "ref_id": "b76",
                "title": "MESH DESCRIPTOR Infertility EXPLODE ALL TREES 2963 #2 (unexplained or idiopathic):TI,AB,KY 11267 #3 #1 AND #2 404 #(unexplain* adj5 infertil*):TI,AB,KY 603 #(unexplain",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF77": {
                "ref_id": "b77",
                "title": "MESH DESCRIPTOR Insemination",
                "authors": [],
                "year": null,
                "venue": "Artificial EXPLODE ALL TREES",
                "volume": "359",
                "issue": "13",
                "pages": "45--60",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF78": {
                "ref_id": "b78",
                "title": "TI,AB,KY 213 #17",
                "authors": [
                    {
                        "first": "",
                        "middle": [],
                        "last": "Superovulat",
                        "suffix": ""
                    }
                ],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF79": {
                "ref_id": "b79",
                "title": "ovar* adj3 stimulat*):TI,AB,KY 2155 #19",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "1355",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF80": {
                "ref_id": "b80",
                "title": "#21 #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19",
                "authors": [
                    {
                        "first": "A",
                        "middle": [
                            "B"
                        ],
                        "last": "Coh ; Ti",
                        "suffix": ""
                    }
                ],
                "year": null,
                "venue": "",
                "volume": "386",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF81": {
                "ref_id": "b81",
                "title": "#23 (Clomiphene or clomifene or Serophene):TI,AB,KY 1601 #24 clomid",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "603",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF82": {
                "ref_id": "b82",
                "title": "MESH DESCRIPTOR Selective Estrogen Receptor Modulators EXPLODE ALL TREES 2838 #26 (selective estrogen receptor modulator*):TI,AB,KY 721 #27",
                "authors": [],
                "year": null,
                "venue": "5461 #29 #22 OR #23 OR #24 OR #25 OR #26 OR #27",
                "volume": "258",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF83": {
                "ref_id": "b83",
                "title": "MESH DESCRIPTOR Aromatase Inhibitors EXPLODE ALL TREES",
                "authors": [],
                "year": 1945,
                "venue": "",
                "volume": "700",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF84": {
                "ref_id": "b84",
                "title": ",AB,KY 1186 #34 (anti-?estrogen* or anti?estrogen*):TI,AB",
                "authors": [
                    {
                        "first": "A",
                        "middle": [
                            "B"
                        ],
                        "last": "Ti",
                        "suffix": ""
                    },
                    {
                        "first": "",
                        "middle": [],
                        "last": "Ti",
                        "suffix": ""
                    }
                ],
                "year": null,
                "venue": "#35 #30 OR #31 OR #32 OR #",
                "volume": "610",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF85": {
                "ref_id": "b85",
                "title": "MESH DESCRIPTOR Follicle Stimulating Hormone EXPLODE ALL TREES",
                "authors": [],
                "year": 1909,
                "venue": "",
                "volume": "37",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF87": {
                "ref_id": "b87",
                "title": "TI,AB,KY 3145 #39 (FSH or rFSH or recFSH",
                "authors": [],
                "year": null,
                "venue": "Follicle Stimulating Hormone",
                "volume": "119",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF88": {
                "ref_id": "b88",
                "title": "corifollitropin:TI,AB,KY 114 #45",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF89": {
                "ref_id": "b89",
                "title": "Infertility/ and idiopathic",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF90": {
                "ref_id": "b90",
                "title": "unexplain* adj5 infertil*)",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF91": {
                "ref_id": "b91",
                "title": "unexplain* adj5 subfertil*)",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF92": {
                "ref_id": "b92",
                "title": "idiopathic adj5 subfertil*)",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF93": {
                "ref_id": "b93",
                "title": "idiopathic adj5 infertil*)",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF94": {
                "ref_id": "b94",
                "title": "idiopathic adj3 steril*).tw. (56(unknown adj3 steril*)",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF95": {
                "ref_id": "b95",
                "title": "exp Insemination, Artificial/ (11506) 14",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF96": {
                "ref_id": "b96",
                "title": "ovulation induc",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF97": {
                "ref_id": "b97",
                "title": "ovar* adj2 stimulat*).tw. (6957) 20 ovarian hyperstimulation",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "21",
                "issue": "",
                "pages": "13--20",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF98": {
                "ref_id": "b98",
                "title": "selective estrogen receptor modulators/ (3934) 28 selective estrogen receptor modulator*.tw",
                "authors": [],
                "year": 2084,
                "venue": "",
                "volume": "30",
                "issue": "",
                "pages": "31--53",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF99": {
                "ref_id": "b99",
                "title": "anastrozole).tw. (1756) 36 (anti-?estrogen* or anti?estrogen*).tw",
                "authors": [
                    {
                        "first": "",
                        "middle": [],
                        "last": "Letrozole",
                        "suffix": ""
                    }
                ],
                "year": null,
                "venue": "",
                "volume": "35",
                "issue": "",
                "pages": "32--36",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF100": {
                "ref_id": "b100",
                "title": "exp follicle stimulating hormone/ or exp follicle stimulating hormone, beta subunit/ or exp glycoprotein hormones, alpha subunit/ or exp menotropins/ or exp urofollitropin/ (39456) 39 Follicle Stimulating Hormone*.tw. (18990) 40 (FSH or rFSH or recFSH).tw. (34016) (uFSH or rhFSH).tw. (244)",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF101": {
                "ref_id": "b101",
                "title": ").tw. (89) human menopausal gonadotrop?",
                "authors": [],
                "year": null,
                "venue": "Cochrane Database of Systematic Reviews (urofollitropin or pergonal or bravelle* or follitrin)",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF103": {
                "ref_id": "b103",
                "title": "superovulation",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            },
            "BIBREF104": {
                "ref_id": "b104",
                "title": "8 (unexplained adj2 sterility).tw. (1) 9 ovulation induction.tw. (22) 10 clomiphene.tw",
                "authors": [],
                "year": null,
                "venue": "",
                "volume": "",
                "issue": "",
                "pages": "",
                "other_ids": {},
                "num": null,
                "urls": [],
                "raw_text": "",
                "links": null
            }
        },
        "ref_entries": {
            "FIGREF0": {
                "text": "................................................................................................................................................................................................... PLAIN LANGUAGE SUMMARY....................................................................................................................................................................... SUMMARY OF FINDINGS.............................................................................................................................................................................. BACKGROUND.............................................................................................................................................................................................. OBJECTIVES.................................................................................................................................................................................................. METHODS..................................................................................................................................................................................................... RESULTS........................................................................................................................................................................................................ Figure 1.................................................................................................................................................................................................. Figure 2.................................................................................................................................................................................................. Figure 3.................................................................................................................................................................................................. Figure 4.................................................................................................................................................................................................. Figure 5.................................................................................................................................................................................................. DISCUSSION..................................................................................................................................................................................................",
                "fig_num": null,
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "FIGREF1": {
                "text": "Figure 1.Study flow diagram.",
                "fig_num": "1",
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "FIGREF2": {
                "text": "Figure 2. Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.",
                "fig_num": "23",
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "FIGREF3": {
                "text": "IUI in a stimulated cycle versus TI or expectant management in a natural cycle3.1 Live birth rate per couple (all cycles)Analysis 3.1; Figure4Data on this outcome were reported by two studies (Farquhar 2018; Steures 2006a).We did not pool data from the two studies, because of extreme statistical heterogeneity (I 2 = 91%).The presence of extreme heterogeneity could be due to the use of di erent population groups and OH drugs by the two studies: Farquhar 2018 investigated women with a low chance of natural conception (prediction score of natural conception less than 30%) using clomiphene citrate or letrozole, while Steures 2006a included couples with an intermediate chance of spontaneous conception (prediction score of natural conception between 30% and 40%), using clomiphene citrate or gonadotropins.",
                "fig_num": "3",
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "FIGREF4": {
                "text": "Figure 4. Forest plot of comparison 3: IUI in stimulated cycle versus TI or expectant management in natural cycle; outcome 3.1 Live birth rate per couple.",
                "fig_num": "4311",
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "FIGREF5": {
                "text": "Figure 5. Forest plot of comparison 5: IUI in stimulated cycle versus IUI in a natural cycle; outcome 5.2 Multiple pregnancy rate per couple.",
                "fig_num": "5",
                "num": null,
                "uris": null,
                "type_str": "figure"
            },
            "TABREF0": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td/><td>156 per 1000</td><td>228 per 1000</td><td>OR 1.60</td><td>334</td><td>\u2295\u2295\u229d\u229d</td><td>-</td></tr><tr><td/><td/><td>(145 to 339)</td><td>(0.92 to 2.78)</td><td>(1 study)</td><td>low a</td><td/></tr><tr><td>Multiple pregnancy rate per cou-</td><td>12 per 1000</td><td>6 per 1000</td><td>OR 0.50</td><td>334</td><td>\u2295\u2295\u229d\u229d</td><td>-</td></tr><tr><td>ple</td><td/><td>(0 to 63)</td><td>(0.04 to 5.53)</td><td>(1 study)</td><td>low a</td><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF1": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td/><td/><td/><td/><td>No of Partici-</td><td>Quality of the</td><td/></tr><tr><td/><td/><td/><td/><td>pants</td><td>evidence</td><td/></tr><tr><td/><td/><td/><td/><td>(studies)</td><td>(GRADE)</td><td/></tr><tr><td/><td/><td>1000</td><td>OR 1.53</td><td>334</td><td>\u2295\u2295\u229d\u229d</td><td>-</td></tr><tr><td/><td/><td>(145 to 338)</td><td>(0.88 to 2.64)</td><td>(1 study)</td><td>low a</td><td/></tr><tr><td>Ovarian hyperstimulation syn-</td><td>See comment</td><td>See comment</td><td>-</td><td>-</td><td>See comment</td><td>No data report-</td></tr><tr><td>drome rate per woman -not re-</td><td/><td/><td/><td/><td/><td>ed on outcome</td></tr><tr><td>ported</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Miscarriage rate per couple</td><td>54 per 1000</td><td>42 per 1000</td><td>OR 0.77</td><td>334</td><td>\u2295\u2295\u229d\u229d</td><td>-</td></tr><tr><td/><td/><td>(16 to 107)</td><td>(0.28 to 2.11)</td><td>(1 study)</td><td>low a</td><td/></tr><tr><td>Ectopic pregnancy rate per cou-</td><td>Not estimable (no events</td><td>-</td><td>OR 05.06</td><td>334</td><td>\u2295\u2295\u229d\u229d</td><td/></tr><tr><td>ple</td><td>in control group)</td><td/><td>(0.24 to 1106.21)</td><td>(1 study)</td><td>low a</td><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF2": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Intra-</td><td/><td/><td/><td/><td/><td/><td colspan=\"2\">Cochrane Library</td></tr><tr><td/><td/><td/><td/><td/><td/><td/><td>Better health.</td><td>Informed decisions.</td><td>Trusted evidence.</td></tr><tr><td/><td/><td>1000</td><td>OR 1.59</td><td>208</td><td>\u2295\u2295\u229d\u229d</td><td>-</td><td/></tr><tr><td/><td/><td>(231 to 496)</td><td>(0.88 to 2.88)</td><td>(2 studies)</td><td>low a</td><td/><td/></tr><tr><td>Multiple pregnancy rate per</td><td>43 per 1000</td><td>62 per 1000</td><td>OR 1.46</td><td>316</td><td>\u2295\u2295\u229d\u229d</td><td>-</td><td/></tr><tr><td>couple Pregnancy rate per couple (all cycles) Ovarian hyperstimulation syn-drome rate per woman Miscarriage rate per couple</td><td>234 per 1000 Not estimable (no events in control group) 57 per 1000</td><td>(24 to 148) 340 per 1000 (258 to 436) 91 per 1000 (33 to 228)</td><td>(0.55 to 3.87) OR 1.69 (1.14 to 2.53) OR 2.75 (0.11 to 69.83) OR 1.66 (0.56 to 4.88)</td><td>(4 studies) 517 (6 studies) 68 (1 study) 208 (2 studies)</td><td>low a \u2295\u2295\u229d\u229d low b,c \u2295\u229d\u229d\u229d very low a,b \u2295\u2295\u229d\u229d low a</td><td>---</td><td>Cochrane Database of Systematic Reviews</td></tr></table>",
                "type_str": "table"
            },
            "TABREF3": {
                "text": "Copyright \u00a9 2020 The Cochrane Collaboration.Published by John Wiley & Sons, Ltd.",
                "html": null,
                "num": null,
                "content": "<table><tr><td>6</td></tr></table>",
                "type_str": "table"
            },
            "TABREF4": {
                "text": "The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes.The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).Further research is very unlikely to change our confidence in the estimate of effect.Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.Very low quality: We are very uncertain about the estimate.",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Not estimable (no events in</td><td>-</td><td>OR 3.06</td><td>100</td><td>\u2295\u2295\u229d\u229d</td><td>-</td></tr><tr><td>control group)</td><td/><td>(0.12 to 76.95)</td><td>(1 study)</td><td>low a</td><td/></tr><tr><td>*</td><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF5": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table/>",
                "type_str": "table"
            },
            "TABREF6": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Intra-</td><td/><td/><td/><td/><td/><td/><td colspan=\"2\">Cochrane Library</td></tr><tr><td/><td/><td/><td/><td/><td/><td/><td>Better health.</td><td>Informed decisions.</td><td>Trusted evidence.</td></tr><tr><td>Live birth rate per couple (all cycles)-clomiphene citrate or gonadotropins Multiple pregnancy rate per couple</td><td>90 per 1000 238 per 1000 4 per 1000</td><td>307 per 1000 (165 to 497) 204 per 1000 (123 to 318) 13 per 1000 (2 to 79)</td><td>OR 4.48 (2 to 10.01) OR 0.82 (0.45 to 1.49) OR 3.01 (0.47 to 19.28)</td><td>201 (1 study) 253 (1 study) 454 (2 studies)</td><td>\u2295\u2295\u2295\u229d moderate a \u2295\u2295\u229d\u229d low b \u2295\u2295\u229d\u229d low b</td><td>---</td><td>Cochrane Database of Systematic Reviews</td></tr></table>",
                "type_str": "table"
            },
            "TABREF7": {
                "text": "Copyright \u00a9 2020 The Cochrane Collaboration.Published by John Wiley & Sons, Ltd.",
                "html": null,
                "num": null,
                "content": "<table><tr><td>7</td></tr></table>",
                "type_str": "table"
            },
            "TABREF8": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td/><td>110 per 1000</td><td>366 per 1000</td><td>OR 4.68</td><td>201</td><td>\u2295\u2295\u2295\u229d</td><td>-</td></tr><tr><td/><td/><td>(215 to 549)</td><td>(2.22 to 9.86)</td><td>(1 study)</td><td>moderate a</td><td/></tr><tr><td>Ovarian hyperstimulation syndrome</td><td>See comment</td><td>See comment</td><td>See comment</td><td>See comment</td><td>See comment</td><td>No events in in-</td></tr><tr><td>rate per woman</td><td/><td/><td/><td/><td/><td>tervention or</td></tr><tr><td/><td/><td/><td/><td/><td/><td>control groups</td></tr><tr><td>Miscarriage rate per couple</td><td>31 per 1000</td><td>84 per 1000</td><td>OR 2.87</td><td>454</td><td>\u2295\u2295\u2295\u229d</td><td>-</td></tr><tr><td/><td/><td>(36 to 183)</td><td>(1.18 to 7.01)</td><td>(2 studies)</td><td>moderate a</td><td/></tr><tr><td>Ectopic pregnancy rate per couple</td><td>Not estimable (no</td><td>-</td><td>OR 9.28</td><td>201</td><td>\u2295\u2295\u229d\u229d</td><td>-</td></tr><tr><td/><td>events in interven-</td><td/><td>(0.49 to 174.6)</td><td>(1 study)</td><td>low b</td><td/></tr><tr><td/><td>tion group)</td><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF9": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Outcomes</td><td/><td colspan=\"3\">Illustrative comparative risks* (95% CI)</td><td>Relative effect</td><td>No of Partici-</td><td>Quality of the</td><td>Comments</td></tr><tr><td>cles)</td><td>-</td><td>131 per 1000 Assumed risk</td><td colspan=\"2\">227 per 1000 (142 to 341) risk Corresponding</td><td>OR 1.95 (1.10 to 3.44) (95% CI)</td><td>342 (1 study) pants (studies)</td><td>\u2295\u2295\u2295\u229d moderate a evidence (GRADE)</td><td>-</td></tr><tr><td colspan=\"3\">Multiple pregnancy rate per couple 6 per 1000 IUI in a natural cycle</td><td colspan=\"2\">6 per 1000 (0 to 88) IUI in a stimulat-ed cycle</td><td>OR 1.05 (0.07 to 16.90)</td><td>342 (1 study)</td><td>\u2295\u2295\u229d\u229d low b</td><td>-</td></tr><tr><td colspan=\"2\">Pregnancy rate per couple (all cy-cles) cles) Live birth rare per couple (all cy-</td><td>143 per 1000 139 per 1000</td><td colspan=\"2\">228 per 1000 (144 to 339) (165 to 361) 250 per 1000</td><td>OR 1.77 (1.01 to 3.08) (1.22 to 3.50) OR 2.07</td><td>342 (1 study) (4 studies) 396</td><td>\u2295\u2295\u2295\u229d low a,b moderate a \u2295\u2295\u229d\u229d</td><td>--</td></tr><tr><td colspan=\"3\">Ovarian hyperstimulation syn-drome rate per woman -not report-ed Multiple pregnancy rate per couple Not estimable (no events in See comment control group)</td><td colspan=\"2\">See comment -</td><td>-(0.11 to 78.27) OR 3.00</td><td>-(1 study) 39</td><td>See comment low c \u2295\u2295\u229d\u229d</td><td>No data report-ed on outcome -</td></tr><tr><td colspan=\"2\">Miscarriage rater per couple cles) Pregnancy rate per couple (all cy-</td><td>46 per 1000 63 per 1000</td><td colspan=\"2\">42 per 1000 (15 to 111) (36 to 831) 302 per 1000</td><td>OR 0.91 (0.32 to 2.58) (0.56 to 73.35) OR 6.43</td><td>342 (1 study) (1 study) 26</td><td>\u2295\u2295\u229d\u229d low b low c \u2295\u2295\u229d\u229d</td><td>--</td></tr><tr><td colspan=\"2\">Ectopic pregnancy rate per couple Ovarian hyperstimulation syn-drome rate per woman -not mea-sured</td><td>Not estimable (no events in control group) See comment</td><td>-</td><td>See comment</td><td>OR 5.30 (0.25 to 111.26) Not estimable</td><td>342 (1 study) -</td><td>\u2295\u2295\u229d\u229d See comment low b</td><td>No events in in--tervention and control groups</td></tr><tr><td>Miscarriage rate per couple</td><td/><td>Not estimable (no events in</td><td/><td>-</td><td>OR 5.21</td><td>26</td><td>\u2295\u2295\u229d\u229d</td><td>-</td></tr><tr><td/><td/><td>control group)</td><td/><td/><td>(0.19 to 141.08)</td><td>(1 study)</td><td>low c</td></tr><tr><td colspan=\"2\">Ectopic pregnancy rate per couple</td><td>Not estimable (no events in</td><td/><td>-</td><td>OR 6.48</td><td>211</td><td>\u2295\u229d\u229d\u229d</td></tr><tr><td/><td/><td>control group)</td><td/><td/><td>(0.33 to 127.09)</td><td>(1 study)</td><td>very low b,c</td></tr></table>",
                "type_str": "table"
            },
            "TABREF12": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Database of Systematic Reviews</td></tr><tr><td>without OH compared to timed intercourse (TI) or expectant</td></tr><tr><td>management with or without OH, or following IUI treatment with</td></tr><tr><td>OH compared to IUI in a natural cycle.</td></tr><tr><td>To determine whether, for couples with unexplained subfertility,</td></tr><tr><td>the live birth rate is improved following IUI treatment with or</td></tr></table>",
                "type_str": "table"
            },
            "TABREF15": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Database of Systematic Reviews</td></tr><tr><td>5. PsycINFO; OVID platform (searched from 1806 to 17 October</td></tr><tr><td>2019) (Appendix 5);</td></tr><tr><td>6. CINAHL; EBSCO platform (searched from 1961 to October 2019)</td></tr><tr><td>(Appendix 6).</td></tr><tr><td>We combined the MEDLINE search with the Cochrane highly</td></tr><tr><td>sensitive search strategy for identifying randomised trials in</td></tr><tr><td>MEDLINE: sensitivity-and precision-maximising version (2008</td></tr><tr><td>revision; Lefebvre 2011). We combined the Embase and</td></tr><tr><td>PsycINFO searches with trial filters developed by the Scottish</td></tr><tr><td>Intercollegiate Guidelines Network (SIGN) ( www.sign.ac.uk/</td></tr><tr><td>methodology/filters.html#random).</td></tr><tr><td>Other electronic sources of trials included:</td></tr><tr><td>1. Trial registers for ongoing and registered trials (up to October</td></tr><tr><td>2019):</td></tr><tr><td>a. www.clinicaltrials.gov (a service of the US National Institutes</td></tr><tr><td>of Health);</td></tr><tr><td>b. www.who.int/trialsearch/Default.aspx (The World Health</td></tr><tr><td>Organization International Trials Registry Platform search</td></tr><tr><td>portal) Note: it is now mandatory for Cochrane Reviews to</td></tr><tr><td>include searches of trial registers;</td></tr><tr><td>2. Database of Abstracts of Reviews of E ects (DARE) in</td></tr><tr><td>the Cochrane Library at onlinelibrary.wiley.com/o/cochrane/</td></tr><tr><td>cochrane_cldare_articles_fs.html (for reference lists from</td></tr><tr><td>relevant non-Cochrane reviews) (up to October 2019);</td></tr><tr><td>3. Web of Knowledge at wokinfo.com/ (another source of trials and</td></tr><tr><td>conference abstracts) (up to October 2019);</td></tr><tr><td>4. OpenGrey at www.opengrey.eu/ for unpublished literature from</td></tr><tr><td>Europe (up to October 2019);</td></tr><tr><td>5. LILACS database at regional.bvsalud.org/php/index.php?</td></tr><tr><td>lang=en (for trials from the Portuguese-and Spanish-speaking</td></tr><tr><td>world) (up to October 2019);</td></tr><tr><td>6. PubMed and Google Scholar (for recent trials not yet indexed in</td></tr><tr><td>MEDLINE) (up to October 2019);</td></tr><tr><td>7. Epistemonikos database at www.epistemonikos.org/en for</td></tr><tr><td>systematic reviews that are useful for reference-checking for</td></tr><tr><td>trials (up to October 2019);</td></tr><tr><td>8. European Society of Human Reproduction and Embryology</td></tr><tr><td>(ESHRE) and American Society for Reproductive Medicine</td></tr><tr><td>(ASRM) 2019 conference abstracts.</td></tr><tr><td>1. Cochrane Gynaecology and Fertility Specialised Register;</td></tr><tr><td>PROCITE platform (searched 17 October 2019) (Appendix 1);</td></tr><tr><td>2. CENTRAL; via the Cochrane Register of Studies Online (CRSO);</td></tr><tr><td>web platform (searched 17 October 2019) (Appendix 2);</td></tr><tr><td>3. MEDLINE; OVID platform (searched from 1946 to 17 October</td></tr><tr><td>2019) (Appendix 3);</td></tr><tr><td>4. Embase; OVID platform (searched from 1980 to 17 October 2019)</td></tr><tr><td>(Appendix 4);</td></tr></table>",
                "type_str": "table"
            },
            "TABREF16": {
                "text": "Cochrane Database of Systematic Reviews unbalanced groups.The main reason for dropout was financial constraints, so this introduces a considerable bias.In three of the included studies(Bhattacharya 2008; Farquhar 2018; Steures  2006a)expectant management was performed instead of TI.Seven studies used gonadotropins for ovarian hyperstimulation.Arcaini 1996 o ered both gonadotropins and clomiphene citrate, which resulted in a high-dose hyperstimulation.Five studies used clomiphene only, one study used clomiphene and letrozole (Farquhar 2018) and Crosignani 1991 did not report the method of ovarian hyperstimulation.The di erent fertility centres in this multicentre trial used di erent treatments.More details on drug dose and method can be found in the prognostic factor table (Appendix 7) and the Characteristics of included studies table.",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health.</td></tr><tr><td colspan=\"2\">Additional gonadotropin-releasing hormone agonist (GnRHa) was</td></tr><tr><td colspan=\"2\">used by Chung 1995 and Murdoch 1991. All studies used human</td></tr><tr><td colspan=\"2\">chorionic gonadotropin (hCG) (5000 to 10,000 IU) for triggering</td></tr><tr><td colspan=\"2\">ovulation. Chung 1995 also provided hCG in the post-ovulatory</td></tr><tr><td>phase.</td><td/></tr><tr><td/><td>1. IUI in a natural cycle versus expectant management in a natural</td></tr><tr><td/><td>cycle: one trial (Bhattacharya 2008)..</td></tr><tr><td/><td>2. IUI in a stimulated cycle versus TI in a stimulated cycle: seven</td></tr><tr><td/><td>trials (Agarwal 2004; Arcaini 1996; Chung 1995; Crosignani 1991;</td></tr><tr><td/><td>Janko 1998; Karlstrom 1993; Melis 199</td></tr><tr><td/><td>3. IUI in a stimulated cycle versus TI or expectant management in a</td></tr><tr><td/><td>natural cycle: three trials (Deaton 1990; Farquhar 2018; Steures</td></tr><tr><td/><td>2006a).</td></tr><tr><td/><td>4. IUI in a natural cycle versus expectant management in a</td></tr><tr><td/><td>stimulated cycle: one trial (Bhattacharya 2008).</td></tr><tr><td/><td>5. IUI in a stimulated cycle versus IUI in natural cycle: four trials</td></tr><tr><td/><td>(Arici 1994; Goverde 2000; Guzick 1999; Murdoch 1991)</td></tr></table>",
                "type_str": "table"
            },
            "TABREF21": {
                "text": "Clomiphene citrate or letrozole(Farquhar 2018)Cochrane Database of Systematic Reviews Treatment with IUI in a stimulated cycle probably results in a higher cumulative pregnancy rate compared to treatment with expectant management in a natural cycle (OR 4.68, 95% CI 2.22 to 9.86; 1 RCT, 201 women; moderate-quality evidence).The evidence suggests that if we assume the chance of a pregnancy with expectant management in a natural cycle to be 11%, the chance of a pregnancy with IUI in a stimulated cycle would be between 22% and 55%.",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health.</td></tr><tr><td colspan=\"2\">3.3.3 Clomiphene citrate or gonadotropins (Steures 2006a)</td></tr><tr><td colspan=\"2\">It is uncertain whether treatment with IUI in a stimulated cycle</td></tr><tr><td colspan=\"2\">results in a higher cumulative pregnancy rate compared to</td></tr><tr><td colspan=\"2\">treatment with expectant management in a natural cycle (OR 0.80,</td></tr><tr><td colspan=\"2\">95% CI 0.45 to 1.42; 1 RCT, 253 women, low-quality evidence).</td></tr></table>",
                "type_str": "table"
            },
            "TABREF22": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Analysis 3.5</td></tr><tr><td>Data on this outcome were reported only by Farquhar 2018. It is</td></tr><tr><td>uncertain whether treatment with IUI in a stimulated cycle results</td></tr><tr><td>in a lower ectopic pregnancy rate compared to treatment with</td></tr><tr><td>expectant management in a natural cycle (OR 9.28, 95% CI 0.49 to</td></tr><tr><td>174.60; 1 RCT, 201 women; low-quality evidence)</td></tr><tr><td>Bhattacharya 2008 studied this comparison with IUI in a natural</td></tr><tr><td>cycle compared to TI in a clomiphene citrate-stimulated cycle.</td></tr></table>",
                "type_str": "table"
            },
            "TABREF24": {
                "text": "Cochrane Database of Systematic Reviews Timing:Stimulated cycle: IUI 24 hour after luteinising hormone surge or 36 hr after hCG injection Cancellation criteria: no rise in oestradiol or development of follicles, presence of > 3 follicles Duration of treatment: 3 cycles max Cochrane Database of Systematic ReviewsInterventionsIUI with letrozole versus IUI in natural cycle.In the group allocated to ovarian stimulation, women will receive oral tablets letrozole 5 mg daily from cycle day 3 -5 for 5 days.Investigators will treat the couples for 3 cycles, with a time horizon of 4 months",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library Cochrane Library Cochrane Library Cochrane Library Cochrane Library Cochrane Library Cochrane Library Cochrane Library Cochrane Library Cochrane Library Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health. Trusted evidence. Informed decisions. Better health. Trusted evidence. Informed decisions. Better health. Trusted evidence. Informed decisions. Better health. Trusted evidence. Informed decisions. Better health. Trusted evidence. Informed decisions. Better health. Trusted evidence. Informed decisions. Better health. Trusted evidence. Informed decisions. Better health. Trusted evidence. Informed decisions. Better health. Trusted evidence. Informed decisions. Better health. Trusted evidence. Informed decisions. Better health. Trusted evidence. Informed decisions. Better health.</td><td>Cochrane Database of Systematic Reviews Cochrane Database of Systematic Reviews Cochrane Database of Systematic Reviews Cochrane Database of Systematic Reviews Cochrane Database of Systematic Reviews Cochrane Database of Systematic Reviews Cochrane Database of Systematic Reviews Cochrane Database of Systematic Reviews Cochrane Database of Systematic Reviews Cochrane Database of Systematic Reviews</td></tr><tr><td colspan=\"2\">or clomiphene on reproductive outcome a er intrauterine Dickey 2005 Agarwal 2004 (Continued) Arcaini 1996 (Continued) Bhattacharya 2008 (Continued) Chung 1995 (Continued) Farquhar 2018 (Continued) Goverde 2000 (Continued) Guzick 1999 (Continued) Melis 1995 (Continued) Steures 2006a (Continued) NCT03455426 (Continued)</td><td/></tr><tr><td colspan=\"3\">insemination: a prospective, multicenter randomized trial. Human Reproduction 2013;28 suppl 1:i71-i73 O-172. Prentice 1995 {published data only} Prentice A, Sacks GP, Morton NC, Deary AJ, Smith SK. Controlled ovarian stimulation (superovulation) and intrauterine insemination for the treatment of unexplained and minor male factor infertility. Human Reproduction 1995;10:112. Serhal 1988 {published data only (unpublished sought but not used)} Serhal PF, Katz M, Little V, Woronowski H. Unexplained infertility -the value of Pergonal superovulation combined with intrauterine insemination. Fertility and Sterility 1988;49(4):602-6. Dickey RP. Risk factors for high-order multiple pregnancy and multiple birth a er controlled ovarian hyperstimulation: results of 4,062 intrauterine insemination cycles. Fertility and Sterility 2005;83(3):671-83. ESHRE 2006 Andersen AN, Gianaroli L, Felberbaum R, De Mouzon J, Nygren KG. Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE. Human Reproduction 2006;21(7):1680-97. Fauser 2005 Blinding of outcome as-sessment (detection bias) All outcomes Low risk Blinding was not possible because of the nature of the interventions and non-blinding was not likely to affect the outcomes of interest Incomplete outcome data (attrition bias) All outcomes High risk There was an unequal dropout in the treatment group due to financial rea-sons; Nr of withdrawals: IUI + OH 26 (37%); TI + OH 1 (total 19%) Selective reporting (re-porting bias) Unclear risk Reported on live birth, but authors provided additional information on on-going pregnancies and twin pregnancies resulting in different data used for meta-analysis All outcomes Blinding of outcome as-sessment (detection bias) All outcomes Low risk Blinding was not possible because of the nature of the interventions and non-blinding was not likely to affect the outcomes of interest Incomplete outcome data (attrition bias) All outcomes Low risk A total of 16 cancelled treatment cycles is described and analysed according to ITT. People who dropped out are clearly stated in a table Selective reporting (re-porting bias) Unclear risk Did not report on live birth, but did not intend to report on live birth Bias Authors' judgement Support for judgement Random sequence genera-Low risk Sequence generated by independent statistician Risk of bias Bias Authors' judgement Support for judgement Age: IUI + NC 31.6 years (\u00b1 3.7); IUI + OH 31.7 years (\u00b1 3.9) Duration of subfertility: IUI + NC 3.9 years (\u00b1 1.7); IUI + OH 4.2 years (\u00b1 1.9) Basic fertility work-up normal, semen normal when &gt; 20 million progressive motile in ejaculate Previous treatment: not stated N randomised: 932 (465 treated with IUI); N with unexplained subfertility: 211 Blinding of outcome as-Low risk Blinding was not possible because of the nature of the interventions and non-Risk of bias Age: IUI + NC 32 years (\u00b1 4) IUI + OH 32 years (\u00b1 4) sessment (detection bias) blinding was not likely to affect the outcomes of interest Duration of subfertility: IUI + NC 3.8 years (\u00b1 2.6); IUI + OH 3.5 years (\u00b1 2.2) All outcomes Bias Authors' judgement Support for judgement Basic fertility work-up normal, semen normal (according to WHO 1992) tion (selection bias) Allocation concealment (selection bias) Low risk Adequate; central telephone randomisation system Blinding of participants and personnel (perfor-mance bias) All outcomes Unclear risk Blinding was not possible because of the nature of the interventions Random sequence genera-tion (selection bias) Low risk Blocked randomisation scheme Allocation concealment (selection bias) Low risk Adequate; numbered sealed envelopes Blinding of participants and personnel (perfor-Unclear risk Blinding was not possible because of the nature of the interventions Outcomes Live birth Clinical pregnancy Miscarriage Multiple pregnancy Ectopic pregnancy Interventions Previous treatment: no previous treatment. (Pt excluded if previous ART) Incomplete outcome data Low risk Exclusion numbers were published for the overall group.The author provided Random sequence genera-Low risk Computer-generated sequence in balanced blocks Outcomes Primary outcome: ongoing pregnancy leading to live birth Comparison: IUI + NC versus IUI + OH (versus IVF) Stimulation method: 75 IU FSH (starting dose) until 1 to 3 follicles of 18 mm were seen on USS hCG was withheld if &gt; 3 follicles of 18 mm or &gt; 6 of 14 mm were present Timing: Stimulated cycle: 10,000 IU hCG, IUI 40 hr to 42 hr after hCG; Natural cycle: IUI 20 hr to 30 hr after detection of urinary LH-surge Cycles were cancelled when &gt; 3 follicles of 18 mm or &gt; 6 follicles of 14 mm were present Duration of treatment: 6 cycles max Interventions Comparison: IUI + NC versus IUI + OH Stimulation method: 150 IU FSH/day, day 3 to day 7 (attrition bias) All outcomes additional information: 1/52 (IUI + OH group) withdrew, 4/56 (TI + OH group) tion (selection bias) Secondary outcome: clinical pregnancy, multiple pregnancy, miscarriage rates, pregnancy compli-withdrew. Reasons for dropout were family problems, poor response or exag-gerated response Allocation concealment Low risk Adequate; via opaque sealed envelopes cations and participants' costs Ovulation: IUI + OH: 10,000 IU hCG when 2 follicles of &gt; 18 mm were present IUI + NC: urine LH testing Selective reporting (re-Low risk Live birth data and complication numbers were available for analysis (selection bias) Starting date March 15, 2018 Timing: IUI + OH: 36 hr to 40 hr after hCG IUI + NC: IUI the day after urinary LH surge porting bias) Blinding of participants and personnel (perfor-Unclear risk Blinding was not possible because of the nature of the interventions Contact information Shuo Huang, PhD; 86-13601203410; homelyleaf@aliyun.com Fauser BC, Devroey P, Macklon NS. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 2005;365(9473):1807-16. Other bias Low risk Baseline demographic characteristics similar between the 2 groups Other bias Low risk Nothing detected Blinding of outcome as-sessment (detection bias) Low risk Blinding was not possible because of the nature of the interventions and non-blinding was not likely to affect the outcomes of interest mance bias) All outcomes OHSS Notes Outcomes Live birth per couple OHSS Cycles were cancelled if serum E2 concentration &gt; 3000 pg/ml Other bias Unclear risk Insufficient information was reported to make a conclusive judgement on par-ticipant demographic characteristics mance bias) Notes All outcomes Duration of treatment: 4 cycles max This study investigated women with unexplained infertility and those with mild endometriosis and Tummon 1997 {published data only} Tummon IS, Asher LJ, Martin JS, Tulandi T. Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis. Fertility and Sterility 1997;68(1):8-12. Van Eekelen 2019 {published data only} Van Eekelen R, Van Geloven N, Van Wely M, McLernon DJ, Mol F, Custers IM, et al. Is IUI with ovarian stimulation e ective in couples with unexplained subfertility?. Human Reproduction 2019;34(1):84-91. Wadhwa 2013 {published data only} Wadhwa LA, Khanna RA, Gupta TA, Gupta SA, Arora SA, Nandwani S. Evaluation of role of GnRH antagonist in intrauterine insemination (IUI) cycles with mild ovarian hyperstimulation (MOH). Fertility and Sterility 2013;100 Suppl(3):S17-S18. Xu 2014 {published data only} Xu BF, Wang GY, Fan WM, Chen Q, Zhang AJ. Which is the best protocol of ovarian stimulation prior to artificial insemination by donor. Journal of Reproduction and Contraception 2014;25(1):41-8. Zikopoulos 1993 {published data only} Zikopoulos K, West C, Thong P, Kacser E, Morrison J, Wu F. Homologous intra-uterine insemination has no advantage over timed natural intercourse when used in combination with ovulation induction for the treatment of unexplained infertility. Human Reproduction 1993;8(4):563-7. Zolghadri 2012 {published data only} Zolghadri J, Younesi M, Tabibi A, Khosravi D, Behdin S, intercourse method in controlled ovarian hyperstimulation. Iranian Journal of Reproductive Medicine 2012;10(Suppl 1):42. Random sequence genera-tion (selection bias) Unclear risk Not stated Allocation concealment (selection bias) Unclear risk Unclear Blinding of participants and personnel (perfor-mance bias) Unclear risk Blinding was not possible because of the nature of the interventions 5 women with treated minimal endometriosis were included as unexplained subfertility Risk of bias Bias Authors' judgement Support for judgement Random sequence genera-tion (selection bias) Low risk Computer-generated random-number table Outcomes PR per couple and per cycle Ectopic Miscarriage rate Notes ITT analysis: possible IUI was not possible on Sundays Outcomes PR per cycle Notes ITT analysis: not possible Author replied; could not provide additional information Multicentre ESHRE trial A power calculation was performed Participants tor subfertility N randomised: 120 (unexplained IUI + NC and IUI + TI), 258 total Participants Couples with unexplained subfertility and couples with stage I or II treated endometriosis or male fac-tion (selection bias) Check 2013 Not RCT Couples with unexplained subfertility and couples with male factor subfertility Methods Random sequence genera-Low risk Computer-generated random-number sequence Multicentre (10 clinical sites), USA Barros-Delgadillo 2010 Did not include comparison of interest to this review Trial design: Parallel Bias Authors' judgement Support for judgement PR per 1st cycle Single centre, the Netherlands Guzick 1999 Other bias Low risk Barros Delgadillo 2008 Not RCT Nothing detected Multiple pregnancies Duration of treatment: 2 cycles max Methods Risk of bias Trial design: parallel Total delivered Timing: not described No cancellation criteria were given porting bias) Aboulghar 1993 The trial was not randomised Goverde 2000 Selective reporting (re-Low risk Live birth and complication data were reported 10 cycles were abandoned because no treatment available at the weekend Vafayee H. Comparison of intrauterine insemination with timed Gleicher 2000 Methods Trial design: parallel Single centre, Italy Participants Couples with unexplained subfertility N randomised: IUI + OH 36; TI + OH 32 Age: IUI + OH 34.6 years (\u00b1 4.9); TI + OH 33.4 years (\u00b1 4.7) Duration of subfertility: IUI + OH 4.2 years (\u00b1 1.6); TI + OH 3.9 years (\u00b1 2.3) Basic fertility work-up normal, semen normal, not further specified Previous treatment: not stated Interventions Comparison: IUI + OH versus TI + OH Stimulation method: 100 mg CC/day, day 3 to day 7 and 1 to 3 ampoule hMG/day Ovulation: 10,000 IU hCG when 2 to 6 follicles of &gt; 17 mm were present Timing IUI or TI: 24 hr and 48 hr after hCG Duration of treatment: 5 cycles max Outcomes PR per couple Miscarriage rate Ectopic PR Multiple pregnancies OHSS Pregnancy confirmed by USS Notes ITT analysis: yes Risk of bias Bias Authors' judgement Support for judgement Arcaini 1996 Methods Trial design: cross-over (after 1 cycle) Single centre, USA Participants Couples with unexplained subfertility and couples with male-factor subfertility N randomised: 26 Age: mean 33 yrs (range 24 yrs to 41 yrs) Duration of subfertility: mean 3.5 yrs (range 1 yr to 15 yrs) Unexplained subfertility: basic fertility work-up normal, semen normal according to WHO 1987 criteria Previous treatment: no Interventions Comparison: IUI + NC versus IUI + OH Stimulation method: 50 mg CC/day, day 5 to day 9 Timing: Natural cycle: urinary LH test, IUI on day of LH peak and the next day Stimulated cycle: 10,000 IU hCG when at least 1 follicle of 18 mm was present; IUI 32 hr after hCG No cancellation criteria were given Duration of treatment: 4 cycles max Outcomes Live birth and PR per couple PR per 1st cycle PR per cycle Miscarriage rate Ectopic PR Multiple pregnancies Pregnancy confirmed by USS showing gestational sac Notes ITT analysis: yes Author provided additional information Arici 1994 All outcomes Incomplete outcome data (attrition bias) All outcomes Low risk Loss to follow-up and participants who received alternative treatment are pre-sented in a flow-chart; Nr of withdrawals: 4 Selective reporting (re-porting bias) Low risk Live birth data and adverse events are published Other bias Low risk Nothing detected Methods Trial design: parallel Single centre, UK Participants Couples with unexplained subfertility N randomised: 100 Age: IUI + OH 31.8 years (\u00b1 3.1); TI + OH 32.1 years (\u00b1 4.0) Duration of subfertility: IUI + OH 4.7 years (\u00b1 2.0); TI + OH 5.3 years (\u00b1 2.6) Basic fertility work-up normal and semen 15 million motile per ejaculate Previous treatment: not stated Interventions Comparison: IUI + OH versus TI + OH Stimulation method: FSH 150 IU/day and GnRH nasal spray from day 21 on Ovulation: 5000 IU hCG when &lt; 4 follicles &gt; 16mm hCG post-ovulatory for luteal support Timing TI: 24 hr + 48 hr after hCG Timing IUI: 36 hr to 48 hr after hCG Duration of treatment: 3 cycles max Chung 1995 Blinding of outcome as-sessment (detection bias) All outcomes Low risk Blinding was not possible because of the nature of the interventions and non-blinding was not likely to affect the outcomes of interest Incomplete outcome data (attrition bias) All outcomes Unclear risk 8/50 withdrawn and 6 treatment cycles cancelled in TI group, 4/50 withdrawn and 11 treatment cycles cancelled in IUI group. Reason for cycle cancellation was excessive response. Reason for withdrawal was not stated Selective reporting (re-porting bias) Low risk Live birth data and complication numbers were reported Other bias Low risk Nothing detected Methods Data from centre 10: Hedon, Montpellier, France Trial design: cross-over (after 1 cycle) Multi centre (19 European fertility centres, 4 centres comparing IUI versus TI), Multiple European coun-tries Participants Couples with unexplained subfertility N randomised: unclear; N analysed: total 90 (centre 10; 18 participants) Age: &lt; 38 yrs Duration of subfertility: &gt; 3 yrs Basic fertility work-up normal, semen normal according to WHO 1987 Crosignani 1991 polycystic ovarian syndrome and a prediction score of natural conception leading to livebirth in the next year of &lt; 30% Risk of bias Bias Authors' judgement Support for judgement Random sequence genera-tion (selection bias) Low risk Computer-generated randomisation sequence Allocation concealment (selection bias) Low risk Allocations were concealed in sequentially-numbered, sealed, opaque en-velopes Blinding of participants and personnel (perfor-mance bias) All outcomes Unclear risk Notes ITT analysis: yes Some dropouts because of spontaneous pregnancy Risk of bias Bias Authors' judgement Support for judgement Random sequence genera-tion (selection bias) Low risk Computer-generated randomisation schedule Allocation concealment (selection bias) Low risk Adequate; numbered, masked and sealed envelopes Outcomes Blinding of outcome as-Low risk Blinding was not possible because of the nature of the interventions and non-Live birth per couple sessment (detection bias) blinding was not likely to affect the outcomes of interest PR per couple Ectopic PR Methods Trial design: parallel All outcomes Murdoch 1991 Incomplete outcome data Low risk D A T A A N D A N A L Y S E S IUI + OH group, 3 participants lost to follow-up, TI + NC group, 2 lost to fol-Pregnancy defined by 2 positive hCG tests. This is biochemical pregnancy, therefore not included in (attrition bias) low-up, 2 still pregnant analysis Notes ITT analysis: not possible Author replied; provided additional information UK Participants Couples with unexplained subfertility All outcomes Selective reporting (re-Low risk Live birth and complications reported Comparison 1. Statistical method Effect size porting bias) N randomised: 39; IUI + NC 19; IUI + OH 20 Risk of bias Bias Authors' judgement Support for judgement Age: IUI + NC 30.5 years (\u00b1 3.1); IUI + OH 30.1 years (\u00b1 2.9) Other bias Low risk Nothing detected 1 Live birth rate per couple (all cy-1 Odds Ratio (M-H, Fixed, 95% Totals not selected Duration of subfertility: IUI + NC 5.7 years (\u00b1 2.4); IUI + OH 5.1 years (\u00b1 1.9) cles) CI) Basic fertility work-up done, semen normal (according to WHO 1987) Blinding was not possible because of the nature of the interventions Blinding of outcome as-sessment (detection bias) All outcomes Low risk Blinding was not possible because of the nature of the interventions and non-blinding was not likely to affect the outcomes of interest Incomplete outcome data (attrition bias) All outcomes Low risk Used ITT as part of the analyses Selective reporting (re-Low risk All outcomes reported were prespecified in the Methods section Blinding of participants and personnel (perfor-mance bias) All outcomes Unclear risk Blinding was not possible because of the nature of the interventions Blinding of outcome as-sessment (detection bias) All outcomes Low risk Blinding was not possible because of the nature of the interventions and non-blinding was not likely to affect the outcomes of interest Incomplete outcome data (attrition bias) All outcomes Unclear risk Random sequence genera-tion (selection bias) Unclear risk Author could not guarantee whether or not participants were truly randomised Allocation concealment (selection bias) Unclear risk Author could not guarantee whether or not participants were truly randomised Blinding of participants and personnel (perfor-mance bias) Unclear risk Blinding was not possible because of the nature of the interventions Previous treatment: no Interventions Comparison: IUI + NC versus IUI + OH (vs GIFT) ART: assisted reproductive technology 2 Multiple pregnancy rate per cou-1 Odds Ratio (M-H, Fixed, 95% Totals not selected CC: clomiphene citrate ple CI) DIPI: direct intraperitoneal insemination Stimulation method: 75 IU hMG/day and 200 micro gram buserelin 4 times daily intranasal Ovulation: 5000 IU hCG, when &lt; 4 follicles of &gt; 16mm were seen. Timing: 30 hr to 36 hr after hCG EM: expectant management 3 Pregnancy rate per couple (all cy-1 Odds Ratio (M-H, Fixed, 95% Totals not selected FSH: follicle stimulating hormone cles) CI) hCG: human chorionic gonadotropin Natural cycle: IUI on alternate days until ovulation confirmed on USS Cycles were cancelled if &gt; 4 dominant follicles were present hMG: human menopausal gonadotropin 4 Miscarriage rate per couple 1 Odds Ratio (M-H, Fixed, 95% Totals not selected hr: hour(s) CI) ITT: intention-to-treat Duration of treatment: 3 cycles max IUI: intra-uterine insemination 7/120 withdrew before 1st treatment cycle. Details on dropout not separately available for unexplained subfertility. Some participants dropped out because of spontaneous pregnancy. It is not known whether these participants are in-cluded in the IUI unexplained subfertility group All outcomes Blinding of outcome as-sessment (detection bias) Low risk Blinding was not possible because of the nature of the interventions and non-Outcomes 5 Ectopic pregnancy rate per couple 1 Odds Ratio (M-H, Fixed, 95% Totals not selected OH: ovarian hyperstimulation PR per couple and per cycle CI) PR: pregnancy rate Live birth USS: ultrasound scan Multiple pregnancies blinding was not likely to affect the outcomes of interest porting bias) Selective reporting (re-Low risk Live birth and complication data were reported All outcomes Characteristics of excluded studies [ordered by study ID] Clinical pregnancy defined by USS showing foetal heart activity Previous treatment: not stated Interventions Comparison: IUI + OH versus TI + OH Stimulation method: not stated Ovulation: not described Other bias Low risk Not detected porting bias) Other bias Low risk Nothing detected; baseline demographic characteristics similar between the 2 1 pregnancy between treatment cycles Aanesen 2014 Cohort study groups Incomplete outcome data (attrition bias) All outcomes Unclear risk Withdrawal rates of the total group were presented: 4/465 treatment-related withdrawal, 27/465 not treatment-related. Numbers for unexplained subfertili-ty group are not known Notes Author provided additional information Study Reason for exclusion ITT analysis: yes Analysis 1.1</td></tr></table>",
                "type_str": "table"
            },
            "TABREF25": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health.</td><td/><td/><td/><td colspan=\"3\">Cochrane Database of Systematic Reviews</td></tr><tr><td/><td>Analysis 1.2.</td><td/><td/><td/><td/><td/></tr><tr><td>Study or subgroup</td><td>IUI</td><td>TI</td><td/><td/><td>Odds Ratio</td><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td colspan=\"3\">M-H, Fixed, 95% CI</td><td>M-H, Fixed, 95% CI</td></tr><tr><td>Bhattacharya 2008</td><td>38/167</td><td>26/167</td><td/><td/><td/><td/><td>1.6[0.92,2.78]</td></tr><tr><td/><td/><td>Favours TI</td><td>0.2</td><td>0.5</td><td>1</td><td>2</td><td>5</td><td>Favours IUI</td></tr><tr><td colspan=\"2\">Intra-uterine insemination for unexplained subfertility (Review)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"3\">Copyright \u00a9 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd.</td><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF26": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>IUI</td><td>TI</td><td/><td/><td>Odds Ratio</td><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td/><td>M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td>Bhattacharya 2008</td><td>1/167</td><td>2/167</td><td/><td/><td/><td/><td>0.5[0.04,5.53]</td></tr><tr><td/><td/><td>Favours TI</td><td>0.02</td><td>0.1</td><td>1</td><td>10</td><td>50</td><td>Favours IUI</td></tr><tr><td/><td>Analysis 1.3.</td><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF27": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>IUI</td><td>TI</td><td/><td/><td colspan=\"2\">Odds Ratio</td><td/><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td/><td colspan=\"3\">M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td>Bhattacharya 2008</td><td>38/167</td><td>27/167</td><td/><td/><td/><td/><td/><td/><td>1.53[0.88,2.64]</td></tr><tr><td/><td/><td>Favours TI</td><td>0.1</td><td>0.2</td><td>0.5</td><td>1</td><td>2</td><td>5</td><td>10</td><td>Favours IUI</td></tr><tr><td/><td>Analysis 1.4</td><td/><td/><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF28": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>IUI</td><td>TI</td><td/><td/><td colspan=\"2\">Odds Ratio</td><td/><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td/><td colspan=\"3\">M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td>Bhattacharya 2008</td><td>7/167</td><td>9/167</td><td/><td/><td/><td/><td/><td/><td>0.77[0.28,2.11]</td></tr><tr><td/><td/><td>Favours TI</td><td>0.1</td><td>0.2</td><td>0.5</td><td>1</td><td>2</td><td>5</td><td>10</td><td>Favours IUI</td></tr><tr><td/><td>Analysis 1.5.</td><td/><td/><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF29": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>IUI better</td><td>TI</td><td>Odds Ratio</td><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td>M-H</td><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF30": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Bhattacharya 2008</td><td>2/167</td><td>0/167</td><td/><td/><td/><td/><td>5.06[0.24,106.21]</td></tr><tr><td/><td/><td>Favours TI</td><td>0.001</td><td>0.1</td><td>1</td><td>10</td><td>1000</td><td>Favours IUI</td></tr><tr><td>Comparison 2.</td><td/><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF31": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td colspan=\"2\">Trusted evidence. Informed decisions. Better health.</td><td/><td colspan=\"2\">Cochrane Database of Systematic Reviews</td></tr><tr><td colspan=\"2\">Outcome or subgroup title</td><td>No. of studies</td><td>No. of partici-</td><td>Statistical method</td><td>Effect size</td></tr><tr><td/><td/><td/><td>pants</td><td/></tr><tr><td>2.2 Gonadotropins</td><td/><td>2</td><td>208</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>1.61 [0.44, 5.89]</td></tr><tr><td colspan=\"2\">2.3 Clomiphene Citrate and Go-</td><td>1</td><td>68</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>1.88 [0.32, 11.00]</td></tr><tr><td>nadotropins</td><td/><td/><td/><td/></tr><tr><td colspan=\"2\">3 Pregnancy rate per couple (all</td><td>6</td><td>517</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>1.69 [1.14, 2.53]</td></tr><tr><td>cycles)</td><td/><td/><td/><td/></tr><tr><td>3.1 Clomiphene Citrate</td><td/><td>1</td><td>40</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>0.30 [0.03, 2.93]</td></tr><tr><td>3.2 Gonadotropins</td><td/><td>4</td><td>319</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>1.68 [1.03, 2.75]</td></tr><tr><td colspan=\"2\">3.3 Clomiphene Citrate and Go-</td><td>1</td><td>68</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>2.62 [0.98, 6.98]</td></tr><tr><td>nadotropins</td><td/><td/><td/><td/></tr><tr><td colspan=\"2\">3.4 Clomiphene citrate OR Go-</td><td>1</td><td>90</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>1.72 [0.50, 5.89]</td></tr><tr><td>nadotropins</td><td/><td/><td/><td/></tr><tr><td colspan=\"2\">4 Moderate or severe ovarian hy-</td><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>Totals not selected</td></tr><tr><td colspan=\"2\">perstimulation syndrome rate</td><td/><td/><td/></tr><tr><td>per woman</td><td/><td/><td/><td/></tr><tr><td colspan=\"2\">4.1 Clomiphene Citrate and Go-</td><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>0.0 [0.0, 0.0]</td></tr><tr><td>nadotropins</td><td/><td/><td/><td/></tr><tr><td colspan=\"2\">5 Miscarriage rate per couple</td><td>2</td><td>208</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>1.66 [0.56, 4.88]</td></tr><tr><td>5.1 Gonadotropins</td><td/><td>2</td><td>208</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>1.66 [0.56, 4.88]</td></tr><tr><td colspan=\"2\">6 Ectopic pregnancy rate per cou-</td><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>Totals not selected</td></tr><tr><td>ple</td><td/><td/><td/><td/></tr><tr><td>6.1 Gonadotropins</td><td/><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>0.0 [0.0, 0.0]</td></tr><tr><td/><td/><td/><td/><td>Statistical method</td><td>Effect size</td></tr><tr><td colspan=\"2\">1 Live birth rate per couple (all</td><td>2</td><td>208</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>1.59 [0.88, 2.88]</td></tr><tr><td>cycles)</td><td/><td/><td/><td/></tr><tr><td>1.1 Gonadotropins</td><td/><td>2</td><td>208</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>1.59 [0.88, 2.88]</td></tr><tr><td colspan=\"2\">2 Multiple pregnancy rate per</td><td>4</td><td>316</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>1.46 [0.55, 3.87]</td></tr><tr><td>couple</td><td/><td/><td/><td/></tr><tr><td>2.1 Clomiphene Citrate</td><td/><td>1</td><td>40</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>0.43 [0.02, 11.18]</td></tr></table>",
                "type_str": "table"
            },
            "TABREF32": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health.</td><td/><td/><td/><td/><td/><td>Cochrane Database of Systematic Reviews</td></tr><tr><td>Study or subgroup</td><td>IUI+OH</td><td>TI+OH</td><td/><td colspan=\"2\">Odds Ratio</td><td/><td>Weight</td><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td colspan=\"3\">M-H, Fixed, 95% CI</td><td>M-H, Fixed, 95% CI</td></tr><tr><td colspan=\"2\">Test for overall effect: Z=1.53(P=0.13)</td><td/><td/><td/><td/><td/></tr><tr><td/><td/><td>Favours TI+OH</td><td>0.2</td><td>0.5</td><td>1</td><td>2</td><td>5</td><td>Favours IUI+OH</td></tr><tr><td/><td>Analysis 2.2.</td><td/><td/><td/><td/><td/></tr><tr><td>Study or subgroup</td><td>IUI+OH</td><td>TI+OH</td><td/><td colspan=\"2\">Odds Ratio</td><td/><td>Weight</td><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td colspan=\"3\">M-H, Fixed, 95% CI</td><td>M-H, Fixed, 95% CI</td></tr><tr><td>2.1.1 Gonadotropins</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Chung 1995</td><td>20/50</td><td>9/50</td><td/><td/><td/><td/><td>31.03%</td><td>3.04[1.21,7.6]</td></tr><tr><td>Melis 1995</td><td>16/52</td><td>18/56</td><td/><td/><td/><td/><td>68.97%</td><td>0.94[0.42,2.12]</td></tr><tr><td>Subtotal (95% CI)</td><td>102</td><td>106</td><td/><td/><td/><td/><td>100%</td><td>1.59[0.88,2.88]</td></tr><tr><td colspan=\"2\">Total events: 36 (IUI+OH), 27 (TI+OH)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Heterogeneity: Tau =0; Chi =3.53, df=1(P=0.06); I =71.67%</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for overall effect: Z=1.53(P=0.13)</td><td/><td/><td/><td/><td/></tr><tr><td>Total (95% CI)</td><td>102</td><td>106</td><td/><td/><td/><td/><td>100%</td><td>1.59[0.88,2.88]</td></tr><tr><td colspan=\"2\">Total events: 36 (IUI+OH), 27 (TI+OH)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Heterogeneity: Tau =0; Chi =3.53, df=1(P=0.06); I =71.67%</td><td/><td/><td/><td/><td/></tr><tr><td/><td/><td>Favours TI+OH</td><td>0.2</td><td>0.5</td><td>1</td><td>2</td><td>5</td><td>Favours IUI+OH</td></tr><tr><td colspan=\"3\">Intra-uterine insemination for unexplained subfertility (Review)</td><td/><td/><td/><td/></tr><tr><td colspan=\"5\">Copyright \u00a9 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd.</td><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF33": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>IUI+OH</td><td>TI+OH</td><td>Odds Ratio</td><td>Weight</td><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td>M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td>2.2.1 Clomiphene Citrate</td><td/><td/><td/><td/><td/></tr><tr><td>Karlstrom 1993</td><td>0/17</td><td>1/23</td><td/><td>18.4%</td><td>0.43[0.02,11.18]</td></tr><tr><td>Subtotal (95% CI)</td><td>17</td><td>23</td><td/><td>18.4%</td><td>0.43[0.02,11.18]</td></tr><tr><td>Total events: 0 (IUI+OH), 1 (TI+OH)</td><td/><td/><td/><td/><td/></tr><tr><td>Heterogeneity: Not applicable</td><td/><td/><td/><td/><td/></tr><tr><td>Test for overall effect: Z=0.51(P=0.61)</td><td/><td/><td/><td/><td/></tr><tr><td>2.2.2 Gonadotropins</td><td/><td/><td/><td/><td/></tr><tr><td>Chung 1995</td><td>3/50</td><td>1/50</td><td/><td>13.83%</td><td>3.13[0.31,31.14]</td></tr><tr><td>Melis 1995</td><td>3/52</td><td>3/56</td><td/><td>40.06%</td><td>1.08[0.21,5.61]</td></tr><tr><td>Subtotal (95% CI)</td><td>102</td><td>106</td><td/><td>53.9%</td><td>1.61[0.44,5.89]</td></tr><tr><td>Total events: 6 (IUI+OH), 4 (TI+OH)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Heterogeneity: Tau =0; Chi =0.54, df=1(P=0.46); I =0%</td><td/><td/><td/><td/></tr><tr><td>Test for overall effect: Z=0.72(P=0.47)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">2.2.3 Clomiphene Citrate and Gonadotropins</td><td/><td/><td/><td/></tr><tr><td>Arcaini 1996</td><td>4/36</td><td>2/32</td><td/><td>27.7%</td><td>1.88[0.32,11]</td></tr><tr><td>Subtotal (95% CI)</td><td>36</td><td>32</td><td/><td>27.7%</td><td>1.88[0.32,11]</td></tr><tr><td>Total events: 4 (IUI+OH), 2 (TI+OH)</td><td/><td/><td/><td/><td/></tr><tr><td>Heterogeneity: Not applicable</td><td/><td/><td/><td/><td/></tr><tr><td>Test for overall effect: Z=0.7(P=0.49)</td><td/><td/><td/><td/><td/></tr><tr><td>Total (95% CI)</td><td>155</td><td>161</td><td/><td>100%</td><td>1.</td></tr></table>",
                "type_str": "table"
            },
            "TABREF34": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Total events: 10 (IUI+OH), 7 (TI+OH)</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Heterogeneity: Tau =0; Chi =1.17, df=3(P=0.76); I =0%</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Test for overall effect: Z=0.77(P=0.44)</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Test for subgroup differences: Chi =0.64, df=1 (P=0.73), I =0%</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Favours TI+OH</td><td>0.02</td><td>0.1</td><td>1</td><td>10</td><td>50</td><td>Favours IUI+OH</td></tr><tr><td>Analysis 2.3</td><td/><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF35": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health.</td><td/><td/><td/><td/><td/><td>Cochrane Database of Systematic Reviews</td></tr><tr><td>Study or subgroup</td><td>IUI+OH</td><td>TI+OH</td><td/><td/><td>Odds Ratio</td><td/><td>Weight</td><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td/><td>M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td colspan=\"2\">Test for overall effect: Z=1.04(P=0.3)</td><td/><td/><td/><td/><td/></tr><tr><td>2.3.2 Gonadotropins</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Chung 1995</td><td>21/50</td><td>9/50</td><td/><td/><td/><td/><td>14.14%</td><td>3.3[1.32,8.23]</td></tr><tr><td>Janko 1998</td><td>10/36</td><td>7/36</td><td/><td/><td/><td/><td>13.69%</td><td>1.59[0.53,4.79]</td></tr><tr><td>Karlstrom 1993</td><td>3/15</td><td>3/24</td><td/><td/><td/><td/><td>5%</td><td>1.75[0.3,10.07]</td></tr><tr><td>Melis 1995</td><td>22/52</td><td>23/56</td><td/><td/><td/><td/><td>34.6%</td><td>1.05[0.49,2.26]</td></tr><tr><td>Subtotal (95% CI)</td><td>153</td><td>166</td><td/><td/><td/><td/><td>67.42%</td><td>1.68[1.03,2.75]</td></tr><tr><td colspan=\"2\">Total events: 56 (IUI+OH), 42 (TI+OH)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Heterogeneity: Tau =0; Chi =3.54, df=3(P=0.32); I =15.24%</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for overall effect: Z=2.09(P=0.04)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">2.3.3 Clomiphene Citrate and Gonadotropins</td><td/><td/><td/><td/><td/></tr><tr><td>Arcaini 1996</td><td>22/36</td><td>12/32</td><td/><td/><td/><td/><td>13.38%</td><td>2.62[0.98,6.98]</td></tr><tr><td>Subtotal (95% CI)</td><td>36</td><td>32</td><td/><td/><td/><td/><td>13.38%</td><td>2.62[0.98,6.98]</td></tr><tr><td colspan=\"2\">Total events: 22 (IUI+OH), 12 (TI+OH)</td><td/><td/><td/><td/><td/></tr><tr><td>Heterogeneity: Not applicable</td><td/><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for overall effect: Z=1.92(P=0.05)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">2.3.4 Clomiphene citrate OR Gonadotropins</td><td/><td/><td/><td/><td/></tr><tr><td>Crosignani 1991</td><td>7/42</td><td>5/48</td><td/><td/><td/><td/><td>10.53%</td><td>1.72[0.5,5.89]</td></tr><tr><td>Subtotal (95% CI)</td><td>42</td><td>48</td><td/><td/><td/><td/><td>10.53%</td><td>1.72[0.5,5.89]</td></tr><tr><td colspan=\"2\">Total events: 7 (IUI+OH), 5 (TI+OH)</td><td/><td/><td/><td/><td/></tr><tr><td>Heterogeneity: Not applicable</td><td/><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for overall effect: Z=0.86(P=0.39)</td><td/><td/><td/><td/><td/></tr><tr><td>Total (95% CI)</td><td>248</td><td>269</td><td/><td/><td/><td/><td>100%</td><td>1.69[1.14,2.53]</td></tr><tr><td colspan=\"2\">Total events: 86 (IUI+OH), 63 (TI+OH)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Heterogeneity: Tau =0; Chi =6.52, df=6(P=0.37); I =8.01%</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for overall effect: Z=2.58(P=0.01)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for subgroup differences: Chi =2.97, df=1 (P=0.4), I =0%</td><td/><td/><td/><td/><td/></tr><tr><td/><td/><td>Favours TI+OH</td><td>0.01</td><td>0.1</td><td>1</td><td>10</td><td>100</td><td>Favours IUI+OH</td></tr><tr><td colspan=\"2\">Analysis 2.</td><td/><td/><td/><td/><td/></tr><tr><td>Study or subgroup</td><td>IUI+OH</td><td>TI+OH</td><td/><td/><td>Odds Ratio</td><td/><td>Weight</td><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td/><td>M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td>2.3.1 Clomiphene Citrate</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Karlstrom 1993</td><td>1/17</td><td>4/23</td><td/><td/><td/><td/><td>8.67%</td><td>0.3[0.03,2.93]</td></tr><tr><td>Subtotal (95% CI)</td><td>17</td><td>23</td><td/><td/><td/><td/><td>8.67%</td><td>0.3[0.03,2.93]</td></tr><tr><td colspan=\"2\">Total events: 1 (IUI+OH), 4 (TI+OH)</td><td/><td/><td/><td/><td/></tr><tr><td>Heterogeneity: Not applicable</td><td/><td/><td/><td/><td/><td/></tr><tr><td/><td/><td>Favours TI+OH</td><td>0.01</td><td>0.1</td><td>1</td><td>10</td><td>100</td><td>Favours IUI+OH</td></tr></table>",
                "type_str": "table"
            },
            "TABREF36": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health.</td><td/><td/><td/><td colspan=\"3\">Cochrane Database of Systematic Reviews</td></tr><tr><td/><td>Analysis 2.5.</td><td/><td/><td/><td/><td/></tr><tr><td>Study or subgroup</td><td>IUI+OH</td><td>TI+OH</td><td/><td/><td>Odds Ratio</td><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td colspan=\"3\">M-H, Fixed, 95% CI</td><td>M-H, Fixed, 95% CI</td></tr><tr><td colspan=\"2\">2.4.1 Clomiphene Citrate and Gonadotropins</td><td/><td/><td/><td/><td/></tr><tr><td>Arcaini 1996</td><td>1/36</td><td>0/32</td><td/><td/><td/><td/><td>2.75[0.11,69.83]</td></tr><tr><td/><td/><td>Favours TI+OH</td><td>0.001</td><td>0.1</td><td>1</td><td>10</td><td>1000</td><td>Favours IUI+OH</td></tr></table>",
                "type_str": "table"
            },
            "TABREF37": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>IUI+OH</td><td>TI+OH</td><td/><td/><td>Odds Ratio</td><td/><td>Weight</td><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td/><td>M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td>2.5.1 Gonadotropins</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Chung 1995</td><td>3/50</td><td>1/50</td><td/><td/><td/><td/><td>18.08%</td><td>3.13[0.31,31.14]</td></tr><tr><td>Melis 1995</td><td>6/52</td><td>5/56</td><td/><td/><td/><td/><td>81.92%</td><td>1.33[0.38,4.65]</td></tr><tr><td>Subtotal (95% CI)</td><td>102</td><td>106</td><td/><td/><td/><td/><td>100%</td><td>1.66[0.56,4.88]</td></tr><tr><td>Total events: 9 (IUI+OH), 6 (TI+OH)</td><td/><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Heterogeneity: Tau =0; Chi =0.41, df=1(P=0.52); I =0%</td><td/><td/><td/><td/><td/></tr><tr><td>Test for overall effect: Z=0.91(P=0.36)</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Total (95% CI)</td><td>102</td><td>106</td><td/><td/><td/><td/><td>100%</td><td>1.66[0.56,4.88]</td></tr><tr><td>Total events: 9 (IUI+OH), 6 (TI+OH)</td><td/><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Heterogeneity: Tau =0; Chi =0.41, df=1(P=0.52); I =0%</td><td/><td/><td/><td/><td/></tr><tr><td>Test for overall effect: Z=0.91(P=0.36)</td><td/><td/><td/><td/><td/><td/></tr><tr><td/><td/><td>Favours TI+OH</td><td>0.02</td><td>0.1</td><td>1</td><td>10</td><td>50</td><td>Favours IUI+OH</td></tr><tr><td colspan=\"2\">Analysis 2.6</td><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF38": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>IUI+OH</td><td>TI+OH</td><td/><td/><td>Odds Ratio</td><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td colspan=\"3\">M-H, Fixed, 95% CI</td><td>M-H, Fixed, 95% CI</td></tr><tr><td>2.6.1 Gonadotropins</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Chung 1995</td><td>1/50</td><td>0/50</td><td/><td/><td/><td/><td>3.06[0.12,76.95]</td></tr><tr><td/><td/><td>Favours TI+OH</td><td>0.001</td><td>0.1</td><td>1</td><td>10</td><td>1000</td><td>Favours IUI+OH</td></tr><tr><td>Comparison 3.</td><td/><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF39": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td colspan=\"2\">Trusted evidence. Informed decisions. Better health.</td><td/><td colspan=\"2\">Cochrane Database of Systematic Reviews</td></tr><tr><td colspan=\"2\">Outcome or subgroup title</td><td>No. of studies</td><td>No. of partici-</td><td>Statistical method</td><td>Effect size</td></tr><tr><td/><td/><td/><td>pants</td><td/></tr><tr><td colspan=\"2\">3 Pregnancy rate per couple (all cy-</td><td>3</td><td/><td>Odds Ratio (M-H, Fixed, 95%</td><td>Totals not selected</td></tr><tr><td>cles)</td><td/><td/><td/><td>CI)</td></tr><tr><td>3.1 Clomiphene Citrate</td><td/><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95%</td><td>0.0 [0.0, 0.0]</td></tr><tr><td/><td/><td/><td/><td>CI)</td></tr><tr><td colspan=\"2\">3.2 Clomiphene Citrate or Letro-</td><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95%</td><td>0.0 [0.0, 0.0]</td></tr><tr><td>zole</td><td/><td/><td/><td>CI)</td></tr><tr><td colspan=\"2\">3.3 Clomiphene Citrate or Go-</td><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95%</td><td>0.0 [0.0, 0.0]</td></tr><tr><td>nadotropins</td><td/><td/><td/><td>CI)</td></tr><tr><td colspan=\"2\">4 Miscarriage rate per couple</td><td>2</td><td>454</td><td>Odds Ratio (M-H, Fixed, 95%</td><td>2.87 [1.18, 7.01]</td></tr><tr><td/><td/><td/><td/><td>CI)</td></tr><tr><td colspan=\"2\">4.1 Clomiphene Citrate or Letro-</td><td>1</td><td>201</td><td>Odds Ratio (M-H, Fixed, 95%</td><td>6.25 [0.74, 52.91]</td></tr><tr><td>zole</td><td/><td/><td/><td>CI)</td></tr><tr><td colspan=\"2\">4.2 Clomiphene Citrate or Go-</td><td>1</td><td>253</td><td>Odds Ratio (M-H, Fixed, 95%</td><td>2.28 [0.84, 6.20]</td></tr><tr><td>nadotropins</td><td/><td/><td/><td>CI)</td></tr><tr><td colspan=\"2\">5 Ectopic pregnancy rate per cou-</td><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95%</td><td>Totals not selected</td></tr><tr><td>ple</td><td/><td/><td/><td>CI)</td></tr><tr><td/><td>Analysis 3.</td><td/><td/><td/></tr><tr><td colspan=\"2\">1 Live birth rate per couple (all cy-</td><td>2</td><td/><td>Odds Ratio (M-H, Fixed, 95%</td><td>Totals not selected</td></tr><tr><td>cles)</td><td/><td/><td/><td>CI)</td></tr><tr><td colspan=\"2\">1.1 Clomiphene Citrate or Letro-</td><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95%</td><td>0.0 [0.0, 0.0]</td></tr><tr><td>zole</td><td/><td/><td/><td>CI)</td></tr><tr><td colspan=\"2\">1.2 Clomiphene Citrate or Go-</td><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95%</td><td>0.0 [0.0, 0.0]</td></tr><tr><td>nadotropins</td><td/><td/><td/><td>CI)</td></tr><tr><td colspan=\"2\">2 Multiple pregnancy rate per cou-</td><td>2</td><td>454</td><td>Odds Ratio (M-H, Fixed, 95%</td><td>3.01 [0.47, 19.28]</td></tr><tr><td>ple</td><td/><td/><td/><td>CI)</td></tr><tr><td colspan=\"2\">2.1 Clomiphene Citrate or Letro-</td><td>1</td><td>201</td><td>Odds Ratio (M-H, Fixed, 95%</td><td>5.05 [0.24, 106.53]</td></tr><tr><td>zole</td><td/><td/><td/><td>CI)</td></tr><tr><td colspan=\"2\">2.2 Clomiphene Citrate or Go-</td><td>1</td><td>253</td><td>Odds Ratio (M-H, Fixed, 95%</td><td>2.0 [0.18, 22.34]</td></tr><tr><td>nadotropins</td><td/><td/><td/><td>CI)</td></tr></table>",
                "type_str": "table"
            },
            "TABREF40": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>Favours TI+NC</td><td>TI+NC</td><td>Odds Ratio</td><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td>M-H, Fixed, 95% CI</td><td>M-H, Fixed, 95% CI</td></tr><tr><td>3.1.1 Clomiphene Citrate or Letrozole</td><td/><td/><td/><td/></tr><tr><td>Farquhar 2018</td><td>31/101</td><td>9/100</td><td/><td>4.48[2,10.01]</td></tr><tr><td>3.1</td><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF41": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Steures 2006a</td><td>26/127</td><td>30/126</td><td/><td/><td/><td/><td/><td/><td>0.82[0.45,1.49]</td></tr><tr><td/><td/><td>Favours TI+NC</td><td>0.1</td><td>0.2</td><td>0.5</td><td>1</td><td>2</td><td>5</td><td>10</td><td>Favours IUI+OH</td></tr><tr><td>Analysis 3.2.</td><td/><td/><td/><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF42": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health.</td><td/><td/><td/><td/><td/><td>Cochrane Database of Systematic Reviews</td></tr><tr><td>Study or subgroup</td><td>IUI+OH</td><td>TI+NC</td><td/><td/><td>Odds Ratio</td><td/><td>Weight</td><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td colspan=\"3\">M-H, Fixed, 95% CI</td><td>M-H, Fixed, 95% CI</td></tr><tr><td colspan=\"2\">3.2.2 Clomiphene Citrate or Gonadotropins</td><td/><td/><td/><td/><td/></tr><tr><td>Steures 2006a</td><td>2/127</td><td>1/126</td><td/><td/><td/><td/><td>66.84%</td><td>2[0.18,22.34]</td></tr><tr><td>Subtotal (95% CI)</td><td>127</td><td>126</td><td/><td/><td/><td/><td>66.84%</td><td>2[0.18,22.34]</td></tr><tr><td>Total events: 2 (IUI+OH), 1 (TI+NC)</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Heterogeneity: Not applicable</td><td/><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for overall effect: Z=0.56(P=0.57)</td><td/><td/><td/><td/><td/></tr><tr><td>Total (95% CI)</td><td>228</td><td>226</td><td/><td/><td/><td/><td>100%</td><td>3.01[0.47,19.28]</td></tr><tr><td>Total events: 4 (IUI+OH), 1 (TI+NC)</td><td/><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Heterogeneity: Tau =0; Chi =0.22, df=1(P=0.64); I =0%</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for overall effect: Z=1.16(P=0.24)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for subgroup differences: Chi =0.22, df=1 (P=0.64), I =0%</td><td/><td/><td/><td/><td/></tr><tr><td/><td colspan=\"2\">Favours TI+NC</td><td>0.002</td><td>0.1</td><td>1</td><td>10</td><td>500</td><td>Favours IUI+OH</td></tr><tr><td colspan=\"2\">Analysis 3.</td><td/><td/><td/><td/><td/></tr><tr><td>Study or subgroup</td><td>IUI+OH</td><td>TI+NC</td><td/><td/><td>Odds Ratio</td><td/><td>Weight</td><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td colspan=\"3\">M-H, Fixed, 95% CI</td><td>M-H, Fixed, 95% CI</td></tr><tr><td colspan=\"2\">3.2.1 Clomiphene Citrate or Letrozole</td><td/><td/><td/><td/><td/></tr><tr><td>Farquhar 2018</td><td>2/101</td><td>0/100</td><td/><td/><td/><td/><td>33.16%</td><td>5.05[0.24,106.53]</td></tr><tr><td>Subtotal (95% CI)</td><td>101</td><td>100</td><td/><td/><td/><td/><td>33.16%</td><td>5.05[0.24,106.53]</td></tr><tr><td>Total events: 2 (IUI+OH), 0 (TI+NC)</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Heterogeneity: Not applicable</td><td/><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for overall effect: Z=1.04(P=0.3)</td><td/><td/><td/><td/><td/></tr><tr><td/><td colspan=\"2\">Favours TI+NC</td><td>0.002</td><td>0.1</td><td>1</td><td>10</td><td>500</td><td>Favours IUI+OH</td></tr></table>",
                "type_str": "table"
            },
            "TABREF43": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>Favours TI+NC</td><td>TI+NC</td><td/><td/><td>Odds Ratio</td><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td/><td>M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td>3.3.1 Clomiphene Citrate</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Deaton 1990</td><td>8/23</td><td>4/28</td><td/><td/><td/><td/><td>3.2[0.82,12.5]</td></tr><tr><td>3.3.2 Clomiphene Citrate or Letrozole</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Farquhar 2018</td><td>37/101</td><td>11/100</td><td/><td/><td/><td/><td>4.68[2.22,9.86]</td></tr><tr><td colspan=\"2\">3.3.3 Clomiphene Citrate or Gonadotropins</td><td/><td/><td/><td/><td/></tr><tr><td>Steures 2006a</td><td>29/127</td><td>34/126</td><td/><td/><td/><td/><td>0.8[0.45,1.42]</td></tr><tr><td/><td/><td>Favours TI+NC</td><td>0.01</td><td>0.1</td><td>1</td><td>10</td><td>100</td><td>Favours IUI+OH</td></tr><tr><td colspan=\"2\">Analysis</td><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF44": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health.</td><td/><td/><td/><td/><td/><td>Cochrane Database of Systematic Reviews</td></tr><tr><td>Study or subgroup</td><td>IUI+OH</td><td>TI+NC</td><td/><td/><td>Odds Ratio</td><td/><td>Weight</td><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td/><td>M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td colspan=\"2\">Test for overall effect: Z=1.61(P=0.11)</td><td/><td/><td/><td/><td/></tr><tr><td>Total (95% CI)</td><td>228</td><td>226</td><td/><td/><td/><td/><td>100%</td><td>2.87[1.18,7.01]</td></tr><tr><td colspan=\"2\">Total events: 19 (IUI+OH), 7 (TI+NC)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Heterogeneity: Tau =0; Chi =0.71, df=1(P=0.4); I =0%</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for overall effect: Z=2.32(P=0.02)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for subgroup differences: Chi =0.7, df=1 (P=0.4), I =0%</td><td/><td/><td/><td/><td/></tr><tr><td/><td/><td>Favours TI +NC</td><td>0.01</td><td>0.1</td><td>1</td><td>10</td><td>100</td><td>Favours IUI+OH</td></tr><tr><td colspan=\"2\">Analysis 3.5.</td><td/><td/><td/><td/><td/></tr><tr><td>Study or subgroup</td><td>IUI+OH</td><td>TI+NC</td><td/><td/><td>Odds Ratio</td><td/><td>Weight</td><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td/><td>M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td colspan=\"2\">3.4.1 Clomiphene Citrate or Letrozole</td><td/><td/><td/><td/><td/></tr><tr><td>Farquhar 2018</td><td>6/101</td><td>1/100</td><td/><td/><td/><td/><td>14.88%</td><td>6.25[0.74,52.91]</td></tr><tr><td>Subtotal (95% CI)</td><td>101</td><td>100</td><td/><td/><td/><td/><td>14.88%</td><td>6.25[0.74,52.91]</td></tr><tr><td>Total events: 6 (IUI+OH), 1 (TI+NC)</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Heterogeneity: Not applicable</td><td/><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for overall effect: Z=1.68(P=0.09)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">3.4.2 Clomiphene Citrate or Gonadotropins</td><td/><td/><td/><td/><td/></tr><tr><td>Steures 2006a</td><td>13/127</td><td>6/126</td><td/><td/><td/><td/><td>85.12%</td><td>2.28[0.84,6.2]</td></tr><tr><td>Subtotal (95% CI)</td><td>127</td><td>126</td><td/><td/><td/><td/><td>85.12%</td><td>2.28[0.84,6.2]</td></tr><tr><td colspan=\"2\">Total events: 13 (IUI+OH), 6 (TI+NC)</td><td/><td/><td/><td/><td/></tr><tr><td>Heterogeneity: Not applicable</td><td/><td/><td/><td/><td/><td/></tr><tr><td/><td/><td>Favours TI +NC</td><td>0.01</td><td>0.1</td><td>1</td><td>10</td><td>100</td><td>Favours IUI+OH</td></tr></table>",
                "type_str": "table"
            },
            "TABREF45": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>IUI+OH</td><td>TI+NC</td><td/><td/><td>Odds Ratio</td><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td/><td>M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td>Farquhar 2018</td><td>4/101</td><td>0/100</td><td/><td/><td/><td/><td>9.28[0.49,174.6]</td></tr><tr><td/><td/><td>Favours TI+NC</td><td>0.01</td><td>0.1</td><td>1</td><td>10</td><td>100</td><td>Favours IUI+OH</td></tr><tr><td>Comparison 4.</td><td/><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF46": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td/><td/><td>Statistical method</td><td>Effect size</td></tr><tr><td>1 Live birth rate per couple (all cy-</td><td>1</td><td>Odds Ratio (M-H, Fixed, 95%</td><td>Totals not selected</td></tr><tr><td>cles)</td><td/><td>CI)</td><td/></tr><tr><td>2 Multiple pregnancy rate per cou-</td><td>1</td><td>Odds Ratio (M-H, Fixed, 95%</td><td>Totals not selected</td></tr><tr><td>ple</td><td/><td>CI)</td><td/></tr><tr><td>3 Pregnancy rate per couple (all cy-</td><td>1</td><td>Odds Ratio (M-H, Fixed, 95%</td><td>Totals not selected</td></tr><tr><td>cles)</td><td/><td>CI)</td><td/></tr><tr><td>4 Miscarriage rate per couple</td><td>1</td><td>Odds Ratio (M-H, Fixed, 95%</td><td>Totals not selected</td></tr><tr><td/><td/><td>CI)</td><td/></tr><tr><td>5 Ectopic pregnancy rate per couple</td><td>1</td><td>Odds Ratio (M-H, Random,</td><td>Totals not selected</td></tr><tr><td/><td/><td>95% CI)</td><td/></tr><tr><td colspan=\"2\">Analysis 4.1</td><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF47": {
                "text": "Copyright \u00a9 2020 The Cochrane Collaboration.Published by John Wiley & Sons, Ltd.",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health.</td><td/><td/><td/><td/><td colspan=\"4\">Cochrane Database of Systematic Reviews</td></tr><tr><td/><td>Analysis 4.2</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>Study or subgroup</td><td>IUI+NC</td><td>TI+OH</td><td/><td/><td colspan=\"2\">Odds Ratio</td><td/><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td/><td colspan=\"3\">M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td>Bhattacharya 2008</td><td>38/167</td><td>23/175</td><td/><td/><td/><td/><td/><td/><td>1.95[1.1,3.44]</td></tr><tr><td/><td/><td>Favours TI+OH</td><td>0.1</td><td>0.2</td><td>0.5</td><td>1</td><td>2</td><td>5</td><td>10</td><td>Favours IUI+NC</td></tr></table>",
                "type_str": "table"
            },
            "TABREF48": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>IUI+NC</td><td>TI+OH</td><td/><td/><td>Odds Ratio</td><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td/><td>M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td>Bhattacharya 2008</td><td>1/167</td><td>1/175</td><td/><td/><td/><td/><td>1.05[0.07,16.9]</td></tr><tr><td/><td/><td>IUI+NC better</td><td>0.01</td><td>0.1</td><td>1</td><td>10</td><td>100</td><td>TI+OH better</td></tr><tr><td/><td>Analysis 4.3.</td><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF49": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>IUI+NC</td><td>TI+OH</td><td/><td/><td colspan=\"2\">Odds Ratio</td><td/><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td/><td colspan=\"3\">M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td>Bhattacharya 2008</td><td>38/167</td><td>25/175</td><td/><td/><td/><td/><td/><td/><td>1.77[1.01,3.08]</td></tr><tr><td/><td/><td>Favours TI+OH</td><td>0.1</td><td>0.2</td><td>0.5</td><td>1</td><td>2</td><td>5</td><td>10</td><td>Favours IUI+NC</td></tr><tr><td/><td>Analysis 4.</td><td/><td/><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF50": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>IUI+NC</td><td>TI+OH</td><td/><td/><td>Odds Ratio</td><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td/><td>M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td>Bhattacharya 2008</td><td>7/167</td><td>8/175</td><td/><td/><td/><td/><td>0.91[0.32,2.58]</td></tr><tr><td/><td/><td>Favours TI+OH</td><td>0.01</td><td>0.1</td><td>1</td><td>10</td><td>100</td><td>Favours IUI+NC</td></tr><tr><td/><td>Analysis 4.5</td><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF51": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Bhattacharya 2008</td><td>2/167</td><td>0/175</td><td/><td/><td/><td/><td>5.3[0.25,111.26]</td></tr><tr><td/><td/><td>Favours TI+OH</td><td>0.001</td><td>0.1</td><td>1</td><td>10</td><td>1000</td><td>Favours IUI+NC</td></tr><tr><td>Comparison 5.</td><td/><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF52": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td colspan=\"2\">Trusted evidence. Informed decisions. Better health.</td><td/><td colspan=\"2\">Cochrane Database of Systematic Reviews</td></tr><tr><td colspan=\"2\">Outcome or subgroup title</td><td>No. of studies</td><td>No. of partici-</td><td>Statistical method</td><td>Effect size</td></tr><tr><td/><td/><td/><td>pants</td><td/></tr><tr><td colspan=\"2\">2 Multiple pregnancy rate per</td><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>Totals not selected</td></tr><tr><td>couple</td><td/><td/><td/><td/></tr><tr><td>2.1 Gonadotropins</td><td/><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>0.0 [0.0, 0.0]</td></tr><tr><td colspan=\"2\">3 Pregnancy rate per couple</td><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>Totals not selected</td></tr><tr><td>(all cycles)</td><td/><td/><td/><td/></tr><tr><td>3.1 Clomiphene Citrate</td><td/><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>0.0 [0.0, 0.0]</td></tr><tr><td colspan=\"2\">4 Miscarriage rate per couple</td><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>Totals not selected</td></tr><tr><td>4.1 Clomiphene Citrate</td><td/><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>0.0 [0.0, 0.0]</td></tr><tr><td>4.2 Gonadotropins</td><td/><td>0</td><td/><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>0.0 [0.0, 0.0]</td></tr><tr><td colspan=\"2\">5 Ectopic pregnancy rate per</td><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>Totals not selected</td></tr><tr><td>couple</td><td/><td/><td/><td/></tr><tr><td>5.1 Gonadotropins</td><td/><td>1</td><td/><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>0.0 [0.0, 0.0]</td></tr><tr><td/><td/><td>Analysis 5.1</td><td/><td/></tr><tr><td/><td/><td/><td/><td>Statistical method</td><td>Effect size</td></tr><tr><td colspan=\"2\">1 Live birth rate per couple</td><td>4</td><td>396</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>2.07 [1.22, 3.50]</td></tr><tr><td>(all cycles)</td><td/><td/><td/><td/></tr><tr><td>1.1 Clomiphene Citrate</td><td/><td>1</td><td>26</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>3.75 [0.29, 47.99]</td></tr><tr><td>1.2 Gonadotropins</td><td/><td>3</td><td>370</td><td>Odds Ratio (M-H, Fixed, 95% CI)</td><td>2.02 [1.18, 3.45]</td></tr></table>",
                "type_str": "table"
            },
            "TABREF53": {
                "text": "Copyright \u00a9 2020 The Cochrane Collaboration.Published by John Wiley & Sons, Ltd.",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health.</td><td/><td/><td/><td/><td/><td>Cochrane Database of Systematic Reviews</td></tr><tr><td/><td>Analysis 5.2.</td><td/><td/><td/><td/><td/></tr><tr><td>Study or subgroup</td><td>IUI+OH</td><td>IUI + NC</td><td/><td/><td>Odds Ratio</td><td/><td>Weight</td><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td/><td>M-H, Fixed, 95% CI</td><td/><td>M-H, Fixed, 95% CI</td></tr><tr><td>5.1.1 Clomiphene Citrate</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Arici 1994</td><td>2/10</td><td>1/16</td><td/><td/><td/><td/><td>3.11%</td><td>3.75[0.29,47.99]</td></tr><tr><td>Subtotal (95% CI)</td><td>10</td><td>16</td><td/><td/><td/><td/><td>3.11%</td><td>3.75[0.29,47.99]</td></tr><tr><td colspan=\"2\">Total events: 2 (IUI+OH), 1 (IUI + NC)</td><td/><td/><td/><td/><td/></tr><tr><td>Heterogeneity: Not applicable</td><td/><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for overall effect: Z=1.02(P=0.31)</td><td/><td/><td/><td/><td/></tr><tr><td>5.1.2 Gonadotropins</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Goverde 2000</td><td>22/61</td><td>14/59</td><td/><td/><td/><td/><td>45.92%</td><td>1.81[0.82,4.02]</td></tr><tr><td>Guzick 1999</td><td>25/111</td><td>10/100</td><td/><td/><td/><td/><td>41.14%</td><td>2.62[1.19,5.77]</td></tr><tr><td>Murdoch 1991</td><td>1/20</td><td>2/19</td><td/><td/><td/><td/><td>9.83%</td><td>0.45[0.04,5.39]</td></tr><tr><td>Subtotal (95% CI)</td><td>192</td><td>178</td><td/><td/><td/><td/><td>96.89%</td><td>2.02[1.18,3.45]</td></tr><tr><td colspan=\"2\">Total events: 48 (IUI+OH), 26 (IUI + NC)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Heterogeneity: Tau =0; Chi =1.89, df=2(P=0.39); I =0%</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for overall effect: Z=2.55(P=0.01)</td><td/><td/><td/><td/><td/></tr><tr><td>Total (95% CI)</td><td>202</td><td>194</td><td/><td/><td/><td/><td>100%</td><td>2.07[1.22,3.5]</td></tr><tr><td colspan=\"2\">Total events: 50 (IUI+OH), 27 (IUI + NC)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Heterogeneity: Tau =0; Chi =2.11, df=3(P=0.55); I =0%</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for overall effect: Z=2.71(P=0.01)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"2\">Test for subgroup differences: Chi =0.22, df=1 (P=0.64), I =0%</td><td/><td/><td/><td/><td/></tr><tr><td/><td colspan=\"2\">Favours IUI +NC</td><td>0.01</td><td>0.1</td><td>1</td><td>10</td><td>100</td><td>Favours IUI+OH</td></tr></table>",
                "type_str": "table"
            },
            "TABREF54": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>IUI + OH</td><td>IUI + NC</td><td/><td/><td>Odds Ratio</td><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td colspan=\"3\">M-H, Fixed, 95% CI</td><td>M-H, Fixed, 95% CI</td></tr><tr><td>5.2.1 Gonadotropins</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Murdoch 1991</td><td>1/20</td><td>0/19</td><td/><td/><td/><td/><td>3[0.11,78.27]</td></tr><tr><td/><td/><td>Favours IUI+NC</td><td>0.005</td><td>0.1</td><td>1</td><td>10</td><td>200</td><td>Favours IUI+OH</td></tr><tr><td/><td>Analysis 5.3.</td><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF55": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>IUI + OH</td><td>IUI + NC</td><td/><td/><td>Odds Ratio</td><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td colspan=\"3\">M-H, Fixed, 95% CI</td><td>M-H, Fixed, 95% CI</td></tr><tr><td>5.3.1 Clomiphene Citrate</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Arici 1994</td><td>3/10</td><td>1/16</td><td/><td/><td/><td/><td>6.43[0.56,73.35]</td></tr><tr><td/><td/><td>Favours IUI + NC</td><td>0.01</td><td>0.1</td><td>1</td><td>10</td><td>100</td><td>Favours IUI + OH</td></tr><tr><td/><td>Analysis 5.4</td><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF56": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>IUI+OH</td><td>IUI+NC</td><td/><td/><td>Odds Ratio</td><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td colspan=\"3\">M-H, Fixed, 95% CI</td><td>M-H, Fixed, 95% CI</td></tr><tr><td>5.4.1 Clomiphene Citrate</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Arici 1994</td><td>1/10</td><td>0/16</td><td/><td/><td/><td/><td>5.21[0.19,141.08]</td></tr><tr><td>5.4.2 Gonadotropins</td><td/><td/><td/><td/><td/><td/></tr><tr><td/><td/><td>Favours IUI+NC</td><td>0.001</td><td>0.1</td><td>1</td><td>10</td><td>1000</td><td>Favours IUI+OH</td></tr><tr><td/><td>Analysis 5.</td><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF57": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td>Study or subgroup</td><td>IUI+OH</td><td>IUI+NC</td><td/><td/><td>Odds Ratio</td><td/><td>Odds Ratio</td></tr><tr><td/><td>n/N</td><td>n/N</td><td/><td colspan=\"3\">M-H, Fixed, 95% CI</td><td>M-H, Fixed, 95% CI</td></tr><tr><td>5.5.1 Gonadotropins</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Guzick 1999</td><td>3/111</td><td>0/100</td><td/><td/><td/><td/><td>6.48[0.33,127.09]</td></tr><tr><td/><td/><td>Favours IUI+NC</td><td>0.001</td><td>0.1</td><td>1</td><td>10</td><td>1000</td><td>Favours IUI+OH</td></tr><tr><td>A P P E N D I C E S</td><td/><td/><td/><td/><td/><td/></tr><tr><td>Appendix 1.</td><td/><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            },
            "TABREF58": {
                "text": "",
                "html": null,
                "num": null,
                "content": "<table><tr><td colspan=\"2\">Cochrane Library Cochrane Library Cochrane Library</td><td>Trusted evidence. Informed decisions. Better health. Trusted evidence. Informed decisions. Better health. Trusted evidence. Informed decisions. Better health.</td><td/><td/><td colspan=\"3\">Cochrane Database of Systematic Reviews Cochrane Database of Systematic Reviews Cochrane Database of Systematic Reviews</td></tr><tr><td colspan=\"4\">(raloxifene or tamoxifen).tw. (35757) Appendix 7. Prognostic factors in included studies (Continued)</td><td/><td/><td/></tr><tr><td colspan=\"4\">or/23-33 (83442) Guzick 1999 IUI+NC: 32 (\u00b1 4) exp aromatase inhibitor/ (30464) IUI+OH: 32 (\u00b1 4) Aromatase inhibitor*.tw. (11332) letrozole.tw. (5079) Study ID Age distribution &lt; 40 yrs (femara or anastrozole).tw. (3927) (anti-?estrogen* or anti?estrogen*).tw. (10783) IUI+NC: 3.8 (\u00b1 2.6) IUI+OH: 3.5 (\u00b1 2.2) Subfertility years Murdoch IUI+NC: 30.5 (\u00b1 3.1) IUI IUI+NC: 5.7 (\u00b1 2.4) 1991 +OH: 30.1 (\u00b1 2.9) IUI+OH: 5.1 (\u00b1 1.9) or/35-39 (41113) exp follitropin/ (51623) exp human menopausal gonadotropin/ (8961) 1. IUI versus timed intercourse both in 1 study natural cycle exp urofollitropin/ (1693) Follicle Stimulating Hormone*.tw. (19800) Bhat-TI+NC: 32 (\u00b1 3.4) IUI+NC: TI+NC: 30 (25 -38) (FSH or rFSH or recFSH).tw. (42009) (uFSH or rhFSH).tw. (361) (hpFSH or pFSH).tw. (225) (follitropin or Gonal F).tw. (3170) tacharya 2008 32 (\u00b1 3.7) (TI is expectant manage-ment) IUI+NC:30 (25 -40) 4. IUI with OH versus TI in natural cycle 3 studies months (Inter quartile range) Deaton 33 (\u00b1 4.0) 3.5 (\u00b1 1.7)</td><td>Mixed 40% sec-Prim/sec in-ondary fertility Mixed 5/34 (15%) secondary Mixed 117/386 (30%) Secondary Mixed</td><td>No Previous treatment No Not stated Not stated</td><td>FSH 150 IU Stimulation Method hMG (low dose) 75 IU + GnRHa No stimula-tion CC 50 mg</td><td>Single Single in-semina-IUI+OH: tion Single IUI+NC: til USS ev-idence of ovulation Single Single</td></tr><tr><td colspan=\"3\">(menotropin* or menopur).tw. (852) 1990</td><td/><td>21/51 (41%)</td><td/><td/></tr><tr><td colspan=\"3\">corifollitropin.tw. (226) 2. IUI versus timed intercourse both in</td><td>7 studies</td><td>secondary</td><td/><td/></tr><tr><td colspan=\"4\">(urofollitropin or pergonal or bravelle* or follitrin).tw. (2064) stimulated cycle</td><td/><td/><td/></tr><tr><td colspan=\"3\">Follistim*.tw. (282) Farquhar IUI+OH: 34.4 (\u00b1 3.5)</td><td>Months (range)</td><td>Mixed</td><td>33/201</td><td>CC; 50 -150</td><td>Single</td></tr><tr><td colspan=\"4\">(Puregon or humegon or menogon).tw. (2191) human menopausal gonadotrop?in.tw. (1942) growth hormone.tw. (57637) HMG.tw. (18196) gonadotrop?in*.tw. (64234) Agarwal 2004 IUI+OH: 29.52 (\u00b1 3.65) TI +OH: 28,83 (\u00b1 4,76) IUI+OH: 4.91(\u00b1 2.72) TI+OH: 4.93 (\u00b1 3.27) Arcaini IUI+OH: 34.6 (\u00b1 4.9) IUI+OH: 4.2 (\u00b1 1.6) 2018 TI+NC: 33.6 (\u00b1 3.7) (TI is expectant manage-ment) IUI+OH:41.0 (31.0 -60\u20220) TI+NC: 46.0 (27.8-60\u20220) or/41-57 (184628) 22 or 34 or 40 or 58 (306922) 12 and 59 (3139) 1996 TI+OH: 33.4 (\u00b1 4.7) TI+OH: 3.9 (\u00b1 2.3) Steures IUI+OH: 33 (\u00b1 3.5) IUI+OH: 2.0 (\u00b1 0.5) 2006 TI+NC: 33 (\u00b1 3.1) TI+NC: 1.9 (\u00b1 0.5) (TI is expectant manage-Clinical Trial/ (954250) Randomized Controlled Trial/ (572677) Chung 1995 IUI+OH: 31.8 (\u00b1 3.1) IUI+OH: 4.7 (\u00b1 2.0) ment) exp randomization/ (84808) Single Blind Procedure/ (36997) Double Blind Procedure/ (164394) TI+OH: 32.1 (\u00b1 4.0) TI+OH: 5.3 (\u00b1 2.6) 5. IUI in natural cycle versus TI with OH 1 study</td><td>Mixed 32/113 (28%) secondary Mixed 176/201 (87.6%) sec-ondary 7/68 (10%) secondary Mixed 58/253 (23%) secondary Not clear</td><td>No Not stated (16.4%) Not stated Not stated</td><td colspan=\"2\">CC 50 -150 mg Single High dose: mg, or letro-zole; 2.5 -7.5 mg Double CC100mg and FSH 37 -150 Not stated hMG 75 -225 IU or CC 50 -IU 150 mg hMG 150 IU IUI: Single starting dose and GnRHa TI: Double</td></tr><tr><td colspan=\"3\">Crossover Procedure/ (61141) Placebo/ (330524) Randomi?ed controlled trial$.tw. (213916) Crosignani 2008 1991 &lt; 38 yrs tacharya 32 (\u00b1 3.7) Bhat-TI+OH: 32 (\u00b1 3.5) IUI+NC:</td><td>months (Inter quartile &gt; 3 yrs IUI+NC: 30 (25 -40) TI+OH: 30 (24 -38)</td><td>(28%) Not clear 109/387 Mixed</td><td>Probably Not stated</td><td>Not stated CC 25 -50 mg</td><td>Not stated Single</td></tr><tr><td colspan=\"3\">Rct.tw. (34381) Janko 1998 Not stated random allocation.tw. (1919) randomly.tw. (420773) * Mean age in years (\u00b1 SD) randomly allocated.tw. (33522) Karlstrom 32 (range 21 -38) or range allocated randomly.tw. (2487) 1993 (allocated adj2 random).tw. (810) Single blind$.tw. (23587) Double blind$.tw. (197107) ((treble or triple) adj blind$).tw. (1025) W H A T ' S N E W</td><td>&gt; 3 yrs range) * Mean duration in 5 (range 2 -14) years (\u00b1 SD) or range</td><td>Not clear Mixed 49/148 (33%) secondary (in-cl Pt in DIPI groups)</td><td>Not stated No</td><td>hMG (10 amp per cycle) * Daily dose hMG (low-dose step-up) 75 IU starting dose OR CC 100 mg</td><td>Not stated IUI: Single TI: Double</td></tr><tr><td colspan=\"3\">placebo$.tw. (293366) Melis 1995 33.1 (\u00b1 5.2) prospective study/ (557816) or/61-79 (2331046) Date Event</td><td>4.3 (\u00b1 1.4)</td><td>Not clear Description</td><td>Yes, all par-ticipants</td><td>High dose: FSH 225 IU</td><td>Single</td></tr><tr><td colspan=\"2\">case study/ (65015)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"4\">case report.tw. (385105) 3. IUI in natural cycle versus IUI in stimu-17 October 2019 New citation required but conclusions 4 studies</td><td colspan=\"3\">The conclusions of the review have not changed.</td></tr><tr><td colspan=\"3\">abstract report/ or letter/ (1076178) lated cycle have not changed</td><td/><td/><td/><td/></tr><tr><td colspan=\"2\">or/81-83 (1516287)</td><td/><td/><td/><td/><td/></tr><tr><td colspan=\"4\">80 not 84 (2278531) Arici 1994 33 (range 24 -41) 17 October 2019 New search has been performed 3.5 (range 1 -15)</td><td colspan=\"4\">Not clear Update of review and literature search; 1 new study added (Far-No CC 50 mg IUI+NC:</td></tr><tr><td colspan=\"7\">(exp animal/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or humans).ti.) (5836378) quhar 2018)</td><td>Double</td></tr><tr><td colspan=\"2\">85 not 86 (2120418)</td><td/><td/><td/><td/><td/><td>IUI+OH:</td></tr><tr><td colspan=\"2\">60 and 87 (920)</td><td/><td/><td/><td/><td/><td>Single</td></tr><tr><td>Goverde</td><td colspan=\"2\">IUI+NC: 31.6 (\u00b1 3.7)</td><td>IUI+NC: 3.9 (\u00b1 1.7)</td><td>Mixed</td><td>Not stated</td><td>hMG 75 IU</td><td>Single</td></tr><tr><td colspan=\"3\">PROCITE platform 2000 IUI+OH: 31.7 (\u00b1 3.9)</td><td>IUI+OH: 4.2 (\u00b1 1.9)</td><td>ondary 13.5% sec-</td><td/><td>starting dose</td></tr><tr><td colspan=\"2\">Searched 17 October 2019</td><td/><td/><td/><td/><td/></tr></table>",
                "type_str": "table"
            }
        }
    }
}